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This annual report Covers the research activities of the Institute of Bioinorganic 
and Radiopharmaceutical Chemistry of the Research Center Rossendorf Inc. 
(FZR) in 1994. Significant progress has been made since the start of the Institute in 
1992. The year 1994 is best described as a year of further consolidation. 
The subjects of our work in 1994 are presented in this volume in 37 reports dealing 
with various aspects of radiotracers. 
Our main objectives are derived from an awareness of the very important role 
modern nuclear medicine is playing, as expressed explicitiy in the synonym in viv0 
biochemistry, Radiopharmaceuticals are the molecular probes used for the diagnosis 
and eure of disease. For full exploitation of its potential, this discipline of in vivo 
biochemistry requires great commitment to interdisciplinary research into tracers. 
The emphasis is on fundamentals on the molecular level, leading to new approaches 
in tracer design : the tracer chemistry and structure-biodistribution relationships. 
The goals imply exploiting technetium coordination chemistry. New classes of 
complexes of technetium or rhenium, the convenient model nuclide for radioactive 
technetium, have been synthesized and characterized. Technetium has an intricate 
coordination chemistry that does not go weil with the organic nature of biochemical 
substrates. One of the main achievements of the year was the successful approach 
to make complexes of technetium biochemically reactive by functionalization of a 
coordinate ligand. Functionalization is focused on two areas. The first is specific 
binding, as in ligand-receptor interactions. The second is enzymatic hydrolysis in the 
target or a nontarget. The studies also constitute a contribution to applied bio- 
inorganic chemistry. 
A second Part of this report describes the progress in our synthetic m r k  on I1c- 
tracers and precursors. These studies follows the concept of labelling substances in 
metabolically stable positions. During the year further peparatory w r k  has been 
done to start PET studies in patients. The preparation of PET radiopharmaceuticals 
presents unique issues for the legal and regulatory communities. To assure that the 
in-house prepared radiopharmaceuticals meet the standards of safety and dicacy 
according to Good Manufacturing Practice, a comprehensive System of in-house 
standards as weil as documentation covering the entire process of preparation and 
quality assurance has been established. 
The biological and biochemical section of this report informs on the Progress 
attained in 1994 in methodological work on an in vitro model of the blood-brain 
barrier and the in vivo microdialysis technique. Transport through the blood-brain 
barrier and uptake of tracers in normal and tumour cells have been studied. Different 
in vitro binding assays have successfully been used to i den t i  and quantify binding 
of various new ligands to brain receptors. 
The research activities of our lnstitute have been performed in the following three 
organisational units: 
The SPECT Tracer Group (Head: H. Spies) deals with the design, synthesis 
and chemical characierization of metal coordination compounds, primarily 
technetium complexes. 
The PET Tracer Group (Head: J. Steinbach ) is engaged in the cbemistry and 
radiopharmacy of "C and "F labelled compounds, and in the setup of the 
Rossendorf PET Center, which is jointly run by the Institute and the Ciinic and 
Polyclinic of Nuclear Medicine of the University Hospital. 
The Biochemical Group (Head: P. Brust) is working on SPECT and PET 
relevant biochemical and biological projects. This includes the characteriza- 
tion and assessment of new compounds developed in the two synthetically 
oriented groups mentioned above. 
The achievements attained so far have only been possible because of the dedication 
and commitment of ttie permanent and temporary staff, the Ph.D. students and 
coilaborators inside and outside the Rossendori Research Center. I would like to 
express my thanks to all of them. 
Bernd Johannsen 
II. 
RESEARCH REPORTS 
1. TECHNETIUM AND RHENIUM COMPLEXES WlTH THIOETHER 
LIGANDS 
6.OXORHENIUM(V) COMPLEXES DERIVED FROM THE 
POTENTIALLY TETRADENTATE LIGAND 1,8-DIHYDROXY-3,6- 
DITHIAOCTANE 
H.-J. Pieizsch, H. Spies, P. Leibnitr', G. Reck' 
1 Bundesanstalt für Materialforschung Berlin 
Recently W found that ligand exchange reaction of the potentially tetradentate li- 
gand 1.8-dihydroxy-3,6-dithiaoctane ("$(OH)z0*) with [ReOCIJ leads to the formation 
of a violet microcrystalline complex of the general formulation [ReO("S20(OH)")ClJ 
(1) [<I. 
Now the proposed structure is confirmed by X-ray diiraction. The molecular struc- 
ture is shown in Fig. 1. Selected bond distances and angles are contained in 
Table 1. 
By analogy with the appropriate technetium complex [2] the rhenium compound 
consists of discrete monomolecular units containing the [O=R~-O-]'' core. 
While in the binuclear oxorhenium0l) derived from neutral dithiaalkanes (31 the posi- 
tion tmns to the [Re=OIs core is occupied by a bridging oxygen, the trans position in 
(1) is occupied by an oxygen of one of the terminal hydroxy groups. The sewnd hy- 
droxy group remains non-coordinated. 
The infrared spectrum shows the characteristic Stretching vibration indicating the 
Re=o3* core at 940 cm". 
Due to the presence of diverse leaving groups in the coordination sphere of (I), 
namely the only weakly bonded chelate, the two chloro ligands and the non- 
coordinated hydroxy group, manifold subsequent reactions can be anticipated. 
First attempts to functionalize the Yree" hydroxy group are described in the following. 
Fig. 1: Structure of [Re0{8-hydro>o/-3,6-dithiaoctan-l-olato-(O,S,S))CI~ (I) 
Table 1: Selected bond distances (A) and angles (deg) of [ReO{8-hydroxy-3,6- 
dithiaoctan-1 -olato-(O,S,S))CId (1) 
J 
Re-S(2) 
Re-O(1) 
Re-O(2) 
Cl(2)-Re-0(2) 
S(1)-Re-S(2) 
S(1)-Re-O(1) 
S(1)-Re-O(2) 
S(2)-Re-O(1) 
S(2)-Re-O(2) 
O(1)-Re-O(2) 
2.43716) 
2.388(6) 
2.428(6) 
90.2(2) 
174.4(2) 
SO. l(2) 
90.5(5) 
94.2(7) 
94.1(2) 
168.5(3) 
89.9(5) 
2.439(7) 
1.92(2) 
1 .71(2) 
104.5(7) 
84.9(2) 
86.1(5) 
88.0(7) 
78.6(5) 
86.9(7) 
164.8(8) 
Experiments fo fhe derivafizafion of fhe ,,free" hydroxy gmup by esferificafion 
W e n  an acetonic solution of (1) reacts with acetyl chloride (or acetic anhydride) at 
ambient temperature the colour of the reaction mixture changes from violet to tur- 
quoise. The product crystallizes as dark green crystals by slow evaporation of the 
reaction mixture (Fig. 2). 
X-ray structure analysis shows that esterification with acetyl chloride (or acetic an- 
hydride) surprisingly leads to the cleavage of the Tc-0,- bond and subsequent for- 
mation of the ~ O X O  bridged compound (2) containing four ester groups (reaction way 
B). The Same product is obtained by ligand exchange reaction starting frorn 
[ReOCIJ in acetonelacetyl chloride (reaction way A). 
Fig. 2: Formation of the binuclear cornplex (2) while esterification of the mononuclear 
compound ( I )  with acetyl chloride 
I Complex (2) shows an intense and characteristic Stretching vibration band beiween 
650 and 700 cm-' indicating the Re-0-Re rnoiety, as reported previously for sirnilar 
&%0314" species (M = Tc, Re) 13.41. Absorptions beiween 900 and 1000 cm-' which 
can be assigned to the ~ e = 0 ~ '  core are not obsewed. The bands indicating the es- 
ter groups are found at 1744 crn*'. 
The rnoiecuiar structure of the binuclear compound (2) is Show in Fig. 3. Selected 
bond distances and angles are listed in Table 2. 
(2) consists of hnro independent [ReO(CH3C(0)O-&HZ)&-(CHz)TS-(CHz)TO(O)- 
CCH3}CM units bridged by an oxygen atom. The characteristic feature is the pres- 
ence of the O=Re-0-Re=O backbone which shows a considerable deviation from 
linearity. 
In this respect the stnrcture is comparable to those found for the technetium complex 
pkO(.S~)Ct2]Z0 (((s = 5,s-dithiadodecane) 121 as well as for ihe corresponding 
rhenium complexes [ReO(Bu-S-CHzCHz-S-Bu)Clz] 151, [ReO(pyr)~Clz]~O (pyr = pyri- 
dine) 161 and IReO(1 -Meim)zCl&O (I-Meim = 1-methylimidazole) F]. 
Fig. 3: CELLGRAF [B] drawing of 
W-0x0-bis[(l .B-diacetoxy-3,6-dithiaoctane)dichlorooxoenium] (2) 
As illustrated in Fig. 3 the rhenium atoms are centred in an octahedron with the 
equatorial plane formed by an donor sei. 
The molecule adopts a staggered conformation in which the ReS2C12 planes are 
mutually rotated by approximately 170 " about the O=Re-0-Re=O axis. 
Table 2: Selected bond distances (A) and angles (deg) of p-0x0-bis[(l.8-diacetoxy- 
References 
[I] Pietzsch, H.J. et al., Annual report 1993, p. 82, Institute of Bioinorganic and 
Radiopharmaceuticai Chemistry, FZR-32 
121 Pietzsch, H.J. et al., Polyhedron 12 (1993) 187 
Tisato, F. et al., Inorg. Chim. Acta 164 (1989) 127 
Tisato, F. et al., J. Chem. Soc. Dalton Trans. (1991) 1301 
Pietzsch, H.-J. et al., Polyhedron, in press 
Lock, C. et al., Can. J. Chem. 56 (1978) 179 
Pearson, C. et al., Acta Crystallogr. Sect.C 50 (1994) 42 
Reck, G. et al., CELLGRAF- a Programme for representation of organic and 
inorganic crystal structures, Analytical Centre, Berlin (1989/1991) 
UNUSUAL FORMATlON OF A MONOCARBONYL RHENIUM(II1) 
COMPLEX. MOLECULAR STRUCTURE OF [Re{N(CH2CH2S),}(CO)] 
M. Glaser, H. Spies, F. E.   ahn', T. ~ügger', K. ~lostermann~ 
1 Institut für Anorganische und Analytische Chemie, Freie Universität Berlin 
2 Institut für Analytische Chemie, TU Dresden 
Introduction 
Up to now only a few technetium complexes containing a tripodal ligand with sulphur 
donors have been described 11-31 and characterized by X-ray analysis 1431. Re- 
cently we reported synthesis and stnictural characterization of some trigonal 
bipyramidai technetium and rhenium complexes obtained using tris(2-mercapto- 
ethyl)amine 161. In the context of our efforts to use the terminal ester group in 
[R~(NCH&HZS)~(CNCH~CO~R)] (  = Me, Et) for binding the rhenium chelate to bio- 
molecules we found that mild alkaline hydrolysis leads to the formation of the car- 
boxylic acid [Re(NCHzCHzS)s(CNCH,C4H)] 2 but treatment with acidic Solution re- 
sults in the unexpected carbonyl complex [R~(NCHZCH~S)~(CO)] 3. We describe 
here the synthesis and charaderuation of both compounds. 
Experimental 
Preparafions: 
[Re(NSd(CNR)] 1: The required isocyanide complexes were prepared accord- 
ing to procedures described earlier [$J. 
[Re(NS3)(CNCH&O2H)]2: The ester complex& (50 mg, 101 pmol) was dissoived in 
THF (5 cm3) and a solution of LiOH X H20 (7 mg, 167 pmol in 0.5 cm3 water) was 
added. After stining for 1 h at room temperature the THF was evaporated by a nitro- 
gen stream. The remaining aqueous phase diluted with water (1 cm3) was sus- 
pended with cation-exchange resin (10 cm3, D O M  50 WX8, 100 - 200 pm). After 
2 h the acid complex 2 was extracted with MeCN (4 X 2 cm3). Removal of the solvent 
and recrystallization (MeCNIH20 = 1011) produced olive green needles. 
Yield: 27.4 mg, (58 %), m.p. 197 - 205 "C (decomp.) 
Elemental analysis: (Found C, 23.33; H, 3.38; N, 5.96; S, 20.18, C S H ~ ~ N ~ S ~ O ~ R ~  
requires C, 23.22; H, 3.25: N, 6.02; S, 20.66 %) 
IR absorptions: v,Jcm-' 1924vs (CN), 1720 (CO) (KBr) 
UVMS absorptions: &lnm (MeCN) (ddm3 morl cm-') 438 (1 IOOO), 313 (5000). 
354 (1000) and 438 (1400) 
NMR data: 614 (90 MHz; solvent CDCL; standard SiMe,) 11.81 (1 H, br m, C02H), 
5.37 (2H, s, CH2NC) and 2.88 (12H, m, 3 SCH2CH2). 
[Re(NS3)(CO)] 3: (a): To a solution of the complex (50 mg, 101 pmol) in CH2CI2 
(I cm3), toluene (10 crn3) and concentrated hydrochloric acid (1 cm3, 37 %) were ad- 
ded. The mixture was stirred and refluxed for 1 h under nitrogen. The organic layer 
was separated, washed with water (3 X 5 cm3) and dried over Na2S04 and the sol- 
vent evaporated in vacuo. Recrystallization of the residue from CH2Cl2IEtOH pro- 
duces rhomboedric red-orange coloured crystals suitable for X-ray structural analy- 
sis. 
Yield: 26.4 mg (64 %), m.p. 235 - 237 "C (decomp.) 
Elemental analysis: (Found C, 20.56; H, 2.70; N, 3.24; S, 24.31; C7H3~NS30Re 
requires C, 20.59; H, 2.94; N, 3.43: S, 23.54 %) 
FAB-MS: M* 409. 
IR absorptions: v ~ c m * '  (KBr) 1876 (CO) 
UVNIS absorptions: h,.Jnm (CH2C12) 257 (ddm3 mol' c ~ ' )  498 (22900), 
321 (1500). 367 (IIOO), 398 (1300) and 498 (200) 
NMR data: &(90 MHz; solvent CDC13; standard SiMe,) 3.22 (m, SCHZCHZ). 
(bJ: T0 a soiutiDn of the complex & (I0 mg. 19 pmol) in GH2C12 (1 cm?, toluene 
(5 cm3) and concentraied hydrochloric acid (1 cm3, 37 %) w r e  added. The reactton 
continued as described in (a) and the isolation of the complex 3 was carried out in 
the Same manner as above (4.6 mg, 60 %). The identity with the former product was 
confirmed by its i& (TLC), m.p. and IR spectrum. 
Readion of with hydrochloric acid: Under reaction conditions used for the 
preparation of 3 described above after 3 hours of refluxing the carbonyl complex was 
formed only in small tralces according to TLC (acetoneICHCb = 116, Rf = 0.4) and the 
starting complexes were unchanged. 
Results and discussion 
Preparation of the isocyanide complexes: Trigonal bipyramidal rhenium(ll1) com- 
plexes [Re(NS3)(CNR)] I are prepared by substitution reaction using the correspond- 
ing phosphane complex [Re(NS3)PPhMed [6,71. 
Reactions of fhe CO-ordinafed isocyanides: The ester group in & is saponified under 
mild conditions. Treatment with LiOH in THF formes the lithium salt, which is con- 
verted to the acid complex 2 without isolation or purification by means of a cation- 
exchange resin. The olive green compound 2 shows a similar UVNlS spectrum as 
the original ester compound, suggesting no significant modification in the coordi- 
nation sphere. 
Saponification carried out in the two-phase System toluenelconcentrated hydrochlo- 
ric acid under a nitrogen atmosphere takes a diierent Course. Aiter refluxing under 
nitrogen for 1 hour the water phase turns an orange colour during bleaching of the 
organic phase. On continuation of the reaction, an orange lipophilic compound is 
formed as indicated by the increasing colouring of the organic layer. Working up re- 
sults in a crystalline complex which reveals a strong IR absorption at 1876 cm-', 
suggesting a coordinated carbonyl group. Both streams we applied are given in 
Scheme I. 
The composition and shcture of complex 3 are confirmed by the FAB mass spec- 
trum and X-ray structural analysis [see also Fig. I]. Trigonal bipyramidal rhenium 
wmplexes owing to an analogous Pattern of coordination but without chelating li- 
gand are described [11,12]. 
The formation of3 has also been observed with the 0x0-free complexes m. While 
the N-2-ethyl-morpholinyl isocyanide complex delivers 3 in significant yieids, this 
reaction also takes place with the 0x0-free t-butyl, phenyl or cyclohexyl isocyanide 
derivatives Ice but in less amouri2s. 
Scheme 1: Formation of the acid complex2 and the carbonyl complex3 starting 
from {Re[N(CH2CH2S)3]CNR) I 
1 R - I a-e 
a -CH*COOEt 
It is diicult to reconcile these results with a mechanism which involves rearrange- 
ment at the ester carbonyl group. A possible explanation is a reaction sequence in- 
cluding hydrolysis of the isocyanide group. 
Protonation of isocyanide nitrogen (a) leads to the orange coloured species mich is 
observed in the water phase. This phenomenon also corroborates a general Change 
at the rhenium chromophore. The isocyanide carbon atom is attacked by a water 
molecule @) leading to a dipolar tautomeric structure and subsequent elimination of 
the amine produces 3 (C). Comparable pathways shown for a technetium c~mplex [8] 
and a platinum CO-ordinated isocyanide [SI both leading to carbonyl complexes en- 
Courage us to propose a possible explanation of formation (Scheme 2). 
Fig. 1: FA6 mass spectrum and ORTEP-drawing of 3 
We suppose that low yields of product 3 from Ice may be due both to steric con- 
straints at the isocyanides and to the lack of a heteroatom, which causes an induc- 
tive electron-withdrawing effect. The intactness of the tripodal chelate unit [Re(NS,)] 
under applied conditions can be considered evidence of the high stability of this co- 
ordination type. 
Scheme 2: Proposed mechanism for the formation of the carbonyl complex 
[Re(NW(CO)I 2. 
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3. A NEW 0x0 RHENIUM COMPLEX WTH 
BIS(2-THIOLAT0ETHYL)AMlNE AND BENZENETHIOLATE 
M. Glaser, H. Spies, F. E.   ahn,' T. ~ü~ge r , '  K. Klostermann? D. Scheller 
'lnstitut für Anorganische und Analytische Chemie, Freie Universität Berlin 
*lnstitut für Analytische Chemie, TU Dresden 
lnboduction 
Our earlier work on complex formation of rhenium with the tripodal chelating sulphur 
ligand tris(2-mercaptoethyl)amine "N(SH)j reveals the occurrence of five- 
coordinated Re(lll) complexes. Until now, only a few Papers dealing with Tc0 [ I41 
or Re0 cornplexes 151 with such a type of ligand are known. Other representatives of 
oxo-complexes containing a tripodal ligand are known with hydrotris-pyrazolylborate 
derivatives 16-13] or the remarkable 'Kläui-ligand" [14,15]. 
Surprisingly, we were able to isolate an oxo-rheniumo complex in mich the meta1 
is coordinated by the tridentate ligand HSCH~CHZNHCHZCH~SH and benzenethiol. 
Experimental 
Preparation of {[bis(2-fhiolaf~thyI)amine][benzenefhioa]oxorheniu(V) & 
A stirred soiution of 70 mg (69 pmol) pzNEtJIReO(SPh)4] [I61 and 29 p1 (206 pmol) 
N(SH)J in 5 ml acetonitrile is refluxed under nitrogen for 3.5 hours. After removal of 
the solvent using a vacuum evaporator the crude product is dissolved in CHCh and 
put on a silica gel column (Merck Kieselgel 60, 40 - 61 Fm, column 15 X 250 mm). 
Some coloured by-products and the released benzenethiol are eluated with pure 
CHC13 followed by a mixture of CHCI3/acetone = 121 to obtain 23.8 mg of an olive 
green compound. Further purification is canied out by semipreparative HPLC (RP 
18, linear gradientfrom 0 - 100 % of eluent acetonitrilelwater = 70130 about 15 min). 
Recrystallization by covering up a concentrated solution in CH2C12 with a layer of 
cyclohexane at room temperature proved to be an alternative possibility for last puri- 
fication. Crystals obtained here are used for X-ray analysis. 
TLC: (CHCI$acetone = 6:l) Rf = 0.23 
Yield: 5.4 mg (1 8 %); green microcrystals; m. p. 230 - 235 "C (decomp.) 
Elemental analysis: (Found C, 27.01; H, 3.11; N, 3.31; S, 21.44; C„H„NS,ORe 
requires C, 26.89; H, 3.16; N, 3.14; S, 21.54 %) 
FAB-MS: M*: 446 
IR absorptions: vmlcm4 (KBr) 3128 (NH), 932 (ReO) 
UVNlS absorptions: L,-/nm (CHzCh) 235.4 (9600), 258.5 sh (7200), 288.0 sh 
(4900), 368.6 (3800), 393.9 (3700), 583 (140) 
'H NMR data: 6,(90 MHz; solvent CDCh; Standard SiMe,) 3.09 - 3.38 (8H, m, 
SCH2CH2N), 7.34 (5H, m, CH-Ar), 9.21 (IH, m, NH) 
Results and discussion 
A FAB experiment and the X-ray structural analysis (see Fig. 1) provided evidences 
for the formation of 2 instead of3. 
Fig. 1: ORTEP drawing of 2. Selected bond distances (A) are: Re-SI: 2.304(5), 
Re-S2: 2.263(6), Re-S3: 2.266(8), Re-0: 1.668(14) and Re-N: 2.166(14). 
The existente of a proton bonded to the nitrogen atom of the amine is unambigu- 
ously found in the IR and NMR spectra. Thus we synthesized a new representatie 
of the rare rhenium 0x0-complexes containing the "NS2" podant. This unexpecteci 
result may be interpreted in a different manner. First, structural anaiysis of the trigo- 
nal bipyramidal arrangement of a rheniumw 0x0 core has not been described hith- 
erb. So it seems ihat the system obviously prefers a Square-pyramidal coordination. 
This fact may explain the cleavage of the N-C bond during ihe readion. This as- 
sumption was supported by a similar CN-cleavage of tertiary amines at a Lewis acid- 
like transition meta! centre [17]. It is more likely, however, that the ligand cetiiied as 
being N(SH)3 may contain considerable arnount of HN(SH)z, from which 2 is formed 
in a typical '[3+1] reactionn [IS]. This is evidenced by the fact that a GC-MS scrutiny 
of the ligand showed a peak due to an impurify of bis(2-mercaptoethy1)amine of 
11 %. 
We therefore have to elaborate a procedure for preparing 2 starting from a corre- 
sponding pure tris- or bisthiol. 
Scheme 1: Formation of [ReO(NS2)SPh] 
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4. PREPARATION OF ETHYL-12-ISOCYANLAURATE AND ITS 
COMPLEXATION WlTH RHENIUM 
M. Glaser, H. Spies, D. scheller', B. Johannsen 
'TU Dresden, Institut für Analytische Chemie 
lntroduction 
All attempts to substitute "C or '"I labelled fatty acids, [I, 21 for myocardium imaging 
by technetium complexes have failed so far [3]. Having at hand a new chelate group, 
in Mich the meta1 is more strongly shielded than in the polar square-pyramidal 0x0 
complexes [4] we intended to evaluate its suitabiiity as fatty acid tracers. Therefore 
we prepared a new o-isocyanide subsiituted iaurinic acid ester for coupling to a lipo- 
philic Re(NS3) [N(SH)3.= tris(2-mercaptoethyl)amine] moiety. Preparation of the 
complex (Re(NS3)[CN(CH2)~~ COOH]] 6 is described. 
Experimental 
12-amnolaunnic acid- It was supplied by Merck 
Preparation of efhyl-12-aminolaurate A stirred Suspension of 10 g (46.4 mmof) 
12-aminolaurinic acid in 100 ml ethanol is passed by dry HCI for 30 minutes. After 
completion of the dissolution the mixture is refluxed for 5 to 6 hours. After removing 
the soivent and addition of 100 ml of a saturated potassium carbonate Solution the 
product is carefully heated to drive out the carbon dioxide. The crude product is per- 
colated and dried on a tile. 
Yield: 6 g (53 %), m. p. 63 - 70 "C, 
Elemental analysis: (Found C, 65.32; H, 12.54; N, 5.21 ;C14H29NOZ~ C2H50H 
requires C, 66.39; H, 12.19; N, 4.84 %) 
IR absorptions: vm, I C ~ '  (Kbr) 3400 - 3300 (NH2) and 1725 (CO) 
Prepamfion of efhS-12-formyllaurafe 3: 567 mg (2.33 mmOi) of 2 dissolved in 10 ml 
ethygoniate ai-e re f iwd  for 8 hours. After vacuum evaporatiin of the solvent the 
product is purRied using column chromatography (column 15 X 250 mm, Merck Kie- 
selgel 60, 0.04 - 0.63 mm, CHCIdacetone = 6:i). The Rf value 0.43 of the thin layer 
chromatogram (Kavalier Silufol, CHClJacetone = 6:l) corresponds with to that ob- 
tained by the method according to 151. 
Yield: 254 g ( 40 %), m. p. 45 - 46 *C 
Elemental analysis: (Found C, 66.77; H, 11.65; N, 5.16, C,5HZ5NO3requires 
C, 66.38; H, 10.77; N, 5.16 %) 
IR absorptions: V„ lun-' (Kbr) 3300 (NH), 1725 (CO) and 1630 (NH) 
Preparation of ethyl-12-isocyanolaurafe & To a stirred and cooled solution (0 "C) of 
4.4 g (0.0162 mol) 3 and 4 g (0.0402 mol) diisopropylamine in 20 ml MeC12 2.5 g 
(0.0162 mol) POCI, diluted in 5 ml MeCh are added. After stirring at 0 "C for 1 h the 
mixture is treated with a solution of 4 g Na2C03 (dehydrated) in 16 ml HzO for 45 min 
at a maximum temperature of 20 "C. After addition of 50 ml of a saturated sodium 
Chloride solution the organic phase is extracted with MeC12 (3 X 20 ml) and dried 
over Na2S04. The solvent is evaporated and the residue purified by column chroma- 
tography [column 15 X 250 mm, Merck Kieselgel 60, 0.04 - 0.063 mm, 
CHC13facetone = 12:l (TLC: Rf = 0.72, Kavalier Silufol, CHC13facetone = 6:l). 
Yield: 1.4 g (34 %), brown oil, softening point - 10 - 20 "C 
IR absorptions: vmm/cm-1 2150 (CN) and 1730 (CO) 
Preparalion of [Re(NS3)(CN(CH2)11C02Etlls To a stirred solution of 50 mg (96.4 
mol) tris(2-thiolatoethyl)amine-dimethyiphenyl-phosphane rhenium(lll) in 5 ml MeCh 
43 pl (173.4 pmol) of 4 in 5 ml MeC12 are added. The new complex appears in R C  
(Kavalier Silufol, toluene) at Rf = 0.07 as opposed to RRI = 0.19 of the staiting phos- 
phane compiex After stirring fOr 90 min at room temperature and removing the sol- 
vent by a nitrogen siream the product is purified using column chromatography 
(column 15 X 250 mm, Merck Kieselgel 60,0.04 - 0.083 mm, CHCIdacetone = 121). 
Yield: 40 mg (65 %), green power, m.p. 108-1 $1 "C 
Elemental anaiysysis: (Found C, 40.21; W, 5-93; N, 4.26; S, 14.74. C ~ ~ H ~ ~ N Z % O Z R ~  
requiresC, 40.17; H, 5.30; N, 4.46; S, 15.32%) 
IR absorptions: vmicm-' (I(&) 2040 @C), 1730 (CO) 
UVMS absorptions: hm&m (MeC1,) 248.3 (26900), 278.5 sh (B300), 310.3 
(ll700), 350.9 (1500). 452.8 (1700) and 585.5 (30 
NMR dafa: &H (90 MHz; soivent CDCb; siandard SiMe4) 4.76 (2N, q, CNCWd, 
Preparafion of [R~(NS~)(CN(CH~)T,CO~H)~ 6: The saponification of 5 is carried out 
according to the procedure described in our preceding article (this report P....). 
TLC (Silufol Kavalier, CHCb/acetone = $23) Rf = 0.46. 
Yield: 20.3 mg (54 %), green powder, m.p. 100 - 104 "C, 
Elemental analysis: (Found C, 38.08; H, 5.46; N, 4.72; S, 15.86, Cf9HzsNZS3O2Re 
requires C, 38.05; H, 4.87; N, 4.67; S, 16.03 % 
IR absorptions: v,&m-' (KBr) 2000 br (NC), 1700 d (CO) 
WNlS  absorptions: hmpxlnm (MeC12) 310 (3.91), 348.4 (2.96), 452.2 (3.06), 
594 (1.7) 
NMR data: & (90 MHz; solvent CDC13; standard SiMe4) 4.77 (2H, t, CNCH2), 
2.97 (12H, m, 3 SCH~CHZ), 2.34 [2H, t, CH&(O)O), 
1.62, 1.28 [18H, (CH2)sl. 
Resuits and discussion 
Fig. 1 illustrates the synthesis of compound 6 &ich starts from 12-aminolaurinic 
acid I including the dehydration of formamide 3 by affeding POC13 according to UGI 
161 (best-proved way of mild preparation of isocyanides), coupling of 4 to rhenium via 
the phosphane complex [Re(PPhMed(NS3)1 prepared according [4] and saponifica- 
tion of the terminal ester group using Iithium hydroxide in tetrahydrofuranlwater 
Fig. 2 gives a comparison of an iodine falty acid 121 and the rhenium complex 6. The 
latter formaliy substikites the aromatic moiety in iodophenyl fatty acids by the 
Re(NS,) unit. 
Fig. 1: Reparation of [Re(NS3)(CN(CH2fnG02H)] 6. 
Fig. 2: 1 5-(4'-~231]iodophenyl)pentadecanoic acid ( ~ ~ J I P P A )  versus 
{Re(NS3)[CN(CH&, COOH]] 6 a s  space filling models 
Experiments'were carried out with respect to a radiopharmaceutical preparation of 
compound & First, phosphanelisocyanide exchange oi 5 can be compieted in 10-4 
molar solutions within 5 minutes. Further it is desirable to avoid the preparation of 
phosphane-substituied precursors and to Start from perrhenate directly. Preliminar- 
ily, we found that it is possible to reduce ammonium perrhenate in a one-pot- 
synthesis by a mixture of "N(SH)B", f-butyl isocyanide and an excess NaBW4 to give 
the known compound fRe(NS3)(t-butyl isocyanide)]. 
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RHENIUM COMPLEXES WlTH BlOLOGlCALLY IMPORTANT LIGANDS 
I. SYNTHESIS AND MOLECULAR STRUCTURE OF (3-THIAPENTANE- 
1 .B-THIOLATO) (P-D-GLUCOSE-1 -THIOLATO) OXORHENIUMDI) 
Th. Fietz, H. Spies, P. ~eibnik', D. schelle? 
1 Bundesanstalt für Materialforschung, Berlin 
'TU Dresden, Institut füf Analytische Chemie 
lntroduction 
In Order to obtain access to novel technetium and rhenium complexes in radiotracer 
design, the principle of preparing mixed-ligand complexes in M ich  small-sized che- 
late units are combined with biologically relevant substituents was applied to I-thio-ß 
-D-glucose. This paper reports the isolation of two oxorhenium0l) complexes 
[ReO(SXS)(tgl)] containing I-thio-ß-D-glucose (Htgl) as CO-ligand and the molecular 
structure of [ReO(SSS)(tgI)I. These wmpounds are meant to illustrate ihe potential 
of the '3+1' mixed-ligand approach [I] to obtain small-sked rhenium chelates substi- 
tuted by carbohydrate moieties. 
Experimental 
The precursors chloro(3-thiapeniane-3.5-dithiolata)oxarhenium~ 2 I;r3 and bencj- 
triethylammonium tetrachlorooxorhenate 4 131 were synthesized following pdous ly  
described methods. 
( ~ - ~ h i a ~ ~ ~ ~ n ~ I . ~ i t h i o l a f ~ ) ( ß - D - ~ ~ ~ ~ ~ ~ - ~ /  oxorhenium(V) 2: 
$10.1 mg (504 pmol) l-thio-ß-~-glucose sodium salt are added while stirring to a 
boiling solution of 170 mg (436 pmoi) 2 in 8 ml acetonitrile. Precipitation of a light- 
brown material from the reaction mixture Starts very soon; after 15 minutes reflux the 
readion is completed. The solvent is removed in Mcuo and the residue extracted 
with hot water, and filtered. The filtrate is allowed to evaporate slowly to give red- 
dish-brown needles which are isolated from the mother liquor, washed with methanol 
and diethyl ether and dried. Yield: 81 mg (35 %). m.p. (H20): 218 - 223 'C (dec.) 
Elemental analysis: (Found: C, 21.75, H, 3.50. S, 23.34, CloHl90,ReS, requires 
C, 21.85, H, 3.48, S 23.33 %) 
UVNlS absorptions: hm&nm (H20): 220 (log 6 1 dm3 molS1 cm-' = 4.05); 264 (3.90),; 
362 (3.56); 504 (2.32). 
IR absorptions: vm,/cm-' (KBr) 960s (Re=O). 
[3-(~ethy~azapentane-1.s-dithio1at~](ß-~/u~0se1-fhio1a~o)oxorhenium(V) 3: 
129 mg (241 pmol) 4 were dissolved in 2 ml methanol. A mixture of 36.5 mg 
(241 pmol) 3-(methy1)azapentane-1.5-dithiol and 52.5 mg (241 pmol) l-thio-ß-D- 
glucose sodium salt in 2 ml chloroform was added at 0 "C while stirring. After one 
hour, 5 ml chloroform were added and the mixture refluxed for 10 min. Then precipi- 
tates were removed by filtration and the solution purified by preparative thin layer 
chromatography with methanol as the mobile Phase. The green Zone was removed 
from the plate, eluted with acetonitrile and the solution evaporated to dryness. The 
residue was extracted with a smali amount of hot water, fiitered and the fittrate slowly 
evaporated to give 13.4 mg (10 %) thin greyish-green plates. The product was 
washed with methanol and diethyl ether and dried. M.p. (H20): 178 - 183 OC (&C.) 
UVNtS absorptions: hm&nm {HzO) 264 (log 6 I dm3 mor' cm" = 3.85); 366 (3.60)- 
580 (2.12). 
IR absorption: vrnt>Jcm-' &Br) 948s (Re=O). 
Compound 2 was obtained in a 22 % yield by the Same reaction. In this case, the 
isolation was wrried Out by extracting with Water as described for 3 but without 
chromatography* 
Results and discussion 
Two new neutral oxorheniumM complexes 2 and 3 were obtained by reactions of 
I-thio-ß-D-glucose sodium salt with appropriate rhenium precursors. 2 and 3 were 
characterized by UVNIS, infrared and proton NMR spectroscopy. In addition com- 
plex 2 was characterized by X-ray structure analysis. The fourfold sulfur-coordinated 
2 can be synthesized from both chloro(3-thia-pentane-1.Bdithiolato) oxorhenium(V) 
- 
1 and tetrachlorooxorhenate 4. W e n  starting from I, the yield is significantly lower 
- 
than in similar syntheses with other thiols 121. Since the (alky1)nitrogen compound 
analogous to 1 could not yet be isolated, complex 3 is synthesized from 4 and a 
mixture of thioglucose and 3-(methy1)aza-pentane-1 .ßdithiol in a one-pot reaction. 
This method (Scheme 2) usually gives lower yields when applied to X = S than the 
two-pot reaction via the isolation of 1 and subsequent replacement of the last chlori- 
ne ligand by the monothiolic coligand (Scheme 1). 
Scheme 1: Synthesis of the thioglucose complex 2. 
The 305 MHz proton NMR spectrum of 2 in DMSO-dG shows a paitern for ihe pro- 
tons of the tridentate Iigand (a) as obsewed before 12'31. The exaci values for these 
peaks are: 2.30, 3.54, 3.56 and 4.1 1 ppm (2 H eaeh], The protons af the glucose 
fragment are depicted as followc: 5.52 ppm (1 H, s, HJ; 4. 
each, H,), 3.23 ppm (4 H, s, H& 4.30 (2 H, rn, Hdf and 4.13ppm (I H, Hf; togeiher 
with 2 H of the tridentate ligand). 
Scheme 2: One-pot synthesis of oxorhenium complexes 2 and 3. 
Fig 2: Assignment of the Protons in the 'H NMR spectrum 
Molecular structure of complex 2 
Crystals suitable for X-ray structure analysis were obtained by slow evaporation of 
an aqueous solution of 2. The compound forms bunches of small reddish-brown 
needles. 
The structure analysis shows distorted square-pyramidal coordination of the sulphur 
atoms around the central atom which is situated above the basal plane. The shape 
of the coordination sphere is simifar to that in f [2] and in (3-thiapentane-7.5- 
dithiolato)(ethanethiolato) oxorhenium0l) 141. Furtherrnore, the crystal structure is 
characterized by both intensive intermolecular and intramolecular hydrogen bonds 
via the hydroxy groups. 
Table 1: Selected bond angles ["I of 2 and their e.s.d. 
Table 2: Selected bond lengths [Al of 2 and their e.s.d. 
Atom 1 Atom 2 I Bond distance [Al 
2.309(2) Re S I  
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6. RHENIUM COMPLEXES WlTH BIOLOGICAL IMPORTANT LIGANDS 
2. A CHOLESTEROL MOIETY BONDED T0 RHENIUM(V) 
1 Th. Fietz, H. Spies 
lntroduction 
Steroids and their metabolism play an essential role in the control of iiie processes. 
Therefore it is important to trace the behaviour of steroids and their derivatives in 
vitro and in vivo. Radioactive labelled steroids allow a wide range in tracing and 
modelling experiments as well as in radiodiagnostics and radiotherapy. A number of 
attempts have been made to label steroids or their derivatives with certain rhenium 
cores 11-31. The principle of preparing mixed-ligand complexes in Mich smali-sized 
chelate units are bound to biologically relevant substiiuents (41 is applied to thiocho- 
lesterol as a substituent. Complexes [ReO(SXS)(SR)] (RSH = cholest-5-ene-3ß-thiol; 
HSXSH = tridentate dithiols HSCH2CHrX-CH2CHrSH; X = S, 0) have been pre- 
pared. 
Experimental 
Chloro(3-thiapentane-I.5dithiolafo)oxorhenium(V) 1 151 and benzylttiefhylammonium 
tetrachlorooxorhenate 4 [6] were prepared according to previously described meth- 
ods. 
( 3 - T h i a p e n t a n e - 1 . 5 - d i t h i o I a t o ) ( c h o l e ~  2
49 mg (125 pmol) 1 were dissolved in 5 ml boiling acetonitrile. 93.5 mg (232 vmol) 
cholest-5-ene-3ß-thiol were added and the mixture refluxed. After 10 min, a light- 
brown precipitate was deposited. The whole mixture was evaporated to dryness, the 
residue dissolved in chloroform and ihe solution filtered. The product was purified by 
passing through a silica gel column (20 X 2 cm) with chloroform as eluent. S0me 
ethanol was added to the brown etuate. The eluate was slowiy evaporated to give 
51.5 mg (54.5 %) brown needles. 
Elemental analysis: (Found: C, 49.11; H, 6.85; S, '15.56, C&s30ReS4 requires 
C, 49.24; H, 7.02; S, 16.96 %) 
UVNIS absorpiions: a,WInm(Cii2C12) 343 (log ~ / d d  mol" mi' 3.a): 392 13-51), 
511 (2.231, 
IR absorptions: v-/cm-' (KBr) 956 s (Re-0). 2936 s (CH2) 
(3-Oxapenfana-l.sdithiolato)(cholesf-5ene-fhi0I-3ß-afo)0~0rheni~m(V) 4 : 
119.2 mg (222 vmol) benzytriethylammonium tetrachlorooxorhenate01) were dis- 
solved in 3 ml ethanol and cooled to 0 'C. A mixture of 30.7 mg (222 pmol) 3-oxa- 
pentane-1.5-dithiol and 89.6 mg (222 vmol) cholest-5-ene-3ß-thiol in 2.5 ml chloro- 
form was added while stirring. Cooling and stirring were continued for two hours. The 
mixture was evaporated to dryness, the residue dissolved in chloroform and the so- 
lution filtered. The filtrate was purified by passing through a silica gel column (20 X 2 
cm) with chloroform as eluent. Some ethanol was added to the dark-red eluate. The 
eluate was slowiy evaporated to give 70.8 mg (43.1 %) wine-red needles. 
Elemental anaiysis: (Found: C, 50.41; H, 7.33; S, 12.99, C3,Hs302ReS3 requires 
C, 50.30; H, 7.22; S, 12.99 %) 
UVNlS absorptions: &,,Jnm (CHZCIz) 322 (log ddm3 mol*' cm-' 3.60), 352 (3.65) 
IR absorptions: v,,/cm' (KBr) 968 s (Re-0), 2936 s (CHZ) 
Complexg can be obtained by the latter method in a 16 % yield. The preferred prod- 
uct (60 % yield) in this reaction is 3 
Results and discussion 
Reaction of cholest-5-ene-3ß-thiol (Htchol) with both tetrachlorooxorhenate01) 2 
(Scheme 2) and chloro-(3-thiapentane-l.5-dithiolato)oxorhenium01) (Scheme 1) 
gave new neutral complexes containing a steroid moiety. The complexes are soluble 
in chloroform and dichloromethane but insoluble in acetonitrile, alcohols, dieth- 
ylether and water. 
Complex 3 can be obtained with both these methods. However, the yield of pure 
complex is rather low when starüng from tetrachlorooxorhenate01). This is due to the 
lower reactivity of the mercapto group in the steroid derivative compared to the reac- 
tivity of the thiol groups of the tridentate ligand. A common action of the three thiol 
groups involved on the Re - CI bonds is therefore suppressed. That causes the for- 
mation of 2 in high yields, which does not react with the monothiol under these 
conditions. There is, however, a diierence in the behaviour of the two tridentate li- 
gands employed in the reaction: the oxygen derivative gave 4 in satisfactory yields. 
Scheme 1 : Preparation of wmplex 3. 
Scheme 2: Preparation of complex 4 
- 
Htchol 
.____, 
A n  
SH 0 SH 
The preferred formation of l during the reaction shows that in this special case the 
"3+1" method [4] of forming fourfold sulphur wordinated oxorhenium complexes is 
inferior to the two-pot method [5]. This procedure -where the first step is the forma- 
tion of l from 4 and 3-thiapentane-1.5-dithiol as described in [5]- makes it possible 
allows to convert even less reactive monodentate thiols into '3+Iu complexes. 
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7. NEW MIXED-LIGAND OXORHENIUM(V) COMPLEXES WlTH 
RHENIUM-SELENIUM BONDS. 
MOLECULAR STRUCTURE OF (3-OXAPENTANE-1,5- 
DITHiOLATO)(BENZENESELENOLATO)OXORHENIUM(V) 
Th. Fietz; H.-J. Pietzsch, H. Spies, P. Leibnitz'. D. Scheller2 
'Bundesanstalt für Materiatforschung, Berlin 
T U  Dresden, Institut für Analytische Chemie 
lntroduction 
Rhenium complexes with selenium-containing ligands have been scarcely reported 
[1-6]. According to the HSAB concept U], S donors are more iikely to be bonded to 
rhenium complex cores than, for example, oxygen atoms. Selenium as the successor 
of sulphur in the periodic table's 6th main group should do so even more. Despite 
the high acute toxicity of many selenium compounds and the high sensitivity of -SeH 
groups towards air and humidity, Mich prevent a wide application of selenium donor 
ligands for chemical as well as for pharmaceutical research purposes, we were in- 
terested in the basic mordination chemistry of selenium ligands. 
Experimental 
Benzylfriefhylammonium feirachlorooxorhenate(V) was synthesized according to 
[ I  I]; chloro(3-thiapenfane-1.5dithiolato)oxorf I was synthesized according 
to 191. Crude sodium benzylselenolate was synthesized following the method given in 
[8] and used without previous ac id i i t ion or isolation. 
Benzeneselenol, CeHsSeH, was synthesued from C6HsSe-Se-C6H5 by boiling with 
ethanolic KOH [10j. The solvent was reduced to a small volume by rotary evapora- 
tion and deaerated water was added. The mixiure was acidiiied with diluted sul- 
phuric acid. The selenol was extracted into chloroform, dried and stored under dini- 
trogen. 
Purifcation of the complexes: The reaction mixture was evaporated to dryness on a 
rotary evaporator. The residue was washed with methanol, dissolved in chloroform 
and filtered to remove some small grey waste (elemental selenium?). The product 
was purified by column chromatography (silica gel 60; 0.04-0.063 mm; Merck; elu- 
ent: chloroform). After addition of ethanol to the eluate, it was allowed to evaporate 
slowly to a small volume to give ciystals. The product was washed with methanol 
and diethylether and dried. 
(3-Thiapentane-l.5-dithiolato)(benzeneselenolato)oxorhenium( 2: 
117 mg (300 pmol) 5 were dissolved in 5 ml of boiling acetonitrile and an approxi- 
mately fivefold excess of the crude benzeneselenol solution was added. The colour 
of the mixture turned from ink-blue to brown very soon. The mixture was refluxed for 
15 minutes and processed as described above. Yield: 104.1 mg (68.6 %) of small 
brown needles. 
UVNlS absorptions: h&nm (CHaCN) 301 (log E I dm3 mol-' cm-' = 3.66); 417 (3.56). 
IR absorption: vlcm-' (KBr) 968s (Re=O) 
(3-Thiapentane-1.5-dithio/ato)(benzy~seleno/ato) oxorhenium(V) 3: 
87 mg (225 pmol) 2 were dissolved in 8 ml acetonitrile and an excess of crude so- 
dium (phenyl)methaneselenolate solution was added. The mixture turned from biue 
to brown immediately and was stirred for 5 minutes. It was processed as described 
above. Yield: 41 mg (34.7 %) of dark brown needles. 
UVMS absorptions: h,,,inm (CHBCNI) 291 (log E I dm3 mol-' cm-' = 3.77), 338 (3.44); 
417 (3.57) 
IR absorption: vlcm-' (KBr) 960 (Re=O) 
(3-Oxapentane-7.5-dithiolato)(benzenese/eno/ato) oxorhenium(\l) 4 was synthesized 
by adding a mixture of 38.9 mg (314 pmol) bis(mercaptoethy1)ether and an excess of 
the selenophenol solution to a cooled (0 "C) and stirred solution of 168.3 mg (314 
pmol) [BzNE&][ReOCI4] in 3 ml methanol. A clear reddish brown solution was ob- 
tained after another hour of stining. Yield: 74.2 mg (47.8 %) of large brown needles. 
UVNlS absorptions: &lnm (CHaCN) 287 (log E / dm3 mol" cm-' = 3.69), 392 (3.68). 
IR absorption: dem-' (Ur) 976s (Re=O). 
Results and discussion 
We synthesized three new oxorhenium(V) mixed-ligand complexes with rheniurn- 
selenium bonds according to the "3+1" principle. This principle embodies common 
[I11 or subsequent [9] action of a tridentate dithioi and a monodentate thiol ligand On 
an appropriate oxorhenium0l) precursor. 
Scheme 1: Synthesis of seienium complexes in a M-step procedure [9] 
Scheme 2: One-pot synthesis of complex4. 
Se-Ph 
CI 
us 
amounts of the diselenides, it was impossible to determine the exact stoichiometry of 
the selenol components involved. 
Compound I M.p. ["C]? I Elemental analysis I 
I % C found (calc.) I % H found (calc.) 1 % S found (calc.) 
The 90 MHz proton NMR spectra of complexes 2 and 3 show the typical Patterns 
expected for compounds with 3-thiapentane-1.5-dithiolato ligands [I I]. The signals 
of the protons of the tridentate ligand of 2 are depicted at 1.91 pprn (septet), 3.06 
pprn (td), 3.84 pprn (ddd) and 4.19 (dd, 2H each). The aromatic protons are shifted 
to 7.32 (3H) and 7.81 (2H). In complex 3, the shape of the signals of the tridentate 
ligand is very similar with only slightly different shis: 1.91, 3.06, 3.84 and 4.30 ppm. 
The methylene group is depicted at 5.08 pprn and the aromatic protons in a multiplet 
at 7.39 (5H). 
The spectrum of complex4, however, exhibits a different Pattern oi the chemical shi i  
of the protons of the tridentate ligand. They are shown as three multiplets at 3.35 
(4H), 3.66 (2H) and 4.62 pprn (2H). The aromatic protons are depicted at 7.34 
(3H) and 7.74 ppm (2H). This is very similar to the proton NMR spectrum of 
ReO(SOS)(SPh) [ I  I]. 
Molecular structure of complex 4 
Large single crystals suitable for X-ray structure analysis were obtained by stow 
evaporation of a solution of 4 in chloroforrn and ethanol. This structure analysis is 
one of the first with an ether oxygen and a basic selenium atom coordinated to oxo- 
rhenium. 
The ligands form a distorted tetragonal pyramidal coordination around the cenfral 
atom. Most of the features are similar to those in R~O{SOS~(S-P~-OCHS@)) [Ilf. 
Selected data are gben m Tabfes 1 and 2. 
Tabie 1: Selected bond lengths of 4 and their estimated Standard deviations 
Fig. 1: MoIecular structure of (3sxapentane-4.5-dithiolato)(beruieneseIenolato) 
Table 2: Seiected bond angles of 4 and their estimated standard deviations 
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8. PREPARATION, CHARACTERIZATION AND ENZYMATIC 
HYDROLYSIS OF MIXED LIGAND RelTc COMPLEXES WTH 
DMSA AND DMS ETHYL ESTERS 
S. Seifert, R. Syhre, H. Spies, B. Johannsen 
Ester groups can play an important part in technetium tracer design, as is known for 
Tci99m-ECD and other complexes [I ,2,3]. Studies of their enzymatic hydrolysis have 
revealed stereoselective and animal species dependent factors goveming the hy- 
drolysis rate and kind of products [4]. To gain a greater insight into such factors as 
well as the interplay of coordinated ester functions, we prepared and studied 
iJdO(DMSA/ester~- complexes with up to four coordinated ester groups per mole- 
cule. Such oxocomplexes of rheniumo and technetiumo with meso dimercapto- 
succinic acid (DMSA) andlor its esters occur as mixtures of three stereoisomers 
(syn-endo, syn-exo, anti). 
Eperimental 
The number and position of ester groups in the complex molecule are symbolized as 
follows, without distinguishing isomers: 
0 
M = Tc, Re 
COOR R =  Et 
) = DMS diethylester 
' 2h .. ; = DMS monoethylester 
3' 6 ';-{ 
; ,.; 
i =DMSA 
Re complexes 1 - 6 were prepared by ligand exchange reaction of equimolar 
amounts of Bu4N[ReOCLJ and pairs af ligands in an acetonic solution and identiiied 
end separated by HPLC. The HPLC analyses were carried out with a PRP-1 column 
(Hamilton, 250 X 4.1 mm, 10 Pm, flow rate 2 mlfmin) or a ChiraDex column (Merck, 
LiChroCART 250 X 4 mm, 5 Pm, tiow rate 1 milmin) using a linear gradient system 
(t,%B): (5,0), (10,50), (10,50) of 0.1 % trifluoroacetic acid in water (A) and 0.1 % 
trifluoroacetic acid in acetonitrile (B). The effluent from the column was monitored by 
UV absorbance at 340 nm. 
The corresponding s9m~c complexes were obtained by stannous chloride reduäion of 
pefiechnetate in aqueous acetonic ligand solutions. According to the general proce- 
dure 0.2 - 0.8 mg of the ligands, 0.1 mg ascorbic acid, and 7.0 mg NaHCOa are dis- 
solved in saline andlor acetone and mixed with 1.0 - 2'0 ml pefiechnetate eluate. 1 
mg SnC12 X 2H20 dissolved in 10 pl ethanol is added and after 5 min the reaction 
solution is filtered through a millipore filter. The following ligand quantities needed 
for preparation (Table 1) were optimized empirically. The relatively high quantities of 
DMS ethylester are caused by impurities of DMS diethylester in this ligand prepara- 
tion mich could not be obtained in crystalline form. The resulting HPLC chroma- 
tograms of the Remc wmplexes therefore show additional peaks of mixed ligand 
complexes with the DMS diethylester ligand. 
Table 1: Optimized quantities of ligands for preparing the 9 B m ~ ~  complexes 
1 Compiex I DMSA I DMS ethvlester I DMS diethvlester lud  1 
For separation of 400 pl samples of 9Bm~c complexes a preparative PRP-1 column 
(305 X 7 mm, 10 Pm, flow rate 4 mllmin) was used. 
Fig. 1 shows as an example the HPLC separation of a preparation containing the 
9Bm Tc complexes 1, 4 and 6. After separation of the wmplex 4 fraction the acetoni- 
trile is evaporated by nitrogen bubbling and heating in a boiling water bath. The 
acidic aqueous solution is neutralized with NaHCOa and aliquots are used for incu- 
bation studies. 
For N, VifrO studies 6 X 10-T mol Re complex or 5 - 10 
MBq %Tc  complex are incubated in a sample vol- 
ume of l ml at 37 "C with 100 U pig liver esterase 
(PLE, E.C. 3.1.1.1., Fluka) in phosphate buffer of 
pH 7.4 or blood plasma of rats (RP) or humans (HP) 
diluted 1:l with phosphate buffer of pH 7.4. 
For in vivo studies 0.5 ml wmplex solution 
(5 - 10 MBq -C) are injected into Wistar rats 
(male, 5 - 6 weeks old). 
Fig. 1: HPLC Separation (PRP-1) of a complex 
mixture obtained by stannous reduction of 
-CO; in aqueous acetonic DMSA I DMS 
diethylester solution 
Results and discussion 
All the above mentioned Qpes of mixed ligand rhenium complexes 2 - 5 are also1 
obtained if a [ReO(DMSA)2]- complex preparation is allowed to stand in ethanolic 
solution. The gradual esterification is helpful for assignment because the same Rt- 
values in HPLC are obsewed as found for direct preparations. 
0 1 2 3 4 
number of ester groups 
Fig. 2: Dependence of F4 values (PRP-1) of the complexes 1 - 6 on the 
number of ester groups 
As expected the ReiTc complexes are eluted from the PRP-1 column according to 
their lipophilicity, which increases with the number of ester groups in the complex 
molecule (Fig. 2). In Table 2 a Summary of the measured data for ="'TC complexes is 
given. In contrast to the PRP-1 column, on the ChiraDex column the more lipophilic 
diethyl ester complex 1 is eluted first, followed by complexes 2, 4 and 3. Complexes 
containing more than two free carboxylate groups are not eluted. A complete sepa- 
ration into the three possible stereoisomers is only possible for complex 6 on the 
PRP-1 column and for the complexes 1 and 2 on the ChiraDex column. All other 
complexes are separated incompletely into two peaks. 
Table 2: Chemical and biological characterization of *"'TC complexes 1 - 6 
Comp. log P Rt [mini enzymatic cleavage 
I 6 - I 1 I 
* Separation of ihe three possible stereoisomers 
No. 
1 
Only ihe complexes 1 and 2 are enzymatically hydrolysed (Fig. 3). While complex i 
reacts with PLE to 2 only, the cleavage in RP solution results also in small portions 
of the diacid complex 3. 
(oct.lwat.) 
0.7 
PLE, RP X 37 'C, ~ ~ 1 . 4 ~  
PLE, RP h 37 Oc, pn 7.4+ 
PRP-1 ChiraDex 
12.5 - 13.5 1 12, 15,16* 
Fig. 3: E~zymatic leavage of 1 and 2 with PLE and RP 
4% 
in vitro in viv0 
PLE RP HP rat 
+ + - + 
It was found by HPLC with the ChiraDex column that in fact the symmetric complex 3 
and not complex 4 is formed. That means that the enzymatic hydrolysis is stopped, 
when one of the two ester groups of a DMS diester ligand molecule is already hydro- 
lysed. No hydrolysis is observed in HP solutions. 
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9. DIFFERENT RATES OF ENZYMATIC CLEAVAGE OF THE THREE 
STEREOISOMERS OF [ReO(DMS D1ESTER)d- COMPLEXES 
S. Seifert, R. Syhre 
The enzymatic cleavage of [ReOikO(DMS diesterhl- complexes with pig liver es- 
terase (PLE) is obviously stopped when one of the two ester groups of a DMS di- 
ester ligand molecule is already hydrolysed as described in the preceding article. 
The individual hydrolysis rates of the syn-endo, syn-exo and anti stereoisomers of 
the ester complexes were determined by a combination of 'H NMR and HPLC, which 
allows to analyse the isomeric Pattern and identity of the three stereoisomers. 
Experimental 
The rhenium complexes [ReO(DMS&)d- (R = Me, Et, i-Bu) Were prepared by ligand 
exchange reaction of Bu4N[ReOCL] with stoichiometric am0untS of DMS dimethyles- 
ter, DMS diethylester and DMS diisobutylester. After crystallization of complexes by 
reducing the volume of the solution, filtratiin, washing and drying the solids are re- 
dissolved in acetone or acetone-ds and analysed. 
The 'H NMR analyses were carried out in acetone-ds solutions using a Varian 
UNlTY 400 system at a 'H frequency of 400 MHz. 
For HPLC analyses a ChiraDex column (E.Merck, 250 X 4 mm, 5 Pm) filled with ß- 
cyclodextrin chemically bonded to silica gel as chiral stationary phase for the sepa- 
ration of enantiomers was used in wnjunction with a linear gradient system of 0.1 % 
irifluoroacetic acid in water (A) 10.1 % trifluoroacetic acid in acetonitrile (B); flow rate 
1.0 mllmin, (t[min]l% B): (10120), (10180) with a gradient +I, (20180), UV absorbance 
at 340 nm. 
For hydrolysis studies 6 X 10-'moI Re complex are incubated at 37 "C in a sample 
volume of 1 ml containing 100 U pig liver esterase (PLE, E.C. 3.1.1.1., Fluka) in 
Phosphate buffer of pH 7.4. 
Results and discussion 
The HPLC system used for the analyses allows a quantitative determination of the 
isomer ratios of the dimethyl- and diethylester complexes (Fig. I), the diisobutyl 
complex however, was not separated into the three isomers by this method. 
Fig. 1: HPLC analyses of [ReO(DMS diethy1ester)d- (A) and 
[ReO(DMS dimethylesterh]- (B) dissolved in acetone 
The identity of the isomers was determined by comparing the percentage yields of 
the isomers measured by HPLC and 'H NMR (Table 1). taking into consideration that 
the anti form shows two singlets of 1:l integral ratio in the 'H NMR spectrum (Fig. 2) 
and that only iess than 20 % of the syn-exo form is contained in an acetonic solution 
[1,21. 
Table 1: Average isomer distribution of [ReO(DMSR2)$complexes 
(R = Me, Et, i-Bu) determined by 'H NMR and HPLC 
[ReO(DMSR&$ 'H NMR j HPLC [%I 
R exo anti end0 exo anti end0 
The elution order of the isomers in HPLC is diierent: while the DMS diethylester 
complex is eluted in the sequence syn-exo - syn-endo - anti, the DMS dimethyiester 
complex is eluted in the order syn-exo - anti - syn-endo. 
Fig. 2: 'H NMR analyses of C-H Proton region (3.8 - 4.1 ppm) of [ReO(DMS 
diethylesier]J (Al and [ReO(DMS dimethyiester)2]- (B) in acetone-ds 
With knowledge of the isomer ratios and identity, the hydrolysis rates of the three 
[ReO(DMS diester)Am isorners during incubation with PLE were deterrnined. 
It was found that cleavage of isorners of the DMS dirnethylester and DMS diethyles- 
ter cornplexes is influenced by stereo-specific factors. After incubation with PLE in 
both Gases, the syn-endo form is hydrolysed significantly faster than the other two 
isomers (Fig. 3). 
0 1 0 L 
0 10 30 M) 120 0 10 30 M) 120 
TIME (MIN.) TIME (MIN.) 
Fig. 3: PLE-hydrolysis rates of stereoisorners of [ReO(DMS dirnethy1ester)zl' (A) and 
[ReO(DMS diethylester)$ (B) cornplexes 
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10. SYNTHESIS OF MK) FURTHER 4-FLUOROBUTYROPHENONE- 
CONTAlNlNG RHENIUM COMPLEXES 
B. Noll, St. Noll, H. Spies 
Synthesis and properties of a rhenium complex [ReO(SXS)(SR)], where R is the 
p-fluoro-butyrophenone moiety of the D2 receptor binding compound spiperone and 
HSXSH is HSCH2CH2XCH2CH2SH (X = S), was described in [I]. The procedure, 
which consists in simultaneous action of boih the tridentate dithiol ligand and 4-mer- 
capto-(p-fluoro)-butyrophenone (RSH) on rheniumo gluconate, was applied to 3- 
oxapentane-I .5-dithiol and 3-methylazapentane-1.5-dithiol as tridentate ligands. The 
compiexes [ReO(SXS)(SR)] (X = 0 (la), X = NMe (Ib)) were obtained in a yield of 
about 15 % after purification by HPLC. The compounds are another two repre- 
sentatives of "spiperoids", which differ with respect to the nature of X in the chelate. 
Fig.1: [ReO(SXS)(SR)l (1) , l a  X = 0, I b  X = NMe 
W N l S  IR 'H NMR [ppm] 
[km (log €11 [cm"~ butyrophenone Protons chelate ring Protons 
------------------------------------------------- 
l a  242(4.24) 968 a) 3.10 (2H) f,g) 3.20 - 3.80 m (6H), 
318(3.42) b) 2.36 rn (2H) 4.65 br (2H) 
347(3.47) C) 3.92 t (2H) 
d) 7.99 m (2H) 
e) 7.08 m (2H) 
l b  239(3.92) 968 a) 3.18 t (2H) 
363(3.02) b) 2.33 m (2H) 
395(2.92) C) 3.85 t (2H) 
d) 7.99 m (2H) 
e) 7.08 m (2H) 
---- - -M--* 
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11. Tc AND Re COMPLEXES DERIVED FROM SPIPERONE 
4. COMPLEX FORMATION OF TECHNETIUM WlTH MAG2 
DERIVATIVES OF o-AMINO-4-FLUORO-BUTYROPHENONE 
H. Spies, St. Noll, B. Noll 
The fluorobutyrophenone moiety is a structural part of several organic receptor-bin- 
ding substances, e. g. of the dopamine Da-binding ligand spiperone. lntroduction of 
this group as a substituent into Tc and Re complexes may therefore help to lend Tc 
and Re coordination wmpounds receptor-binding properties. 
With the aim of making more of such compounds [I] available, a new ligand, 4-(p- 
fluorophenyl)-4-oxobutylemide of mercaptoacetyldiglycine (FB-MAG2) was prepared. 
This compound is expected to fulfil the requirement of having good complexing 
properties and bearing the fluorobutyrophenone substituent. Synthesis of the ligand 
and experiments wncerning complexation with technetium-99 are dealt with. 
Synthesis of F5MAG2 
Synthesis follows the route as shown in Fig. 1. 
wamino-Muoro.b@mphenone (2): 
10 g (0.05 mol) w-chloro-4-fluoro-butyrophenone was dissolved in 140 ml of ethanol. 
After addition of 50 ml of 25 % ammonia the mixture was refluxed for 4 h. The sol- 
vent was removed by rotary evaporafion and 50 ml of water and 50 ml of diethyi 
ether were added to the residue. The layer of diethyl ether was separated and dried 
with sodium sulphate. The solution was filtered and the diethyl ether evaporated. 
The yellow oil was treated with methanolic hydrochloric acid and lyophilized. The 
hydrochloride obtained was dissolved in water and lyophilized again. 
Yield: (6.5 g, 60 %) 
M.p. 39 "C 
TLC: (RP 18llmethanollwater 9:l) Rf 0.65 (W, ninhydrine) 
Elemental analysis: (Found: C, 55.85; H, 5.77; N, 6.75; CI, 16.11, CtoHjjONCIF 
requires C, 55.18; H, 6.02; N, 6.43; CI, 16.29 %) 
I 
Preparing the free amine, the hydrochloride was dissolved in water and treated with 
a sodium bicarbonate solution. The brown oil obtained was extracted with diethyl 
ether and dried in vacuum. 
Yield: (75 %) 
M.p. 163°C 
TLC: (RP 18llmethanoliwater 9:l) Rt. 0.3 (UV, ninhydrine) 
Elemental analysis: (Found: C, 66.89; H, 6.32; N, 8.13, C,OH,~ONF requires 
C, 66.28; H, 6.67; N, 7.73 %) 
'H NMR data: &(250 MHz; solvent DMSO; standard TMS) 1.88-1.96 (2H, -CH2), 
2.86-2.91 (2H, -CO-CHz), 3.89-3.93 (2H, -CH2-N). 7.22-7.27 
(2H, arom.), 7.84-7.87 (ZH, arom.) 
Fig. 1: Reaction scheme of the synthesis of FB-MAG2 and proposed structure of 
Fc-FBWG~] '  
Bu-MAG2 
310 mg (I mmol) benzoyl-MAG2 and 330 mg (I mmol) 0-(?H-benzotriazol-1yl)- 
N,N,N1,N'-tetramethyluronium tetrafluoroborate (TBTU) were dissolved in 2 ml of 1- 
methyl-2-pyrrolidone. After addition of 340 yl (2 mmol) ethyldiisopropylamine and 
stirring for 3 min, the mixture was added to a solution of 145 mg (0.8 mmol) w-amino- 
4-fluoro-butyrophenone in 2 ml of I-methyl-2-pyrrolidone. The reaction solution was 
stirred for 4 h at room temperature and then the solvent was removed in vacuum. 
The residue was dissolved in ethanollwater 1:l and lyophilized. The brown crystals 
were extracted with hot water and rectystaliized from ethanol. 
The separation occurred by MPLC On a Eurosil Bioselect C 18 (300 X 25 mm) CO- 
lumn: 
Eluent A: methanol 
Eluent B: water 
Elution: 5 rnin isocratic 10 % A, 40 min gradient -->50 % A, 20 min isocratic 50 % A 
Pump Speed: 7 mVmin (1.8 MPa) 
detection: 265 nm 
The separation product was vacuum-dned. 
Yield:(l63 mg, 43 %) 
M.p. 185 "C 
TLC: (RP I8llmethanollwater 93) % 0.58 (UV) 
Elemental analysis: (Found: C, 58.03; H, 5.37; N, 8.68; S, 6.81, CaHZ4N305SF 
requires C, 58.34; H, 5.1 1 ; N, 8.87; S, 6.77 %) 
'H NMR data: 6" (250 MHz; solvent DMSO; standard TMS) 1.72-1.76 (ZH, -C&,)), 
2.99-3.03 (ZH, -CHz), 3.11-3.14 (ZH, -CHz), 3.67-3.88 (6H, -C&), 7.31- 
7.36 (2H, arom.), 7.54-7.70 (3H, arom.), 7.72-7.76 (1 H, -NH), 7.91- 
7.93 (2H, arom.), 8.00-8.04 (2H, arom.), 8.14-8.17 (IH, -NH), 
8.51-8.53 (?H, -NH). 
Complexation reaction 
UVNlS spectra depending on the molar ratio TC gluconateiMAG derivative were re- 
wrded by rneans of the spectrophotometer Spewrd M O .  The chromatographic be- 
haviour was determined by thin layer chromatography on silica gel with acetone or 
95 % methanol as the solvent and by HPLC On the RP 18 column (Eurosphere), 
10 min. gradient +I from 100 % A to 10 % A ( eluent A: phosphate buffer pH 5.8, 
eluent B: acetonitrile). 
The S-benzoyl-protected ligand was saponiiied with sodium methylate and used 
without further purification. Ligand exchange reactions carried out, starting from the 
1.3 X 1 o4 M T c 0  gluconate precursor, varying the molar ratio ligand I Tc in the ran- 
ge from 0.5 : 1 to 2 : 1 in neutral end alkaline solution. Tc gluconate was prepared as 
previously described. 
Results 
Gradual addition of an aqueous solution of MAG2-butyrophenone (4) both to a neu- 
tral and alkaline Tc gluconate solution under UV control gives a peak at 330 nm. The 
maximum extinction is found at a molar ratio of about I:? (ligandiic). Because the 
exchange is relatively low, a small excess of the ligand is necessary to consume Tc 
gluconate quantitatively in appropriate time. 
The results of quantitative detemination of the ligand exchange reaction depending 
on the molar ratio MAG2 butyrophenoneiic gluconate by HPLC and TLC (listed in 
Table 1) are in good agreement and pH independent. 
Table. 1: Composition of the ligand exchange reaction m'kiure in dependence on 
the molar ratio MAG2 butyrophenoneiic gluconate, reaction time 30 min 
molar ratio 
(MAG=-but.iic gluc.) 
neutral 
0.5:l 
1:l 
2:1* 
alkaline 
0.5:l 
1 :I 
2:1* 
HPLC TLC 
Tc gluc. TcRIIAG2 -bu. Tc gluc. TC-MAGz-but. 
1 = 2.21' & = 9.03' R$= 0 R$ = 0.8 
[%I [%I 
65 35 64 35 
40 60 36 64 
- >95 - >95 
W1 W1 
62 37 57 43 
32 67 26 74 
- >95 " 3.95 
"slight excess of ligand and after M, min 
The charge of the Tc complex obtained could not be determined because of its ad- 
sorption on the starting point of the silica gel electrophoretic sheets. 
However, the obse~ation that the technetium complex is extractable into methylene 
chloride only in the presence of an organic counter-cation, such as tetrabutyl- 
ammonium chloride, is consistent with the assumed anionic character of the Tc-(FB- 
MAG*) complex These preliminary results confirm the formulation of Tc-(FB-MAG2) 
as a 1:l-complex, in which one of the four donor atoms is the arnide nitrogen derived 
frorn the aminobutyrophenone moiety. 
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12. OCTANOWATER PARTiTION COEFFlClENTS OF SOME RHENIUM 
COMPLEXES 
R. Berger, T. Fietz, M. Glaser, B. Noll, H. Spies 
The lipophiiicity of a molecule is an important characteristic in drug and raditracer 
design, which influences the pharmacokinetic and the pharmacodynamic behaviour 
of a substance (i.e. drug) in the body. 
A quantitative measure of the lipophilicity of a solute is its distribution ratio between 
a water immiscible solvent (e.g. octanol) and an aqueous phase, expressed by the 
Partition wefficient (Polw) as shown in the following relation: 
[mncentrations: co (in octanol), cw (in the water phase)] 
Different methods for the determination and ~alculation of Polw have been described 
[I-61. This articie deals with experimental data of Polw detemination of two series of 
recently synthesized rheniurn complexes 1 and 2 by means of the shaking flask pro- 
cedure. The structure of these complexes is given in Fig. 1. 
In comparison with compound 1, complex 2 does not wntain a Re=03+ wre. 
These compounds are studied in Order to See whether and how a "tuning" of 
lipophilicity may be achieved by small substituent changes in a widely variable 
monodentate coligand present in both types of wmplexes (R' = substituted alkyl, 
aryl and others and R2 = substituted triphenylphosphane and isocyano ligands) [7,8]. 
The experiments for determining the Polw values of the selected rhenium complexes 
were performed by the shaking flask procedure after their dissolution either in the 
octanol or aqueous (water or buffer with an appointed pH value) phase. 
Because of the poor solubility of some wmplexes the dissolution was acwmplished 
by using auxiliary solvents such as acetonitrile or dimethylsulphoxide (DMSO). In 
these cases corrections of the volumes of the immiscible phases were indicated. 
X = 0, S, NMe 
Fig. 1: General structure of rhenium complexes 1 and 2 
After separating the two phases, the UVNlS absorption spectrum of the appropriate 
rhenium complex within the respective phase was measured. For this purpose the 
phases added into ccueites had to be sometimes warmed up for removing a possible 
clouding before recording the absorption spectrum. The wncentrations of the 
phases wuld be calculated by means of extinction coefiicients had to be determined 
from typical absorption maxima of corresponding solvents, and equations suitable for 
necessary volume corrections. 
In Tables 1 - 3 the preliminary values of Po/, of the rhenium complexes studied are 
summariied. These results are supposed to serve as orientation (values obtained by 
only one or iwo measurements have to be veriiied). The aqueous phase consisted of 
redistilled water for most deterrniinations and of disodium hydrogen/potassium di- 
hydrogen phosphate buffers containing a free carboxyl or arnino group (Tab. 3). 
The octanollwater partition coefficients of compounds of particularly high lipophilicity 
have relatively great errors. This is a resuit of the poor solubility of some cornplexes 
in the aqueous phase. 
No substantial influence of the auxiliary Solvent~ can be deduced from the octanoü- 
water partition coefficients determined. The pH dependence of b refleds de- 
protonation of the amino group in alkaline media, while 3 end are deprotonated in 
the pH region considered. 
Compounds within hornologous series Show a graduation of the appropriate partition 
coefficients as expected. This is especialiy true of the series of aliphatic cornpounds. 
Table 1 : Octanollwater partitio~n coefiicients of various rhenium complexes 1 
Vloieculai 
weight 
401.6 
415.6 
429.7 
443.7 
555.9 
463.7 
477.7 
491.8 
445.6 
459.7 
473.7 
486.7 
549.7 
solution in 
octanol 
Polw 
solution in 
acetonitrile 
28 f 4 [n=3] 
52 I 7 [n=2] 
247 i- 90 In=4] 
312 t 200 [n=4] 
SI 5 [n=2] 
52 [n=l] 
20 f 5 [n=3] 
21 f 5 [n=2] 
25 i 8 [n=8] 
4 f 2  [n=lO] 
Table 2: Octanollwater partition coefficients of rhenium complexes 2 
Molecular 
weight 
octanol 
Table 3: Octanoüwater partition coefiicients of rhenium complexes I 
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[R' = -CH2COOH @J, -(CH2)2N(CH3) Co)] and 2 
[RZ = -CN-COOH (cl] depending on pH values 
Leo, A. J. et al., Chem. Rev. 71 (1971) 525 
Braumann, T. et al., J. Chromatogr. 261 1983) 329 
Biagi, G. L. et al., J. Chromatogr. A 669 (1994) 246 
Minick, D. J. etal., J. Med. Chem. 31 (1988) 1923 
Kugel, C. et al., J. Chromatogr. A 667 (1994) 29 
Yamagami, C. et al., J. Chromatogr. 662 (1994) 49 
Fietz, T. et ai., Annual Report 1993 p. 66, Institute of Bioinorganic and Radio 
pharmaceutical Chemistry, FZR-32 
Glaser, M. et al., Annual Report Y 993 p. 70, Institute of Bioinorganic and Radio 
pharmaceutid Chemistry, FZR-32 
pH value Rhenium complex 
13, STABlLlZlNG AQUEOUS SOLUTIONS OF LlPOPHlLIC SUBSTANCES 
BY CYCLODEXTRINS 
R. Berger, H. Spies 
Binding studies on receptor sites may be complicated by poor solubility of the com- 
pounds in aqueous solution. That is so in the case of "spiperone-like" rhenium com- 
plexes (Fig. 1) [I]. 
Studies were therefore carried out regarding the miscibility of their dimethylsulph- 
oxide (DMSO) solutions with water and to enhance the solubility by cyclodextrins. 
Fig. 1: Structure of a 4-fluorobutyrophenone-containing neutral rhenium complex 
(X = S (I), 0 (11) and NCH3 (iil)} 
In Fig. 2 the influence of adding water to the DMSO solution of the rhenium complex 
I1 is shown. 
An addition of water to the DMSO solution in a volume ratio of 1 to 1 does not cause 
any change of solubility (cuwe I), as obsewed by the corresponding UVNlS 
absorption spectrum. If the water is added to the volume of the DMSO solution in a 
15-fold excess the mixiure becomes turbid with the consequence that the rhenium 
complex precipitates (cuwe 2). 
For overcoming this disadvantage cyclodextrin was investigated for its applicability 
as a soiubilizer. 
Cyclodextrins containing six, seven, or eight glucose units in a circle (a-, P-, or Y- 
cyclodextrins) are often used to improve ihe water solubility of poorly-soluble 
ingredients. For the solubiliation of drugs, for instance, concentrations of solubilizer 
from 5 - 50 % are recommended 121. The solubiiity of a lipophilic substance in- 
creases usually linearly proportionally to the cyclodextrin concent~ration in aqueous 
buffer, due to the formation of a complex Hydrophobic interactions drive the lipo- 
philic compound into the cyclodextrin caviiy, displacing water molecules and forming 
the guest-host complex [3,4, 51. 
Fig. 2: Time-dependent solubility of rhenium complex II in DMSO afier adding an 
equal(1) and a 15-fold (2) volume of water 
The solubility of various substances both in water and in 45 % VIV aqueous 2- 
hydroxypropyl-ß-cyclodextrin (HBC) has been investigated 161. 
The usefulness of hydroxypropyl-ß-cyclodextrin to enhance the water solubility of the 
Same rhenium complexes as presented in Fig. 1 has been tested. 
Although it has been recommended that compounds to be dissolved should be 
pulverized and added to the clear solution of solubilizer [2], these experiments were 
generally carried out by dissolving the rhenium complex in a minor volume of DMSO, 
adding a definite amount of HBC to this solution and finally filiing up with small 
portions of water in a measuring vessel. For further studies iof receptorlligand 
binding, the aqueous Iigand solutions should be stable and contain the DMSO as 
well as the HBC in concentrations as mal l  as possible. 
Pure ligand solutions in DMSO and also acetonitrile are stable over weeks, but for 
the assessment of binding to biological material (e.g. iissue homogenates) such 
organic solutions are unsuiiable. 
In Fig. 3 the results of these experiments are summarized. t can be seen that 0nly in 
a solution containing 6 % DMSO and 3 % HBC the rhenium cvtmplex 11 remains 
stable without forming a precipitation for 8 hours at least. The rhenium complexes 
and III show an analogous behaviour. 
Because of the small concentration of aqueous HBC solutions used, the appropriate 
rhenium complex has to be dissolved first in a volume of DMSO designed to produce 
0 20 40 60 80 100 
Time [h] 
Fig. 3: Time-dependent stability of aqueous 5 . lo4  molar solutions of rhenium com 
plex II with different percentages of DMSO and HBC (curves 1,2, 3 contain 
6%and3%,4%and2%, 1 %and l  %DMSOandHBC) 
a concentration of 6 % (VIV) of DMSO. A relatively diluted HBC solution of only 3 % 
(VIV) is obviously suited for stabilizing aqueous solutions of these rhenium 
complexes. 
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14. DOES CYCLODEXTRIN AFFECT LIGANDIRECEPTOR BlNDlNG 
STUDIES ? 
R. Berger, J. Wober, P. Brust, H. Spies 
With respect to our investigations of their potential receptor binding properties, 
technetium and rhenium complexes have been tested concerning their binding to the 
dopamine D2 receptor. 
Substances intended to be used as potential brain agents should have properties 
allowing their penetration through the blood brain barrier. Usually such agents are 
quite lipophilic and, consequently, only poorly soluble in water. For practical appli- 
cations there are manifold efforts to increase the water solubility of these and other 
substances of partial therapeutical interest. In some cases the water solubility of 
lipophilic compounds can be improved by using 2-hydroxypropyl-P-cyclodextrin 
(HBC) as a solubilizer [I, 21. 
We studied the receptor binding of this agents dissolved in an aqueous medium with 
and without cyclodextrin as solubilizer. 
As antagonist of the receptor dopamine D2 (+)-butaclamol was selected. The 
assessment of its binding was carried out by competitive displacement of T~jspipe- 
rone bound to tissue homogenized from rat brain striatum. 
When the radiolabelled ligand is incubated with tissue containing specific binding 
sites for this ligand, a distinct amount of radioactivity is bound. The amount of bound 
tracer is separated from free radioactivity by filtration over glass-fiber filters. 
Background binding to non-receptor sites and lipid phases is measured in the 
presence of an about 1000-fold excess of an unlabelled receptor binding compound, 
e.g. (+)-butaclamol. 
The preliminary results of this binding study are shown in Fig. 1. In this diagram WO 
solutions of (+)-butaclamol of the same concentraiion butwith different solubiiizers in 
aqueous solution are represented by corresponding curves. For solution 1 (+)-bu@- 
clamol is dissolved in a srnall volume of ethanol, end then diluted with water up to a 
concentration of 2 % (viv) of ethanoiic aqueous solution (cuwe 1). The aqueous 
solution 2 of (+)-butaclamol contains HBC and dimethylsulpho~de (DMSO) as 
solubiliiers with cancentrations af 3 % (vlv) and 6 % (VIV) (cuwe 2). For the pre- 
paration of solution 2 (+)-butaclamol is dissolved in a small volume 0f DMSO. T0 this 
solution a definite amount of HBC is added and filled up with water in small portions 
[2]. For curve 2 the value relating to a specific binding of f~ lsp i~erone of 100 Per- 
Cent had to be corrected. Because the underlying measuring sample did not con&ain 
(+)-butaclamoi and thus neither HBC nor DMSO, the infiuence of the last hnro 
compounds had to be considered. In the system containing 3 % HBC and 6 % 
DMSO, the binding of [3~]spiperone is diminished by about 50 percent. This 
decrease was appliid for the correti~on. 
From the curves 1 and 2 %e Same lcwvalue (the concentration of half-maximai 
inhibition) of about 4.X 10* moVl can be denved. 
Apart from the remark On the product Data Sheet of the company RB1 that the HBC 
are not recommended in receptor binding assays 131, neither additional arguments 
nor other related information weie found in the relevant literature. 
The preliminasr resuits show that the use of HBC even as a solubilizer for relatively 
poorly soluble substances doesnSt drastimlly alter the result of the receptoriligand 
binding studies. In particular, solutions of about 3 percent and with a DMSO content 
of up to 6 percent might be quite suitable. 
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15. TECHNETIUM AND RHENIUM COMPLEXES OF DERIVATIZED 
NUCLEIC ACID COMPONENTS 
1. TECHNETIUM COMPLEXES OF URACIL-MAGn LIGANDS 
St. Noll, B. Noll, H. Spies, B. Johannsen, L. ~inkelborg', W. semmlerl 
'lnstitut für Diagnostikforschung Berlin 
Pyrimidine derivatives seem worth beeing included in our studies on "reactive" Tc 
tracers. Pyrimidine moieties are of interest because both of the eminent role pyrimi- 
dines play as nucleic acid constituents in the organism and their potential as delivery 
systems for selective transport of technetium into tissues. For instance, the ability of 
2-thiouracil to be selectively taken up into melanomas [I] gave rise to the proposal 
that derivatives of thiouracil should be used as boron-delivering systems for trans- 
port of boron into melanomas [2]. 
On the other hand, they are also of interest from the point of view of coordination 
chemisw. 
The pyrimidine bases may act as "anchor groups" in biifunctional agents, or agents 
can be designed in which the pyrimidines are integrated parts of the chelate unit by 
coupling them with appropriate 0, N or S-containing moieties. Considering the ability 
of, for example, uracil to exist in diierent tautomeric forms, manifold coordination 
modes are anticipated to occur in the complexation reactions of Tc or Re with such 
chelating agents. 
Preliminary studies involve M different types of bases, a) uracil as the parent 
compound and b) orotic acid as a representafie containing a carboxylic group, both 
substituted with mercaptoacetyl glycine moieties. The following two Papers provide 
information on preliminary studies concerning ligand synthesis, labelling experi- 
ments and bio-behaviour of the resulting cornplexes. 
Synthesis of ligands 
Synthesis of ligands follows the routes shown in Fig. 1. 
~mercap~ace&lamine~racil (MAU) 
5aminouracil reads with chloroacetyl Chloride in 0.2 N sodiurn hydroxide to 
5-chioro-acetylamino-uracil. Subsequent reaction with thiobenzoic acid in sodiurn 
methylatelmethanol yields 5-be~oylmercaptoacetylamino-uracil. 5-mercaptoacetyl- 
I 1 
Fig. I: Readion scheme 
arninouracil was obiained by a special procedure described in [3] in an Overall yield 
of 16 %, based on 5-aminouracil. 
Melting point: 240 "C (subl.) 
TLC (Silufol//n-butanollacetic acidlwater 2:l:l) & 0.75 (UV, 245 nm) 
Elemental analysis: (Found: C, 35.64; H, 3.63; N, 20.57; S, 15.87, C6H703N3S 
requires C, 35.82; H, 3.51 ; N, 20.88; S, 15.93 %) 
1 H NMR data: 6~(250 MHz; solvent DMSO; standard TMS) 2.91 (IH, -SH), 3.50 
(2H, -CHz), 8.10 (?H, -CH), 9.35 (1 H, NH-CO), 10.66 (1 H, NH„& 
I I .50 (1 H, NH„) 
~benzoylmercaptoacetyl diglycylamino uracil (Bz-MAGTAU) 
Benzoylmercaptoacetyl-diglycine was coupled to 5-aminouracil by means of ethyl- 
diisopropylamine and benzotrierzo-lyl-tetramethyluronium-tetrafluorborate. 
Yield: 57 %. 
Melting Point: 293 "C 
TLC (Silufollln-butanollacetic acidlwater 2:l :I) Rf0.70 (W, 245 nm) 
Elemental analysis: (Found: C, 48.42; H, 4.10; N, 16.43; S, 7.38, Ct7H1706N5S 
requires C, 48.68; H, 4.09; N, 16.70; S, 7.64 %) 
1 H NMR data: 6~(250 MHz; solvent DMSO; standard TMS) 3.75 (6H, -CH2), 7.54- 
7.92 (5H, CHmm), 8.18-8.49 (3H, NH-CO), 9.09 (IH, CH-), 10.66 
($H, NHwd, 11.45 N H 4  
Complex formation 
Ligand exchange reactions on T c 0  gluconate were carried out both at the "c.a." 
level and at the "n.c.a." level. Tc gluconate was prepared as previously described 
~41. 
MAU and Tc(V)-gluconate at " c.a. " level 
MAU was added to T c 0  gluconate (1.3 X lodM) both in neutral and in alkaline 
solution. The amount of MAU varies from equimolar ratio ligandfic to an eightfold 
excess. 
MAU and Tc(V) gluconate at "n.c.a. " level 
0.5 mg MAU dissolved in 400 pl 0.1 N sodium hydroxide is added to 2 ml 8 4 m ~ ~  
giuconate prepared according to 141. After a reaction time of 30 min the reaction 
mixture is neutraked by adding 40 p1 1 N hydrochloric acid. 
MAGpAU and Tc(V)-gluconate at "n.c.a." level 
50 pl 1 M sodium methylate was added to 3,4 mg of S-benzoyl protected amino- 
uracil-coupled MAGz dissolved in 200 PI DMSO. After 20 min the saponified ligand 
was added to 2 ml s9m~c gluconate. The incubation time should not be less than 
30 minutes. 
Anirnal studies 
The biodistribution and elimination of Tc-99m-MAU and Tc-99m-MAG2-AU were 
investigated in mice. 74 kBq of the complexes were intravenously injected into mice. 
The animals were sacrificed after 0.5, 1, 3 and 5 h. The percentage of the injected 
dose (% ID) as well as the percentage of the injected dose per gram of tissue 
(% IDIg) were determined. 
Results and discussion 
TC-MAU 
At "c.a." level the formation of a 2:l complex in alkaline solution can be deduced 
from the extinction at 380 nm in the UVNfS SPeCtra depending on the molar ratio 
MAUITc. Ligand exchange in neutral solution is incomplete but yields the Same 
compound as shown by the UVMS spectra. In electrophoresis, both at pH 7 and pH 
2, one anionic cornponent was found with a mobility of - 0.1. Because there is no 
diierence in the mobilities of the Tc-MAU complexes in the pH scale from pH 2 - 7, 
the charge of the complex anion is independent of changes in pH. 
lnvestigations at the "n.c.a." fevel resulted in One component (95 %), detected by 
TLC (silicagelllethanollwater 95:5), Rt = 0.70 and by HPLC (Hypersil ODS; 
60 % MeOH140 % phosphate buffer pH7// 10 % MeOHl9O % phosphate buffer pH 7). 
Rt 2.3 min. 
In electrophoresis in phosphate buffer at pH 7 three components were separated: 
one neutral component (ca. 15 %) and two anions with - 0.1 (35 %) and U,*, - 0.2 
(50 %). 
A Separation into three compounds was also found in glyeine buffer at pH 2: U,, = o 
(ca. 5 - 10 %); urd - 0.2 (ca. 15 %) and um, - 0.5 (Ca. 75 %). 
Whereas at "c.a." level protonation of any functional group of the ligand molecule 
can be excluded because of the electrophoretic behaviour , the pH-dependent be- 
haviour of the main cornponent at "n.c.a." level indicates a protonation of a functional 
group in the ligand molecule. 
Mdney urine llver Intesiine blood 
Fig. 2: Biodistribution ofB"%-~NJ in mice as a function of time 
The biodistribution study of 99" r~-MA~ in mice was carried out without further purifi- 
cation of the reaction mixture and is depicted in Fig. 2. 
TC-MA GrAU 
In comparison with MAU the labelling of MAG2-AU resulted in a relatively homo- 
geneous product detected by electrophoresis. The by-products ( ~ 2 0  %) are probably 
Tc complexes of a higher ligandiic molar ratio analogeous to the by-products occur- 
ring in the preparation of the renal function agent Bm~c -MA~3  151. The lower ion 
mobility (u,~ - 0.25) compared with g9"'l~-MA~3 (urel - 0.6) at pH 7 can be explained 
by the fact that there is no carboxyiic group in the MAG2-AU molecule and by the 
increased molecule size. in TLC (silicagellimethanollwater 955) the main com- 
ponent was found at Rt = 0.7 (ca. 80 %), the by-products at ß& = 0.15 and % = 0.6. 
Purification of the 9 9 m ~ c - ~ ~ ~ a  was carried out by HPLC on Kromasil RP 18 column 
and phosphate buffer pH 58/methanol85115 as etuent (R, = 6.0 min). 
These preliminary results are in accordance with the proposed speculative 
structures shown in Fig. 3. MAG2-AU is expected to form a 1:l complex analogous to 
the well known Tc-JU4G3 renal function agent, whereas MAU can fsrm 4:l Or 2:l 
complexes because there are only two donor atoms avalable in the ligand molecule. 
lnvestigations with MAG2-AU at "c.a." level are in Progress. 
Fig. 3: Proposed structure of Tc-MAU and Tc-MAG2-AU 
The biodistribution study of s S ' " T ~ - ~ ~ ~ 2 - ~ ~  in mice is depicted in Fig. 4. 
Fig. 4: Biodistribution of 9 9 m ~ c - ~ ~ ~ 2 - ~ ~  in mice as a function of time 
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16. TECHNETIUM AND RHENIUM COMPLEXES OF DERlVATlZED 
NUCLEIC AClD COMPONENTS 
2. TECHNETIUM COMPLEXES OF 5-MERCAPTOACETYLAMINO 
OROTIC AClD (MAOA) 
St. Noll, B. Noll, H. Spies, L. ~inkelborg', W. ~emmler' 
'Institut für Diagnostikforschung Berlin 
Orotic acid (6-carboxyuracil) is included in our studies as an interesting functional 
derivative of uracil. Whether or not the carboxylic group present in 6-position will 
pariicipate in the coordination sphere and the influence on bio-behaviour are 
questions of special interest. From a physiological point of view, orotic acid is 
capable of crossing the intact blood barrier and of participating in the protein 
metabolism in the brain. 
Synthesis of 5-mercaptoacetylamino oroüc acid (MAOA) 
Synthesis of the ligand follows the route shown in Fig. I. 
5-mercaptoacetylaminoorotic acid (MAOAJ 
5-chloroacetylamino-orotic acid was obtained by chloroacetylation of 5-aminosrotic 
acid in 1 N sodium hydroxide. Subsequent reaction with thiobenzoic acid gives 
5-benzoyl-mercaptoacefylamino-orotic acid. 5-mercaptoacetylamino-orotic acid was 
obtained following the procedure described in 111. The overall yieid is 8 Yo. 
Melting point: 320 "C (decomp.). 
TLC (Silufolll n-butanollacetic acidlwater 2:l:l) F& 0.25 (UV, ninhydrine) 
Elemental anaiysis: (Found: C, 34.07; H, 2.59; N, 17.39; S, 13.22, CM70sN3S 
requires C, 34.29; H, 2.88; N, 17.14; S, 13.07 %) 
'H NMR data: &(250 MHz; solvent DMSO; standard iMS) 2.74 (IH, SH), 3.67 
(2H, -CH2), 9.30 ( I  H, NH-CO), 10.27 (<H, NH„) 11.28 (1 H, Nhce) 
Fig. 1 : Reaction scheme 
Complex formation 
E-periments were carried out with the MAOA ligand in order to obtain some first 
results conceming the affinity to form complexes with technetium. Reactions at 
"carrier added level were performed with the S-proteded ligand 5-benzoyl- 
mercaptoacetylamino-orotic acid because of its higher stability in comparison with 
the S-unprotected ligand. 
MAOA is expected to form a MAOAITc 2:1 complex analogous to the Tc-MAU 
complex previously reported M. 
Preparafion of the Tc complex at "c.a. " level: 
Complexes were prepared by ligand exchange reacüon, starting from the Tc- 
gluconate complex To 2.1*104 mol Bz-MAOA solved in 400 pI DMSO, 40 pl sodium 
methylate is added. The solution clouds due to the insolubility of the saponified 
ligand. By adding 100 p1 water, the ligand is solved, and the molar equivalents 
according to the IigandlTc molar ratio are added to the Tc-gluconate solution 
(prepared by addition of I * l ~ "mo l  stannous chloride to MO" mol potassium 
pertechnetate in 2 m10.05 M sodium gluconate Solution). 
Preparafion of the Tc complex af "n.c.a. "level 
0.5 mg MAOA solved in 400 pI 0.1 N sodium hydroxide is added to 2 ml -TC 
gluconate prepared according to [3], Afier 30 min the reaction mixture is neutralized 
by adding 40 p1 1 N hydrochloric acid. 
Resutts and discussion 
Addition of MAOA to Tc gluconate under spectrophotometric control leads to an 
increasing absorption maximum at 360 nrn in the UVNlS spectrum. (This value is 
compatible with Tc-carboxylic group coordination in the Tc-MAG2 [4] ). The molar 
ratio of the resulting TcßVIAOA species could not be determined because of 
inwmpiete complex formation, Mich  can be explained either by an incomplete 
saponification of the benzoylic protected ligand or by the pH value of the reaction 
solution beeing too low. Up to a molar ratio of 8:l a steady increase of extinction was 
obsewed. An analogous behaviour is known from the Iigand exchange of MAUiTc 
gluconate in neutral solution 121. 
All analytical data determined are in good agreement both at "c.a." and "n.c.a." level. 
In electrophoresis (phosphate buffer pH 7) the incomplete reaction was confirmed. 
Up to a molar ratio of 4:1, both the Tc-MAOA complex and Tc gluconate are present 
in the reaction mixture. 
It is noteworthy that the Tc-MAOA cornplex has a higher anionic mobility than the Tc- 
MAU wmplex (U& = 0.7 and 0.1). This high rnobility can be explained by an 
additional negative charge of the ToMAOA anion due to the presence of a carb- 
oxylic group. The mobility of Tc-MAOA was diminished to U,, = 0.4 in glycine buffer 
at pH 2 because of protonation of a "free" carboxylic group. 
TLC (Silicagel6O/lethanoI/water 955) shows a peak at Rr = 0.2. In XPLC (RP 18 
columnllphosphate bufferlmethanol 90:lO) the reaction mixture was separated into 
three components with Rt = 1.8 rnin, Rt = 2.4 min and Rt = 2.8 min, 
These peaks indicate the formation of several, probably isomeric complexes, Mich 
was expected in view of our previous experience with the MAG, systern. 
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17. TECHNETIUM AND RHENIUM COMPLEXES OF DERIVATIZED 
NUCLEIC ACID COMPONENTS 
3. COMPLEX FORMATION OF TECHNETIUM WlTH MAG2 
DERIVATNES OF CYTIDINE 
St. Noll, B. Noll, H. Spies, B. Johannsen 
A further extension of our efforts to design Tc and Re complexes of nucleic acid 
components involves nucleosides. As a first representative, cytidine was allowed to 
react with S-benzoylmercaptoacetyldiglycine (Bz-MAG2) to give the corresponding 
amide S-Bz-MAGrCyt. This compound is expected to react as tetradentate SN3 
ligand after removing the benzoylic group and to form a stable anionic oxotechne- 
tium complex to which the nucleoside as the pendant moiety is bound via the 
cytidine-amine group. The article describes the synthesis of the ligand S-Bz-MAG2- 
Cyt and complexation experiments. 
Synfhesis of fhe Iigand 
Synthesis follows the way described in Fig. 1. 
Fig.1: Reaction scheme 
To a mixture of 160 mg (0.5 mmol) benzoyl-MAG2 and 165 mg (0.5 mmol) 0-(IH- 
benzotriazol-1yl)-N,N,N',N'-tetramethyluroni tetrafluoroborate (TBTU) in 1 ml of 
I-methyl-2-pyrrolidone 170 pl ( I  mmol) ethyldiisopropylamine was added while 
stirring vigorously. After 3 min the solution was dropped to 97.3 mg (0.4 mmol) 
cytidine dissolved in 1 mi of I-methyl-2-pyrrolidone and stirring was continued for 
4 h at room temperature. After that the solvent was removed in vacuum, the residue 
was dissolved in ethanoilwater 1:l and dried again. The brown crystals were 
extracted with hot water and on cooling the reaction product began to crystallize. 
Yield: (144 mg, 67 %) 
M.p. 136 "C 
TLC: (Silufolll n-butanollacetic acidlwater 2:l :I) Rf 0.75 (UV) 
(RP 18/lmethanol/water 9:l) Rt 0.7 (UV) 
Elemental analysis: (Found: C, 49.60; H, 4.81; N, 12.79; S, 5.96, CzHZ5N509S 
requires C, 49.34; H, 4.71; N, 13.08; S, 5.99%) 
'H NMR data: 6~(250 MHz; solvent DMSO; standard TMS) 3.59 (2H, CHiOH), 3.79 
(2H, -CHyN), 3.80 (2H, CHz), 3.98 (2H, -CHzN), 5.03-5.78 (4H, 
ribose), 7.12 (1 H, heterocycl.), 7.57 - 7.94 (SH, arom.), 8.21 (1 H, NH), 
8.43 (1 H, heterocycl.), 8.53 (1 H, NH), 10.91 (?H, NH). 
Complexation reaction 
UVNlS spectra depending on the molar ratio Tc gluconateiMAG derivative were re- 
corded by means of the spectrophotometer Specord S10. The chromatographic 
behaviour was determined by thin layer chromatography on silica gel and 95 % 
ethanol as the solvent and by HPLC on an RP 18 column (Hypersil ODS), 3 min 
isocratic, 15 min gradient +I from 100 % A io 10 % A (solvent A: 0.01 M phosphate 
buffer pH 5.9, eiuent B: methanol). 
The S-benzoyl-protected ligand was saponified with sodium methylate and used 
without furiher purification. The ligand exchange reactions at "c.a." level were 
carried out with 5 X lo4 M T c 0  gluconate precursor by varying the molar ratio 
IigandiTc in the range from 0.5 : 1 to 2 : I in neutral and alkaline solution. 
Tc gluconate was prepared as previously described. 
Results 
Addition of an aqueous solution of MAGTCyt to a neutral Tc gluconate solution gives 
a UV absorption at 360 nm, the extinction is increased with the increase of the molar 
ratio IigandlTc (Fig. 1). The maximum extindion is only obtained with an excess of 
the ligand and is not altered by alkalization of this neutral solution. 
Fig. 1: UV spectra ofthe ligand exchange reaction TC gluconateAIIA&-Cyt at various 
molar ratios MAGTCyU Tc-gluc., I - 0.5 : 1, 11- 1 : 1; 111 - 2 : 1, IV - 4 : 1 
If the ligand exchange is carried out in alkaline solution, no characteristic UV ab- 
Sorption is observed. It is therefore assumed that the absorption at 360 nm is caused 
by the component I I  obtained by HPLC analysis (Fig. 2). The anionic mobility of this 
complex was 0.6 related to that of pertechnetate both at pH 7.0 and pH 2.0. 
The composition of the readmn mixtures depending On the molar ratio is listed in 
Table 1. 
As indicated by HPLC, ligand exchange reaction with varying ligandltechnetium ratio 
results mainly in two wmplexes of Tc-MAGTCY~. At a 1:l molar ratio in neutral 
solution two wm-plexes I and Ii are obtained as shown in Fig. 2 with I being the 
predominant species. 
Fig. 2: HPLC Separation of the reaction mixtures TdMAG2-Cyt in dependence on the 
pH-value and the molar ratio (I : predominant comptex at molar ratios I 1, 
II : predominant complex in Iigand excess) 
a) molar ratio MAG2-Cyt:Tc-gluc. 2:l; neutral solution 
b) molar ratio MAG2-Cyt:Tc-gluc. $3; neutral soiution 
C) molar ratio MA&CytTc-gluc. I :I ;alkaline solution 
An increase of the molar ratio leads to a reverse of the amounts of I and II. tn 
alkaline solution only the camplex I is formed. A similar behaviour was obse~ed in 
the exchange reaction dih MAG3 as the ligand [I]. 
Table 1: Composition of the reaction mixture in dependence on the molar ratio 
MAG2-CytiTc gluconate and pH, reaction time 30 min 
Molar ratio 
(MAG&# : TC ~Iuc.) 
neutral 
0.5:l 
alkaline 
HPLC 
Tc gluc. Tc-MAGrCyt 
%= 2.21' Rf= 11.0' 
%=11.8' 
Rf = 13.0' 
[%I 
60.0 7.0 
28.0 
5.0 
TLC 
TC gluc. T c - M A G ~ - C ~ ~  
Rf= 0 Rf= 0.8 
A possible explaination is that at low TcJligand ratios and at pHM1 the formation of 
the 1:l complex is preferred while at any excess of ligand complexes with more than 
one ligand molecule bound to the Tc are formed. Compound II seems to be the 2:l 
compiex 
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18. SYNTHESE OF N(21VIERCAPTOETHYL)NICOTINAMIDES 
Zhi Fen Su, St. Noll, H. Spies 
The design of new technetium and rhenium radioiracers may also make use of the 
abiiity of certain organic compounds to undergo redox processes in vivo. 
To explore the principle of Bodor et al. [I], W o  demonstrated that drugs can be 
selectively delivered to the brain, using a dihydropyridinelpyridinium salt redox 
system for the design of redox-sensitive radiotracers, the synthesis of technetium 
and rhenium complexes equipped with the dihydropyridinelpyridinium redox system 
is necessary. This requires appropriate ligands with a pyridinium or dihydropyridine 
moiety. Because in our concept the ligands are intended to react as monodentates 
to form neutral mixed-ligand 3+1" complexes 121, the synthesis is aimed at the SH- 
functionalization of nicotinamide derivatives. 
In continuing our first efforts concerning redox tracers 131, we now repori on the 
synthesis of derivatives of N-(2-mercaptoethy1)-nicotinamide and derived pyridinium 
compounds. 
Functionaliation of the nicotinamide molecule with an -SH group is accomplished by 
introducing a 2-mercaptoethyl group at the amide N-atom. 
Schemes 1 and 2 illustrate two different routes 
Route 1, M ich  is based on a procedure reported by Kuhn [4], involves an intra- 
molecular rearrangement of the thiol ester formed in the reaction of thiol acids with 
aziridine to the corresponding N(2-mercaptoethyl) amides However, the reaction 
was only successful with thioacetic acid and thiobenzoic acid but has so far failed 
with thionicotinic acid. Obviousiy the latier forms dimer products instead of 5 under 
the conditions used for purification of the reaction mixture. 
An alternative rouie 2 starts with nicotinic acid, from Wich N-nicotinoylethylene 
imines 2 were prepared by reaction with ethylene imines in the presence of 
dicyclohexylcarbodiimide in DMF 151. The attached efiyiene imine rings are acti- 
vated and can be opened with thiobenzoic acid to give the S-protested compounds 
3. Subsequent aikylation results in the S-benzoylaied N-afkylpyridinjum salts & The 
-
compounds are obtained in good yields by refluxing 3 with methyl iodide, propyl 
iodide, or benzyl Chloride with or without a solvent. 
Reaction scheme 1: 
The crucial point of the synthesis of the mercapto ligand is ihe removal of the 
protective benzoyl group. Treatment of 3 with sodium methylate followed by acidi- 
fication of ihe mi>bure converts 3 completely into 5 even at 0 "C in about half an 
hour, but a large amount of disulphide is formed as a side product. The reaction 
conditions must iherefore be modiiied. 
Reaction scheme 2: 
References 
[I] Bodor, N. and A. M. Abd el Alim, J. Pharm. Soc. 74 (1985) 241 
121 Spies, H. et al., Annual Report 1992, p. 94, Institute of Bioinorganic and 
Radiopharmaceutical Chemistry, FZR 93-12 
[3] Bergmann, R. et al., Annual Report 1992, p. 122, Institute of Bioinorganic and 
Radiopharmaceutical Chemistry, FZR 93-12 
[4] Kuhn, R. and G. Quadbeck, Chem. Ber. 84 (1951) 844 
[5] Ross,W. C. J. et al., J. Med. Chem. 10 (1967) 257 
19. RADIOCHEMICAL PURITY OF 99M~C-HM-PAO: CRITICAL 
PARAMETERS DURING KIT PREPARATION 
S. Seifert, 0. ~u th ' ,  K. ~antsch', B. Johannsen 
1 Verein für Kernverfahrenstechnik und Analytik, Rossendorf 
The instability of the reconstituted HM-PA0 kit is characterized by the tendency of 
the primary lipophilic complex content to diminish with time, producing a secondary, 
less lipophilic, complex and pertechnetate. Factors Mich  favour the decomposition 
of the lipophilic complex are its own instability, high doses of radiation, the presence 
of excess Sn2' ions and a pH greater than 9 [1,2]. The radiochemical purity 
specification of not less than 80 % lipophilic complex requires that the kit be used 
within 30 min of reconstitution. 
A number of approaches have been tried to extend the post-reconstitution shelf life 
from 30 min and to overcome the restrictions imposed on the eluate used [3,4,5]. 
Additions of weak chelating agents, oxidizing agents, free radical scavengers, 
eihanol, pH-adjusting agents and metal ions Mich could form complexes with HM- 
PA0 w r e  tested. The best results were achieved by the addition of cobalt chloride 
to the reconstituted kii, d i c h  can extend the shelf iiie to at least 5 h post 
reconstitution 161. 
The time and temperature proved to be critical Parameters during the kit preparation. 
We found that without adding any stabilging agents a higher stability of the 
reconstituted kit is obtained, 1 the S~~'/HM-PAO solution is allowed to stand at room 
temperature for at least 1 h before freeze-drying. 
Following the regulations of a usual kit preparation, the ligand and the reducing 
agent are dissolved in Saline or other solvents and mixed to give the stock solution. 
The solution is woled and bubbled with nitrogen to prevent a rapid oxidation of 
stannous Chloride. Aliquots of this solution are bottled as quickly as possible into the 
kit vials, immediately frozen in liquid nitrogen and freeze-dried. Hundreds of vials 
have to be filled at this step of kit production. That results in time diierences of 30 or 
more minutes between bottling of the first and the last vial. As this could be the 
reason of the diierences in radiochemical purity obsewed for individual vials of one 
batch, we made the following eqeriments: 
As a first step the time before bottling was extended to 1 and 2 h. As a second step 
the cooling was omitted and the time was reduced again to one hour. 
Using kits containing 0.5 mg HM-PA0 (94 % d,l form), 5.0 pg SnCIz X 2H20 and 4.5 
mg NaCl in freeze-dried form results in the specified stabilities of the primary 
complex (Table 1). The yields of primary and secondary complex and pertechnetate 
were determined by HPLC (Fig. 1) acwrding to m. Only traces of pertechnetate 
were detected after 60 min. 2 - 3 % of reduced hydrolysed technetium were found On 
an average by TLC. The results are reproducible and only small diierences in 
radiochemical purity are obsewed from via1 to vial. 
The same results were obtained using 7.5 pg SnCh X 2 H20 per via1 as described for 
the original kit formulation. 
Table 1: Stability of the primary complex as a function of time and temperature used 
during kit preparation 
'I0 - 120 min post reconstitution 
Fig. 1: HPLC analyses of " T c  d,I-HM-PA0 10, 35 and 60 min post reconstitution 
with 1.5 GBq -04 
The relatively high background of the chromatograms between 5 and 10 min at 11.0 
GBq or more seems to be caused by the instability of the primary complex, whiich 
increases dramatically if the ligand excess is removed. That is the case during the 
HPLC analysis, because the free iigand is eluted from the column with another 
elution time than the primary complex We separated the primary complex fraction 
and reinjected it after 15 and 35 min. The chromatograms show a nearly quantitative 
decomposition of the primary complex, mainly to pertechnetate (Fig. 2). That means, 
that small amounts of the primary complex decompose during the analysis. 
At present not enough information is available to explain the higher stability of -TC- 
HM-PA0 preparations. A possible explanation could be that time-dependent 
complex fomation of sn2+ and HM-PAO, which is accelerated at room temperature, 
is responsible for the higher stability of the primary complex Corresponding 
investigaiions by HPLC, TLC and electrophoresis studies wiih non-radioactive and 
radioactive "'~n wer@ canied out. The results obtained do not indicate any complex 
fomation of sn2+ with HM-PAO. . 
A time-dependent hydrolysis of stannous ions to a colloidal solution of stannous 
hydroxide should also be discussed as an explanation of the improvement of the 
q u a l i  of the kit. Investigations of freeze-dried samples of various sn2' I HM-PA0 I 
Fig 2: HPLC analyses of -C-HM-PAO after 35 min (a) and reinjection of the 
separated primary complexfraction &er 15 (b) and 35 min (C) 
NaCI solutions by electron microscope studies showed only little change in micros- 
copic appearance. No diierences w r e  observed between ki samples freae-dried 
after 5 and 120 min. 
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20. PREPARATION OF 2-['8F]FLUORO-2-DEOXY-D-GLUCOSE BY 
ALKALINE HYDROLYSIS OF 2-['8F]FLUORO-1,3,4,6-TETRA-0- 
ACETYL-D-GLUCOSE 
1. ELECTROPHlLlC REACTlON 
F. Füchtner, J. Steinbach, R. Lücke, R. Scholz', K. Neubert 
'Technische Universität Dresden, Klinik für Nuklearmedizin 
lntroduction 
Quite a few methods to prepare 'F labelled 2-["F]fluoro-2-deoxy-D-glucose 
(['8F]FDG) have been reported in the literature [I]. The widespread use of the 
radiopharmaceuticai ["FIFDG in diagnostic procedures with Positron Emission 
Tomography (PET) means that efforts towards improving and simpliiying the synthesis 
of I'~F]FDG are worthwhile. 
In 1993 a remote controlled apparatus for routine preparation of ["FIFDG on the basis 
of the electrophilic reaction according to Bida [2] was sei up at Rossendorf 131. Since 
then more than 70 preparations for animai and biochemical experiments and for 
optimization of the preparation procedure have been carried out. The preparation 
system proved to be simple and very reliable. During preparation and determination of 
the chemical and radiochemical purity [4] we found it possible to remove the acetyl 
groups of the 2-["F]fluoro-1 ,3,4,6-tetra-0-acetyl-D-glucose (TA-["FIFDG) by alkaline 
hydrolysis in a very short time and at room temperature. 
This paper reports on the possibility of removing the protective groups by alkaline 
hydrolysis in contrast to the commonly used time-consuming acidic hydrolysis with 
thermal treatment. 
Experimental 
The investigations for optimking the conditions for alkaline hydrolysis were carried out 
in the remote controlled laboratory system described in 131. In contrast to the previous 
procedure we introduced the following modifications. 
FIuorina fion 
The absorption of ihe gaseous acetylhypofiuorite ([''FIAcOF) in a solution of 30 mg 
tri-0-acetyl-D-glud (TAG, for synthesis, MERCK - Schuchardt) in 15 ml 
trichlorofiuoromethane (CFCI„ freon 11, for synthesis, MERCK - Schuchardt) at room 
temperature led to TA-[18F]FDG. 
Removal of protective groups 
Search for optimum mndifions of afkaline hydrolysis 
10 ml of distilled water were added to the remaining 5 ml of CFCI,. By blowing in 
gaseous N, at a flow rate of about 100 mllmin, the remaining solvent was evaporated 
at room temperature. After the evaporation I'~F]F' and TA-[I8F]FDG were in the 
aqueous phase. From the remaining aqueous solution a 1 ml aliquot was mixed with 
different amounts of a sodium hydroxide stock solution (prepared from a standard 
solution, MERCK) and distilled water, so that the final volume was always 2 ml. As a 
result we obtained solutions with sodium hydroxide concentrations of 0.01, 0.05, 0.1, 
0.3, 0.5, 1, 2.5 and 4.5 M NaOH. From each of these solutions a sample was 
immediately analysed by thin-layer chromatography (TLC) [5] after adding the 
hydroxide solution and mixing it. Further samples were taken at time in te~a ls  of 0.5, 
1,2,5, 10and20min. 
Sfandard preparafion procedure 
After the fiuorination of the precursor, 2 ml of 0.3 M sodium hydroxide (prepared from 
a standard solution, MERCK) were added to the remaining solvent. By blowing in 
gaseous N, at a flow of about 100 mllmin the remaining 5 ml CFCI, were evaporated 
at room temperature. During evaporation the TA-I'8F]F~G was dissolved in the 
aqueous phase, the protedive groups were removed and ["FIFDG was formed. 
Purifcation 
The reaction mixture was purified by using a wmbination of liquid chromatographic 
wlumns. On the first column (d, = 6 mm, L = 100 mm, OMNIFIT) filled with 2 ml cation 
exchanger (DOWEX 50 WX 8,100 - 200 mesh, H'-form, SERVA or for pharmaceuticai 
use AG 50W-X, 200 - 400 mesh, H+-form, BIO-RAD) the hydrolysis mixture was 
neutralized. To retain the partly hydrolysed intermediate products, a solid-phase 
extraction was employed on a styrene-divinylbenzene resin (LiChroluP' EN 1 g, 
MERCK) in an LC column (d, = 6 mm, L = 100 mm, OMNIFIT) [6]. For this purpose 
charcoai (adivated carbon, Darco G-90, ALDRICH, fraction > 50 pm) could also be 
used. The last column was a SEP-PAK cartridge ALUMINA A (Millipore) for retention 
of [fs~l~-. 
The ["FJFDG was eluted from the wlumns with sterile water (aqua ad iniectabilia, 
Serum-Werk Bernburg). For isotonic adjustment a calculated amount of NaCl (extra 
pure, MERCK) was added. The sterilization of the final product was achieved by sterile 
filtration (microporous membrane cellulose acetate, 0.22 vm, ALLTECH). 
Results 
Fluorinafion 
After the reaction between TAG and the gaseous [18F]AcOF had taken place about 5 ml 
of solvent remained in the reaction vessel. The step of fluorination took about 35 
minutes, including 10 minutes for transporting the radioactivity from the cyclotron 
through a transporting tube over a distance of 500 m and the evaporation of the 
remaining solvent. The TA-[I8F]FDG yield was about 90 %. 
Removal of profecfive groups 
Search for optimum conditions of alkaline hydrolysis 
The concentration of the sodium hydroxide was optimized so as to minimize both the 
alkaline concentration needed and the reaction time, on the one hand, and to maximize 
the yield of the reaction, on the other. 
Fig. 1 gives an example of the kinetic investigations and shows an autoradiogram of the 
product of hydrolysis with 0.05 M NaOH after different reaction times. These conditions 
were suitable for following up the Course of hydrolysis. 
I 
Fig. 1 
Autoradiogram of a TLC plate 
used for kinetic study of alkaline 
hydrolysis (0.05 M NaOH) 
sampling time 
1 - unhydrolysed TA-fi8FJFDG 
2 - after mixing 
3 - 0.5 min 4 - 1 min 
5 - 2  min 6 - 5  mln 
7 -  10 min 8 - 20 min 
Fig. 2 shows the forrning rate and the yield of forrning ["FIFDG during wnversion of 
TA-["FIFDG to ["FIFDG depending on the concentration of sodium hydroxide. The 
figure shows that the forrning rate for [18F]FDG increases with increasing hydroxide 
wncentration. However, the yield of forrning f8F]FDG reaches a rnaxirnurn at a sodiurn 
hydroxide concentration of 0.3 M. In this case about 90 % of the TA-["FIFDG are 
wnverted into ["FIFDG and the overall yield up to this step of synthesis is about 
yield [% FDG] 
Io0  
0  4 I 
0 1 2 3 4 5 6 7 8 9 1 0  
time [rnin] 
Fig.2 
Dependence o f 
fonning ["FIFDG on 
the sodiurn hydroxide 
concentration and 
reaction time during 
the alkaiine hydrolysis 
starting with the 
reaction rnixture afier 
fluorination 
Using a 0.3 M solution for hydrolysis, the rnaximurn reaction yield is reached after 
about one rninute. in addition, this wncentration is favourabte for the neutralization of 
the reaction rnixture. A cation exchanger with a capacity of only 0.6 mrnol is required 
in this case. 
At higher hydroxide concentrations more ['@F]F- is forrned and the yield for [''FjFDG 
decreases. 
Standard preparafion procedum 
The evaporation of the residual solvent takes about 7 rninutes. The readion prbduct 
is a clear and colourless solution. Fig. 3 shows a seriec of thin-layer chrornatograms 
of the alkaline hydrolysis in comparison with acid hydrolysis. 
The yield of forming [I8F]FDG and 2-[18Flfluoro-2-deoxy-D-mannose ([I8F]FDM) under 
alkaline conditions is between 75 and 80 Oh. This is about 20 % higher than M e n  
using acid reaction conditions. However, without thermal treatrnent of the alkaline 
hydrolysis solution, a residue Peak of a partly hydrolysed TA-[I8F]FDG or of a by- 
product is observed in the chromatogram (see Peak in Fig. 3 marked * ). This Peak is 
found in alt cases of alkaline hydrolysis and has a yield of about 5 % of the Overall 
radioactivity. 
sdioactivity [cpm] 
0 50 100 150 200 
flow direction [mm] 
Fig. 3: TL chromatograms of different hydrolysates 
A - acid hydrolysis, B - alkaline hydrolysis, C - alkaline hydrolysis (partly 
hydrolysed, 0.05 M NaOH, reaction time 2 min, compare Fig. 1) 
1 - [I8F]F., 2 - [I8F]FDG + [l8F]FDM, 3 - partly hydrolysed TA-["FIFDG, 
4 - T A - [ z 8 ~ j ~ ~ ~  
Purification 
The Separation of compound " x " requires an additional purification step in contast to 
the formerly described procedure . A method for the separation of such a polar by- 
product is the solid-phase extraction. Charcoal or polymeric resin is suitable for this 
purpose. 
A separation of [I8F]FDG from the partly hydrolysed by-products by charcoal is only 
obtained under alkaline conditions. Using for example 0.1 M NaOH, ["FJFDG and 
['*F]P are eluted from the charcoal column, whereas the by-product " * " is retained On 
the column. To reproduce charcoal columns with suitable chromatographic proper4ies 
is difficult. 
The polymer resin is simpler to handle and water can be employed as an eluent. A 
further advantage of resin is the possibility of regeneration of the whole 
chromatographic System for multiple use. 
The radiochemical purity of the final product mixture of [18F]FDG and ['8F]FDM is 
determined to >99 %. The concentration of the used solvent CFCI, in the final product 
is analysed by GC to .: 10 pglml. 
Synthesis in general 
The total preparation time afier €OB is about 40 minutes. Taking into consideration 
the splitting of the ["FIF, radioactivity into ['8F]AcOF and ["FIKF, the transporting 
iosses and the synthesis and chromatographic separation, the total yield of ["FIFDG 
is between 25 and 35 % €OS (uncorrected for decay). The yield starting from the 
fluorination step amounts to between 60 to 75 %. 
Conclusion 
The alkaline hydrolysis of TA-["FIFDG during the preparation of ["FIFDG has the 
following advantages: 
- Alkaline hydrolysis results in a reaction yield about 20 % higher than when using 
acid hydrolysis. 
- All steps of synthesis can be performed at room temperature. The synthesis wnit 
therefore becomes simpler, more reliable and easier to control. 
- Because ofthe high Speed of hydrolysis, the step of removing the protective groups 
does not take time in practice. Under acid conditions this step takes about 10 to 20 
minutes. Therefore the yieid of the preparation can be increased by 6 to $3 % by 
time saving. 
- in the Iiterature there is an indication of forming 2-deoxy-2-chloro-D-glucose (CIDG) 
as a chemical impunv during the preparation of [ I 8~ ]~DG,  using acid hydrolysis with 
HCI [7,8]. Using alkaline hydrotysis this by-produd is not formed. 
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21. PREPARATION OF 2-C8F]FLUOROd-DEOXY-D-GLUCOSE BY 
ALKALINE HYDROLYSIS OF 2-['8flFLUORO-i ,3,4,6-TETRA-0- 
ACETYL-D-GLUCOSE 
2. NUCLEOPHILK SUBSTITUTION 
F.Füchtner, J. Steinbach, R.Lücke, R. Scholzl, K. Neubert 
'Technische Universität Dresden, Klinik für Nuklearmedizin 
lntroduction 
The advanced procedutes for routine preparation of 2-[i8F~uoro-2-deo~-D-glucose 
([''FIFDG) are based on nucleophilic substiiution of the trifiate leaving group in 
1,3~6-tetra-O1icetyd2-O-t~flu0romethanesulphony-beta-Dannopyranose PDG- 
precursor) with r8F]F' using a phase-transfer catalyst anaiogous to Hamacher et al. 
[I]. Many rnodifications of the I'%]FDG synihesis have been described since its 
introduction to produce ihis important radiotracer more efficiently. 
The aim of this paper is to report on the possibiiity of applying alkaline hydrolysis 121 
to prepare [I8F]FDG by nucleophilic substitution to shorten the preparation time. 
Experimental 
Fluorination 
The m-camer added ['8F]F- was produced via 18~(p,n)'8F nuclear reaction using 200 
pI ''0 (95 %) enriched water (Chemotrade ChemiehandelsgesellschaftmbH) in a silver 
target 131 using 13 MeV protons of the Rossendorf U-120 cyclotron. 
The investigations for this synthesis were carried out in a simple experimental 
apparatus. The 200 pl [180]waterl['8F]F- wete added to the reaction vessel (15 ml 
teaction via1 with Septum) containing a solution of 4.6 mg potassium carbonate 
(MERCK) and 7 mg KryptofixTM 2.2.2 (MERCK) in 1.5 ml acetonitrilelwater (88 : 12). 
The solution was concentrated to dryness by heating to 90 "C in an oil bath and 
introducing an N, carrier gas flow of 100 mllmin. The process was repeated with 1 ml 
of anhydrous acetonitriie (MeCN, Fluka). A soluiion of 20 mg FDG-precursor (Fluka) 
in 1 ml anhydrous MeCN was added to the reaction vessel and the solution was 
refluxed for 5 minutes at a temperature of 90 "C yielding 2-['8Flfiuoro-l ,3,4,6-tetra-0- 
acetyl-D-glucose (TA-["FIFDG) . 
The reaction solution was evaporated to dryness by heating to 90 *C and using a 
carrier gas flow of N, at 100 mllmin. 
Removal of profective groups 
Search for optirnum conditions of alkaline hydrolysis 
The gas flow leaving the reaction vessel for analysing purposes was passed through 
a cooled via1 to trap the condensate. 10 ml of distilled water were transferred to the 
reaction via1 and the solution mixed by bubbling nitrogen gas through the liquid for one 
minute. A Iml aliquot from this solution was mixed with different volumes of a sodium 
hydroxide stock solution (prepared from a standard solution, MERCK) and distilled 
water, so that the final volume was always 2 ml. As a result we obtained solutions with 
sodium hydroxide concentrations of 0.01, 0.05, 0,1,0.2,0.3, 0.5 and 1 M NaOH. From 
each of these solutions a sample was analysed by thin-layer chromatography (TLC) [4] 
immediately after adding the hydroxide and mixing it. Further samples were taken at 
time intervals of 0.5, 1, 2, 5, 10 and 20 min. 
Standard preparation procedure 
The fluorinated precursor was hydrolysed by adding 2 ml of 0.3 M NaOH to the 
reaction vessel. The hydrolysate was mixed by N, bubbles for one minute at room 
temperature. 
Purification 
For purification purposes the reaction mixture containing ["FIFDG, partly hydrolysed 
TA-[IsF]FDG, ["FIF', KryptofixTM 12.2.21 and by-products was loaded on a column 
System. On the first column (d ,= 6 mm, L = 100 mm, OMNIFIT) filled with 2 ml cation 
exchanger (DOWEX 50 WX 8,100 - 200 mesh, H*-form, SERVA or for pharmaceutical 
use AG 50W-X8, 200 - 400 mesh, H'-form, BIO-RAD) the hydrolysis mixture was 
neutralised and the KryptofixTM 2.2.2 was separated. The concentration of KryptofixN 
2.2.2 was determined by a spectrophotometric method using a lead(ll) 1:l complex 
(stock solution, Pb(CIO,),, 1.5 mgllOO ml) and measuring the absorption of the 
complex at a wavelength of 250 nm [5]. 
To retain the partly hydrolysed intermediate products a solid-phase extraction on a 
cartridge of styrenedivinylbenzene resin (LiChrolut@ EN 0.2 g, MERCK) is applied 161. 
The last column is a SEP-PAK@ cartridge ALUMINA A (Millipore) for retention of [I8F]F- 
The [18F]FDG is eluted from the columns with sterile water (aqua ad iniectabilia, 
Serum-Werk Bernburg). For isotonic adjustment a calculated amount of NaCl (extra 
pure, MERCK) is added. The sterilization of the final product is achieved by sterile 
filtration (microporous membrane cellulose acetate, 0.22 Pm, ALLTECH). 
Results 
Fluorination 
The step of fluorination including all the drying processes, takes about 25 minutes. 
The yield of the substitution step and forming TA-[I8F]FDG is about 80 - 90 %, using 
freshly prepared precursor solution. During evaporation up ta 20 % of the radioactive 
substances are lost, depending On the quality of the precursor. Using a freshly 
prepared charge of FDG-precursor solution, this amount can be reduced to 5 %. 
Analysing the condensate from the cooling trap, we found that about 98 % of ail 
radioadive substances are [18FJF- and the residual aciivity is TA-[j8F]FDG. For 
radiation protedion it is useful to apply an absorption vessel filled with I M NaOH to 
trap the volatile radioactive substances. 
R e m o ~ l  of protective gmups 
Search for optimum conditions of alkaline hydfolysis 
Fig. 1 shows the time needed to reach maximum yield and the yield of forming 
["FIFDG during alkaline hydrolysis depending on the concentration of sodium 
hydroxide. 
yield [% FDG] 
'0° 
60 
50 Fig.1 
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20 
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The figure demonstrates that the forming rate for [I8F]FDG increases with increasing 
hydroxide concentration. The maximum yield of forming [I8F]FDG is obtained at a 
sodium hydroxide concentration of 0.3 M. Under these conditions, all the starting TA- 
["FJFDG is converted into ["FIFDG (about 100 % yield for hydrolysis, s. Fig. 2) and 
the yield of the synthesis up to this step is therefore determined only by the 
fiuorination siep. The hydrolysis using 0.3 M NaOH is suitable for realization of the 
routine synthesis. The time for reaching the maximum yield is only one minute and the 
Capacity Of Mtion exchanger needed for neutralizing the reaction mixture is oniy 0.6 
mmol. 
At higher hydroXi& concentrations more ["FjF- is formed and the yield of [''FIFDG 
decreases. 
The results of aikaline hydrolysis of nucleophilic and electrophilic [2] FDG-synthesis 
are very sirnilar. However, there are also some differences. The region of base 
concentration for the hydrolysis to reach the rnaxirniurn ["FIFDG yield is relatively 
srnall. In addition, we observe lower wnversion rates of TA-[18F]FDG for the 
nucleophilic reaction, using hydroxide concentrations lower than 0.3 M (see Fig. 1 and 
Fig. 2 [2], the slope of the graph is lower). 
Standard preparafion procedure 
The product of hydrolysis is a clear and light brown solution. Fig. 2 dernonstrates thin- 
layer chrornatograrns of reaction sarnples &er fluorination and hydrolysis. 
adioacüvity [cprn] 
2 
0 50 100 150 200 
flow direcfion [mrn] 
Fig. 2: TL chromatograrns 
A - product after fluorination, 1 - ["FjF' = 14 %, 3 - TA-["FIFDG = 86 %J, 
B - alkaline hydrolysate of product A, I - [''FIF = 14 %, 2 - [I8F]FDG = 86 %, 
The overall ["F'JFDG yield using 0.3 M NaOH for hydrolysis is between 80 and 90 %. 
In wntrast to the electrophilic reaction the rernoval of protective groups in these non- 
Carrier added solutions is nearly complete (> 99 %) and no by-products are forrned. 
Purification 
From the final product after purification we determined the radiochernical purity by TLC 
and HPLC [7] to > 99 %. The rnain problerns conceming chemical purity refer 'to the 
content of KrVptofixTM i2.2.21 and MeCN in the final product, Kryptofixnn 12.2.21 in the 
final formulation of iT8frlFDG has been proved to be tmic @I. The effieiency of 
91 
separating KryptofixTM l2.2.21 by cation exchange is suificient. The concentration iS 
detemiined by UV-spectroscopy to 10 pglml. The concentration of the used solvent 
MeCN is analysed by GC to 20 pglml. 
Synthesis in general 
The total preparation time is about 40 minutes. The total yield of the whole procedure 
(EOS) is about 30 to 40 %. The preparation was carried out 24 times with a stariing 
radioactivity level of 500 - 1000 MBq per batch. As a result we obtain a final product 
suitable for radiopharmaceufical use. The preparation time can be reduced by using 
a preparation unit specially designed for the ['"FIFDG synthesis, e.g. using a more 
efficient heating and evaporation System. 
Conclusion 
Alkaline hydrolysis of TA-["FIFDG during the preparation of [I8F]FDG has the 
foilowing advantages: 
- The yield of removing the protective groups is about 100 %. 
- Because of the high speed of hydrolysis, the step of removing the protective groups 
does not take time in practice. Under acid conditions this step takes about 10 to 20 
minutes. Therefore the yield of the preparation can be increased by about 6 to 13 % 
by time saving. 
- The readion process makes it possible to perform the FDG preparation as a one pot 
synthesis in a very simple way. 
- In the literature there is an indication of forming 2-deoxy-2-chloro-D-glucose (CIDG) 
as a chemical impurity during the preparation of [IsF]FDG, using acid hydrolysis with 
HCI [9,10]. Using alkaline hydrolysis this by-product is not formed. 
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22. ASPECTS OF QUALITY CONTROL FOR 
PET-RADIOPHARMACEUTICALS 
1. DETERMINATION OF RADIOCHENICAL PURlTY OF 2-f8qFLUORO-2- 
DEOXY-D-GLUCOSE 
F.Füchtner, J. Steinbach, R. Scholz', R.Lücke, K. Neubert 
'Technische Universität Dresden, Klinik für Nuclearmedizin 
lntroduction 
Radiopharmaceuticals of the highest achievable radiochernical purity are an irnportant 
prerequisite for obtaining reliable quantitative data of PET-studies as well as for 
minimized radiation doses of patients [I]. Therefore, the correct deterinination of 
radiochernical purity is one of the most important criteria of the quality control of the 
final product of 2-['8F]fluoro-2-deoxy-D-glucose ([I8F]FDG) preparation. 
High performance liquid chromatography (HPLC) with an anion exchange separation 
colurnn using a strong basic eluent was reported to be an up-to-date method for 
determining radiochernical purity. In cornbination with radioactivity detection, it seerned 
to be the best control method for the radiochernical purity of fi8F]FDG 121. Last year we 
reported on the determination of the chernical and radiochemical purity of ["FIFDG, 
applying this method 131. 
In the search for optimurn f'8F]~DG-preparation conditions [4,5] the quoted HPLC 
rnethod was used as an analytical technique and we found that using alkaline eluent 
(0.1 M NaOH) during the HPLC separation, the fluarinated precursor 2$aFlfiuoro- 
1,3,4,6-tetra-0-acetyl-D-glucose (TA-[I8F]FDG) was converted into ['8F]FDG. 
This paper focuses on the difference of analytical results obtained by common thin- 
layer chromatography (TLC) and HPLC. As a result we propose a reliable method fOr 
determining radiochemical purity of ["FIFDG. 
Experimental 
To assess the reliability of both analytical rnethods we analysed various samples 
during the whole [I8F]FDG preparation procedure. The investigations were carried out 
in the remote controlled laboratory system described in [6]. The TA-["F]FDG was 
synthesized from gaseous acetylhypofluorite ( [ ' 8 ~ ] ~ c ~ ~ )  and tri-0-acetyl-D-glucal 
(TAG) using the electrophilic addition reaction according to Bida [6]. After evaporation 
of the remaining solvent CFCI„ 2 ml of 1 M HCI were added. The solution was heated 
to 135 "C in order to remove the protective acetyl groups from the TA-["FIFDG 
forming ["FJFDG. In addition, the generated epirner 2-['8F]fluoro-l ,3,4,6-tetra-0- 
acetyl-D-mannosese was hydrolysed to 2-['8F]fluoro-2-deoxy-D-mannose ([I8F]FDM). 
The hydrolysate was purified by using a combination of an anion exchange column (d, 
= 6 mm, L = 100 mm, OMNIFIT, filled with 2 ml anion resin AGa4-X4, 100 - 200 mesh, 
free base form, BIO-RAD) with a SEP-PAK cartridge ALUMINA A (Millipore). 
Samples (100 vI) were taken from the reaction mixture after fluorination (A), during 
hydrolysis (B), at the end of hydrolysis (C) and from the final product after the 
Purification Step (D). The samples were analysed immediately by TLC and HPLC. 
The conditions for the HPLC analysis are described in detail in [3]. TLC analysis was 
performed On plates with a stationary phase of silica gel (DC-Alufolien, Kieselgel 60, 
MERCK). All samples (about 0.5 PI) were spotted on a TLC plate using glass 
capillaries. The chromatographic development was carried out in a chamber filled with 
acetonitrilelwater (955). For the visualization of the chromatograms the dried TLC 
plates wem contacted with an imaging plate (IP-BAS-111, 20x25, FUJI) and spent an 
exposure time of 1 min per 2 KBqlcm2. The information about the distribution of 
radioadivity On the TLC plate was read by a Scanner (bio-imaging analyser, BAS2000, 
FUJI). 
Results 
Chromatograms of identical sarnples of the hydrolysis experiment and of the final 
product obtained by TLC and HPLC are shown in Fig. 1 and 2. 
The TL chromatograms (Fig. 1) demonstrate clearly the different compounds during 
different Stages of reaction Progress. The running time for developing the TLC plates 
is about 20 minutes. The wnversion of the TA-[18F]FDG (A) into intermediate products 
(parily acetylated [j8F]FDG derivates, B) and into [18F]FDG (C) during hydrolysis is 
visible. The radiochemical purity of the final product (D) for ["FIFDG and [18F]FDM is 
determined-to > 99 %.However, a Separation of [18F]FDG and [18F]FDM is not 
achieved, both compounds have similar F+-values. The R,values of the main products 
analysed are given in Table 1. 
300 
radioactivity [cpm] , 
0 50 100 1 50 200 
fiow direction [mm] 
Fig. 1: TL chromatograms of reaxtion mixture 
A - after fluorination, B - during hydrolysis, C - after hydrolysis, 
D -final produd after purificaition 
1 - [18F]P, 2 - ['8F]FDG+['8F]FDM, 3 to 5 - parily hydrolysed TA-fi8FJFDG, 
6 - TA-["FIFDG 
Using HPLC the anaiyiytiwl resulfs are very similar even of very different samples as 
shown in Fig. 2. The samples (A) and (B) are spontaneously and nearly completely 
converied into [ ' 8 ~ ] ~ ~ ~ .  In analogy with the results of alkaline hydrolysis of TA- 
T 8 ~ ] ~ ~ ~  143, residual peaks are olbserved, however eluted before ft8F]F-. By the 
following thermal treatment during hydrolysis in the final hydrolysate (C) these peaks 
become smaller and eventually disappear except for two of them which we can still 
find a long time &er thermal treatment. In the chromatogram of the final product 
obtained after purification (D), we observe a small radiochemical impurity (generated 
during hydrolysis) apart from the ['8F]FDG and ['*F]FDM. The radiochemical purity for 
["FIFDG and ['8F]FDM is measured to > 99 %. 
Table: 1 Rrvalues of the main constituent parts of the analysed samples 
Compound I Peak No I Rfvalue 
C== 4==> 3 2 1 
25WO t I 
0 5 I 0  15 20 
retention time [minl 
Fig. 2: HPtG chromatog~ams af reacfion mixture 
A - after fluorination, B - during hydrolysis, C - after hydrolysis, 
D - finai product after purifrcation 
1 - [18F]FDG, 2 - ["FIFDM, 3 - [lsF]F, 4 - partly hydrolysed TA-["FIFDG and 
by-products 
Conclusion 
- As a result of the self-conversion of TA-[I8F]FDG during the HPLC analysis using 
alkaline eluents, the obtained results do not describe the real Course of the 
preparation of [18F]FDG and the radiochemical purity determined is not identical with 
the real radiochemical purity in the sample. OnIy the peak pattern of hydrolysis 
products (4) gives evidence that the thermal treatment was performed successfully. 
The described HPLC method is therefore not suitable for determining the 
radiochemical purity of the final [18F]FDG product. 
- TLC is a reliable method for determination of the radiochemical purity during the 
preparation of ["FIFDG. An advantage of the TLC method is the possibility to 
analyse several samples (double determination) simultaneously. However, the 
determination of the ['8F]FDG1[18F]FDM ratio in the final product is not possible. 
- For the determination of chemical purity and thus for the specific radioactivity of 
FDG (especially for the nucleophilic substitution reaction) HPLC using an anion 
exchange separation with the basic eluent in combination with a sensitive mass 
detector (electrochemical detection) is the best analytical technique. With this 
method the determination of the ['8F]FDGI['8F]FDM ratio (especially for the 
electrophilic addition reaction) becomes possible, too. 
- The HPLC is an analytical method easy to automate. Efforts should therefore be 
made to find an HPLC separation of ["FIFDG, [I8~]FDM, [I8F]F, TA-['~F]FDG and 
partly hydrolysed TA-['8F]FDG, using radioactivity and electrochemical detection, 
which allows both the determination of radiochemical and chemical purity 
simultaneously. 
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23. SUBSTANCES LABELLED IN METABOLICALLY STABLE POSITIONS: 
5. A PRECURSOR FOR THE SYNTHESIS OF 3-NITRO-13-"C]ANISOLE 
P. Mäding, J. Steinbach, H. Kasper 
Introduction 
The synthesis of nitro-[I-"Clbenzene, the first n.c.a. "C-ring labelled benzenoid 
compound, was described in [1,2] using the principle of synchronous six-electron 
cyclization of hexatriene systems into aromatics. We now try to extend the basic 
principle to other substituted "C-ring labelled benzenoid compounds. 
A prerequisite for "C-ring labelling of other benzenoid compounds according to this 
method is the existence of suitable nonradioactive precursors. For synthesizing 
hitro-[3-"Clanisole, the preparation of 5-dirnethylamino-4-methoxy-penta-2,4-dieny- 
lidene-l-dimethylammonium salt (a pentamethinium a l t )  as a precursor is essential. 
The synthetic method for the generaiion of the unsubstituted pentamethinium salt, the 
5ciimethylaminopenta-2,4-dienylidene-dimethylammonium perchlorate, according to 
[3,4] was therefore modified. 
Experimental conditions and results 
The starting material was 3-hydroxypyridine (Aldrich). At first the 3-hydroxy group had 
to be protected to avoid undesirable side reactions. The protection was carried out by 
means of the Williamson ether synthesis: 
In this way 3-methoxypyridine was obtained in about a 20 % yield. When KOH was 
used instead of NaOEt, there was a lower yield of 3-rnethoxypyridine (12 %). The 
rnethylation of 3-hydroxypyridine with rnethyl iodide in connedion with NaOEt 
produced a yield of only about 10 % of 3-rnethoxypyridine. 
3-Methoxypyridine is reacted with 1 -chlore-2,4-dinitrobenzene to form N-(2,4-dinitro- 
pheny1)-3-methoxy-pyridiniurn Chloride (yield: 31 %): 
MeO 
The instability of such a pyridiniurn salt against bases is used to Open the pyridine 
ring by rernoving the pyridine nitrogen. Reaction of this pyridiniurn salt with dirnethyl- 
arnine produces the 5-dimethylarnino-4-rnethoxy-penta-2,4-dien-I-al (yield: 53 %) and 
2,4-dinitroaniline: 
NH2 
+ 2 Me2NH; + H20 
M e 2 N T O  + of *O2 
- Me2NJ3.HCl OMe 
NO2 
The 5-dirnethyiarnino-4-rnethoxy-penta-2.4-dien-al reacts with dirnethylamine per- 
chlorate or tetrafluoroborate to form the desired pentarnethiniurn salt, the 5-dirnethyl- 
arnino-Q-methoxy-penta-2,4-dienylidene-l-dirnethylamrnoniurn perchlorate (yield: 
18 %) and tetrafluoroborate (yield: 46 %): 
The structures of 5-dimethylarnino4rnethoxy-penta-2.4-dien--al and Wie 5-di- 
methyl-amino~-methoxy-penta-2,4-dienylidene-l-dirnethylarnrnonium salts were 
confirmed by I3C NMR data. 
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24. SUBSTANCES LABELLED IN METABOLICALLY STABLE 
POSITIONS: 
6. THE SYNTHESE OF 3-NITRO-[3-"CJANISOLE 
P. Mäding, J. Steinbach, H. Kasper 
lntroduction 
The applicability of the principle of synchronous six-electron cyclization of 
hexatriene Systems into aromatics for "C-ring labelling of benzenoid cornpounds is 
described in [I, 21. Based on this rnethod, the synthesis of 3-nitt0-[3-~~CJanisole 
being a further new "C-ring-labelled benzenoid compound was worked out using an 
appropriate precursor [3]. 
Principle of the synthesis 
["CJNitromethane C?) reacts in the presence of a base with the homemade precur- 
sor 5-dimethylamino-4-methoxy-penia-2,4-dienylidene-l-dimethylammonium per- 
chlorate or tetrafluoroborate (2) [3] to form 1-dimethylamino-4-methoxy-6-nitro- 
[GHC]hexatriene (&, &) followed by cyclizationl aromatization into 3-nitro-[3-"C]- 
anisole (4) at increased temperatures according to the following equation: 
Experimental conditions 
To determine the extent of conversion and the radiochemical purity, an HPLC 
system (Merck-Hitachi) was used, including a pump, a Rheodyne injector with a 
20 i.ll loop, a LiChrospher 100 RP-18 endcapped column (5pm, 150 X 3.3 mm, 
Merck) and a UV-detector coupled in series with a radioactivity detector FLO- 
ONE\Beta A500 (Canberra Packard). In the course of experiments the mobile phase 
was optimized as regards the composition of the eluents and their linear gradient at 
a flow rate of 0.5 mllmin. 
The results of the product distribution of the "C-labelled compounds after ring clo- 
sure experiments are listed in Table 1. It was worked at various reaction times using 
30 pmol precursor 2 (as tetrafluoroborate), ["C]nitromethane and different kinds 
and amounts of bases at 170 "C in HMPT. The footnotes of Table I describe 
the various linear gradients of the eluents for HPLC investigaiions. 
Opfimization of the reaction condifions: 
At the beginning the reaction conditions worked out for synthesizing nitr~-[I-~'C]- 
benzene [I, 21 were transferred to this process: The gaseous ["C]nitmmethane pro- 
duced according to [I, 21 was introduced in a cooled rnixture of 8 mg (30 pmol) pre- 
Cursor 2 (as tetrafluoroborate) and 3.5 mg (30 pmol) solid t-BuOK in 250 pl HMPT 
followed by heating the well sealed vessel at 170 "C for 7 min. But these conditions 
are not suitable for synthesizing 4 In this way only small amownts of 4 (13.2 %) aS 
well as unconverted 1 (76.1 %) were found by HPLC investigations. Potasslum W.- 
Table 1: Product distribution of the "C-labelled compounds after ring closure expe- 
riments under various conditions. General conditions: 30 pmol precursor 
2 (as tetrafluoroborate), [11C]CH3N0, from [11C]C~31, reaction temperature 
-
of 170 "C, HMPT as solvent 
4b) 
5 
6 
21.9'' 
49.0" 
2 
3 
7 
8 
9 
t-BuOK 
t-BuOK 
NaH 
10 
11 
12 
b, Use of 30 pmol precursor 2 as perchlorate 
t-BuOK 
t-BuOK 
1 65.1 
NaH 
BuLi 
BuLi 
1 13 1 BuLi 1 60 1 10 
This peak is the sum of and 4, because the following linear gradient of the 
60 
120 
30 
BuLi 
BuLi 
BuLi 
eluents was not able to separate these two compounds: 0 min - 70 % waterl30 % 
30 
60 
130 
30 
30 
') Probably l-dimethylamino-4-methoxy-6-nitro-[6-11C]hexatriene (3a) 
40.0 
MeCN; 10 min - 0 % waterlIOO% MeCN; 20 min - 0 % waterl100 % MeCN 
20 
20 
7 
40 
40 
50 
" Shoulder of & at the Peak of -T 4 because the following linear gradient of the eluents 
- 
is not able to separate cornpletely the peaks of & and 4: 0 min - 70 % bufierl30 % 
43.4 
24.0 
20 
20 
35.4 
68.1 
24.9 
- 
7 
20 
10 
10 
10 
10 
MeCN; 10 min - 0 % bufferl100% MeCN; 20 min - 0 % buffert 100 % MeCN; bufFer 
31.4 
24.7 
- 
0.7 
0.3 
83.0 
8.3 
5.3 
- 
= phosphate buffer pH 7 (c[NaH,PO,] = 2.6 mM; c[Na,HPO,] = 5.1 mM) 
13.2 
- 
57.5 
- 
89.OC) 
27.2" 
9.7 
12.6 
14.2 
50.9 
41.3") 
25.4"' 
17.6') 
- 
- 
- 
18.gQ 
23.2" 
24.5" 
70.3 
61.5") 
56.6 
") First efiicient and complete separation of the peaks of & and 4 by using the suitable 
linear gradient of the eluents: 0 min - 70 % bufferl30 % MeCN; 20 min - 0 % bufferl 
100 % MeCN; buffer = phosphate buffer pH 7 (c$NaH,P04] = 0.26 mM; c[Na,HP04] = 
0.51 mM) 
butylate, the base used proved to be too weak. Similar amounts of 4 (17.6 %) were 
obtained using 1.3 mg NaH, 60 % dispersion in mineral oil (30 gmol) instead of 
t-BuOK. But in this way an undesired isomerization reaction took place: 3 was 
probabiy converted into [l'C]methylnitrite (24.9 %). With 130 pmol NaH this 
conversion was the main reaction (83.0 % ["Clmethylnitrite). The amount of 4 was 
~ncreased to 21.9 % by extension of the reaction time to 20 min using 30 gmol t-BuOK. 
A further increase of 4 (49.0 %) could be obtained by use of 7 mg (60 pmol) t-BuOK 
and 20 min reaction time. With 14 mg (120 pmol) t-BuOK and 20 min reaction time a 
decrease of 4 (25.4 %)was found as well as an increase of ["Clmethylnitrite (68.1 %). 
The best yields of 4 were obtained using precursor 2 and BuLi in a molar ratio of 1:1 
or 3:4 and a reaction time of 10 min (6515 %). A greater excess of base relating to the 
precursor shouid be avoided because of the increasing isomerization of ['%]CH3N02 
into ["C]CH,ONO. 
Results and discussion 
The reaction conditions worked out for synthesizing nitro-[I-'"C]benzene [I, 21are not 
suitable for synthesizing 4. Potassium tert.butylate, the base used proved to be tOo 
weak Lithium butyl (1.6 M solution in hexane) is a suitable base for the desired ring 
closure reaction, although a complete cyclizationl aromatization is not possible. Steric 
reasons could be responsible for this phenomenon. 
The optlmized conditions for the synthesis of 4 are: 
Solvent 250 1.11 HMPT 
Precursoc 8 mg (30 pmol) 5-dimethgamind-meihoxy-penta-2,4- 
dienylidene-l-dimefhylammonium tetrafiuoroborate (3 
Base. 20 - 25 p11.6 M BuLi in hexane (30 - 40 pmal) 
Reaction temperature: 170 "C 
React~on time: 10 min 
In th~s way %nitro-[3-%]anisole was prepared with a radiochemical purity of 65&5 %%. 
The reproducible radiochemical yields of 4 (decay-corrected) are in the range of 
6015 %, within a synthesis time from ["C]CH,NO, of 10 min. An HPLC radiogram of 
unpurified 4 is shown in Fig. 1. The efficient and complete separation of the peaks of 
probably & and 4 could be obtained at a flow rate of 0.5 mitmin by using the following 
linear gradient of the eluents: 
0 min - 70 % bufferl 30 % MeCN; 20 rnin - 0 % bufferl 100 % MeCN; buffer = 
Phosphate buffer pH 7 (c[NaH,PO,] = 0.26 mM; gNa,HPO,] = 0.51 mM) 
time Imin] 
Fig. 1: HPLC radiogram obtained from the reaction mixture of the 3-nitro-[3-"C]- 
anisole synthesis 
2.65 min: ["C]CH,ONO; 12.6 % 
6.35 min: 3-amin0-[3-~'C]anisole; 2.6 % 
12.25 min: unidentified product, probably 1-dimethylamino-4-methoxy-6-nitro- 
[6-"C]-hexatriene B); 23.2 % 
13.30 min: 3-nitro-[3-"Clanisole (4); 61.5 % 
(yield [%I, decay-corrected) 
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25. SUBSTANCES LABELLED IN METABOLICALLY STABLE 
POSITIONS: 
7. THE SYNTHESIS OF 3-AMINO-[3-"CIANISOLE - A "C-RING- 
LABELLED SYNTHONE 
P. Mäding, J. Steinbach, H. Kasper 
Introduction 
The synthesis of 3-nitro-13-"C]anisole is described in [I]. In continuation of this work 
the 3-nitro-13-"Clanisole was converted into 3-amino-[3-"Clanisole, another "C-ring- 
labelled benzenoid synthone. 
Experimental conditions and results 
The required 3-nitro-13-"C]anisole (4) was prepared in a Special cyclizationl aromati- 
zation reaction by conversion of ["C]CH,NO, (I) with 5-dimethylamino-l-methoxy- 
penta-2,4-dienylidene-1-dimethylammonium tetrafluoroborate (2) in the presence of 
BuLi in HMPT according to the following equation: 
2 -  k 2 ~ m . ] . .  -. - LiBF4; I. uLi -BUH 0 2 N v ~ e 2  
OMe - Me2NH 
1 
- - 2 OMe Ja -
11 
Stariing from the above reaction mixture, the following reduction was carried out by 
addition of an aqueous solution of sodium sulphide and subsequent heating: 
To determine the extent of conversion and the radiochemical purity of 5, an HPLC 
System (Merck-Hitachi) was used, including a pump, a Rheodyne injector with a 20 pI 
loop, a LiChrospher 100 RP-18 endcapped column (5pm, 150 X 3.3 mm, Merck) and 
a UV-detector coupled in series with a radioactivity detector FLO-ONE\Beta A500 
(Canberra Packard). In the Course of experiments the mobile phase was optimized as 
regards composition of the eluents and their linear gradient at a flow rate of 
0.5 mllmin. The footnotes Rd) of Table I describe the various linear gradients of the 
eluents for HPLC investigations. 
Procedure: 
3-Amino-13-"C]anisole (5) is generated by reduction of the reaction mixture of 4 in a 
one-pot process. 3-Nitro-[3-"Clanisole (g), synthesized from 1, 8 mg (30 pmol) of 2 
and various amounts of BuLi - hexane solution (30, 40 and 60 pmol) in 250 pI HMPT 
at 170 "C and 10 min (see [I]), was reduced by adding a solution of 8 mg of 
Na,S3H20 in 100 pl H,O (50 pmol) and heating at 170 "C. The results of the product 
distribution of the "C-labelled compounds are listed in Table 1. 
5 could be prepared from 4 with a radiochemical purity of 49 I 4  %, if 4 was synthesi- 
- 
zed by use of 30 ... 40 pmol BuLi. The reproducible radiochemical yields of 5 (decay- 
corrected) are in the range of 45rt5 %, within a synthesis time from ["C]CH,N02 of 
16 min. An HPLC radiogram of unpurified 5 is shown in Fig. 1. The Peak at 12.30 min 
is probably 3a, which was not isomerized into E, and a complete cyclizatio~nl 
aromatization was not possible. Steric reasons could be responsible for this pheno- 
menon. The reducing power of sodium sulphide is not strong enough for the reduction 
of the atiphatic nitro group of & 
Table 1: Product distribution of the "C-labelled products affer reduction of several 
batches of 3-nitro-13-"C]anisole with sodium sulphide 
" Linear gradient of the eluents for HPLC: 0 min - 70 % bufferl30 % MeCN; 10 min - 
Experi- 
ment 
no. 
1 ") 
Zc) 
3@ 
4=) 
0 % bufferl 100% MeCN; 20 rnin - 0 % bufferl 100 % MeCN; buffer = phosphate 
buffer pH 7 (c[NaH2P04] = 2.6 mM; c[Na2HPOJ = 5.1 mM) 
@ Linear gradient of the eluents for HPLC: 0 min - 70 % bufferl30 % MeCN; 20 min - 
0 % bufferI100 % MeCN; buffer = phosphate buffer pH 7 (c[NaH,P04] = 0.26 mM; 
c[Na2HP04] = 0.51 mM) 
a, See Table 1 in [I]; used amounts of BuLi for synthesis of 4: 30 pmol, 40 lJmol, 
[%] of 
radioactivity 
of in the 
starting 
reaction 
mixture 
65.1 "') 
70.3a2) 
61.5a2) 
5O.Qa3) 
Reaction 
time 
[min] 
---P 
10 
5 
5 
10 
Product distribution 
(radioactivity [%I is decay-mrrected) 
[llC]methyl- 3-amino- unidentified 3-nitro- 
nitrite [3-"C]anisoIe "C-labelled [3-"Clanisole 
(4)  
11.6 
23.0 
19.5 
58.1 
48.5 
53.0 
45.2 
32.2 
37.7 
23.5 
24.7 
- 
- 
- 
8.5 
- 
time [min] 
Fig. 1: HPLC radiogram obtained from the reaction mixture of the 3-amino-[3-"C]- 
anisole synthesis 
2.60 min: [''C]CH,ONO; 19.5 % 
3.75 min: unidentified product; 2.0 % 
6.55 min: 3-amino-[3-"Clanisole (5); 45.2 % 
12.30 min: unidentified product, probably 
[G-"C]-hexatriene @a); 24.7 % 
13.30 min: 3-nitro-[3-"C]anisole (4); 8.5 % 
(yield I%], decay-corrected) 
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26. SUBSTANCES LABELLED IN METABOLICALLY STABLE 
POSITIONS: 
8. PRECURSOR SYNTHESE F0R"C-RING-LABELLED PYRIDINE 
DERIVATIVES 
K. Chebani, P. Mäding, W. D. Habicher, D. Scheller, J. Steinbach 
lntroduction 
This is a Progress report on our attempts to synthesize precursors for %-ring labelled 
Pyridine derivatives [I]. The 3-bromo-malein-dialdehyde-4,4-dimethylaceta (I) was 
thought to be a precursor for reaction with IilC]nitromethane according to equation (1). 
The further steps were planned as follows (2): 
The synthesizing of (1) had to be performed via equation (3). 
In our last annual report [ I ]  we described the synthesis of (V). Its conversion to (VI) 
and the problem involved are the content of this Paper. 
Experimental and results 
Reaction of  (CH30),CH-CBFCH-COOCH3 (V) with NaBH4+tiCl in diglycol 
The reaction of the ester group in (V) with NaBH, and LiCl in diglycol at 25 "C 
according to [2,3] was not successful. The conditions directed the EIZ-isomeric ratio of 
(V) from 90:lO to 5050. 
Attempts at 110 "C lead to a transesterification reaction yielding (VII) with about 
70 % with only one isomeric form (E) (equation 4). 
The structures of (E-V) , (Z-V) and (VII) were proved by 'H NMR spectra. 
Reaction of (CH,O),CH-CBFCH-COOCH, (V) with a SUrp1u.S of NaBH, in methanol 
The (E) and (2) isomers of (V) were treated for 3 h with 25 % surplus of NaBH, in 
methanol under reflux according to 141. The 13C and 'H NMR spectroscopic 
investigations of the reaction products showed that no reduction took place. lnstead of 
this a Br to CH,O exchange was obsewed. This can be explained by the vinyl- 
homologue structure of the rnolecule, which enables the Substitution of the Br atom at 
the olefinic carbon. 
,. 
The ER isomeric ratio of (VIII) was about 60140. 
Reduction of (CH,O),CH-CBr=CH-COOCH, (V) with LiAIH, 
Compound (V) was reacted with LiAIH, with the molar ratio 1 : 0.5 at -20 "C in ether 
according to [2]. The reaction mixture was distilled between 65 - 77 "C at 400 Pa. An 
HPLC- investi-gation of the distilled product showed a mixture of wmpounds. 
The main product was the 3-bromo-4-methoxy-3-butenol-1 (IX) with an overall yield of 
about 7 %. The desired compound (VI) was found to be only a by-product with an 
overall yield of at most 2 %. 
(W LiAIH4 
-20% ether 
The structures of (IX) and (V!) were proved by 13C and 'H NMR spectra (Fig. I and 2). 
i 
TMS 
Fig. I: 'H NMR spectrum of (8x1 
111 
Fig. 2: 'H NMR spectrum of (VI) 
Other reactions to yield (W) from (V) by means of LiAIH4+ AICI, in ether, (C,H,)+IH in 
tetrahydrofurane and NaBH4+ LiCI in diethylenglycol-diethylether were not successful. 
The poor yield of (VI) in the Overall synthetic route caused us to change the strategies 
for ["Clpyridine generation [5,6]. 
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27. SUBSTANCES LABELLED IN METABOLICALLY STABLE POSITIONS: 
9. SYNTHESIS OF PYRIDINE BY THERMAL REARRANGEMENT OF 
AMINES CONTAlNlNG THEC,N STRUCTURE 
K. Chebani, J. Zessin, J. Steinbach 
lntroduction 
In continuation of our efforts to introduce "C into the pyridine ring we shifted from a 
synthetic route [I ,2] to thermal rearrangement reactions. 
Fora derivative of pyridine, Chebani et al. describe a synthetic route which contains 
the formation of an unsaturated C a  structure followed by an intramolecular cyclization 
reaction. Because of poor yields and unforeseeable reactions we cut short the synthetic 
program. We decided to construct an "C-labelled C,N structure, which could be 
converted to pyridine by high temperatures. Such conversions are well known in 
reforrning processes [3] and should be possible as an alternative and fast synthetic route. 
Bell et al. [4] describe the high temperature dehydrocyclization of various aliphatic 
amines in the presence of iodine. They found that these reactions produce pyridine with 
yields between 9.5 and 41.5 %. The presence of calcium oxide increases the yield of 
pyridine. Pyridine can also be formed by thermal conversion of N-methylpyrrole in ihe 
absence [5] and in the precense of iodine, using a reactor filled with calcium oxide [B]. 
The "C labelled compounds with the required C,N structure were synthesized by addition 
of ["C]CH,I to C, amines in general. n-Butylamine (I), pyrroie sodium (2), 4- 
aminobutanol(3) and 3-pyrrolidinole (4) were selected. (3) and (4) were thougM to be 
compounds which should lead to unsaturated amines by dehydration, thinkable 
precursors of aromatic N-heterocycles. 
(1) (2) (5) (4) 
In the Wst experimenis, the thermal conversion of the unlabelied ed-methyl derivatives 
of (i) to (4) were investigated more closely in order to select suitable precursors and 
conditions for the generation of ["Clpyridine. 
Experimental 
Formation of the N-methyl amines: 
(I), (3) and (4) were reacted with rnethyl iodide in molar amounts, using absolute ethanol 
as a solvent to yield the appropriate N-rnethyl derivatives. For the further experirnents 
the arnrnoniurn salts generated were used directly. Only N-rnethyl butylamine was isolated 
by adding sodiurn hydroxide solution and extraction with diethylether. N-methylpyrrole 
(6) was prepared frorn methyliodide and pyrrole sodiurn, which was synthesized frorn 
pyrrole and sodiurn hydnde. N-rnethyl-3-pymolidinoI (8) was cornmercially available and 
was used without further purification. 
Thermal conversions: 
The thermal wnversions of the rnethylated compounds (5) - (8) were carried out in two 
various, vertically arranged quartz glass tubular reactors (220 rnrn X 15 rnrn and 400 rnrn 
X 12 rnrn). Nitrogen acted as an inert carrier gas. The volurnetric flow rate was in the order 
of 30 rnl per rninute. The substances were directly injected at the beginning of the hot 
Zone of the oven. The temperature range of the different experirnents varied from 400 
to 600 "C. The residence time was in the order of 5 to 15 seconds. 
The following wnfigurations were investigated: 
1. The compounds (5) to (8) passed through the ernpty reactor. 
2. A stoichiornetric amount of iodine was added to the N-rnethylated substances. 
This rnixture passed through the ernpty oven. 
3. According to 2 iodine was added, but the reactor was filled with calciurn oxide. 
4. The CjNcompounds passed through the reactor filled with a dehydrogenation 
catalyst (Pdlactivated carbon/magnesiurn oxide). 
The products of the thermal wnversion were collected in 2 rnl of absolute ethanol and 
ana-lysed by HPLC (WPLC system frorn Mmk-Hitachi, injector with 20 PI loop, 
RP-18 column (150 X 3.3 rnrn) filled with LiChrospher (5 vrn) fmrn Merck, DAD detector). 
The mobile phase started with 100 % phosphate buffer according to Sörensen (2.6 rnM 
NaH2P0, + 5.1 mM Na,HPO,; pH 7) and changed with the following linear gradient to 
acetonitrile: 0 rnin: 100 % bufferlO % MeCN; 10 min: 0 % buffer1100 % MeCN; 20 min: 
0 % buffer1100 % MeCN. The interesting cornpounds were identified by wmparing the 
retention tirnes. In sorne cases the products were analysed by GC-MS by use of a GC 
System HP5890 with the MSD HP5972 (colurnn: Chrornpack HP-5,30 rn, 0.25 rnrn; heliurn 
with 65 rnllrnin; ternperature: 45 "C (2 rnin) to 150 'C at 8 Wrnin). 
Results 
General rules 
The thermal conversion of the N-rnethyl derivatives of the cornpounds (1) - (4) yields 
a rnixture of various substances. The cornposition of this product was nearly constant 
between 400 and 600 *C . 
The use of ethanol as a solvent does not lead to pyridine. Only substituted N-heterocycles 
were obtained under these conditions. The use of benzene as a solvent does not produce 
significant rnodifications of the product cornposition in cornparison with the thermal 
conversion of the pure substances (5) to (8). 
N-Methylbutylamine (5) 
Between 400 and 600 "C, the thermal conversion of (5) by application of the ernpty 
reactor produce only srnall arnounts of pyridine as well as substituted pyridines. The 
quantity of pyridine did not increase significantly if iodine was added to (5) and the 
reactor was filled with calciurn oxide. But in this case, pyrrole was obtained as an 
additional product. 
By application of the palladiurn-based dehydrogenation catalyst, the sarne products were 
forrned. The arnount of pyrrole increased clearly, but the quantity of pyridine was 
unchanged. Apart frorn pyrrole and pyridine, the analysis of the fiuid productc by GC-MS 
showed various rnethyl and dirnethylpyridines, butylpyridine, rnethyl and 
dirnethylpyrroles, nitriles and indole. Under this conditions the share of pyridine lies 
between 7 and 17 % (determined by GC-MS). 
N-Mefhylpyrrole (6) 
In the ernpty reactor? N-rnethylpyrrole rearranges thermically in contrast to [5J into two 
rnain products, which could be identified with GC-MS as 2- and 3methylpyrrole. Pyrrole 
and pyridine were only obtained as by-products in vety srnall quantities. 
By application of the reactor filled with the dehydrogenation catalyst, the thermal conver- 
sion of (6) yields - in c~ntrasi to ibe other investigated N-methyl compounds - a smaller 
nurnber of secondary cornpounds. Tbe anaiysis of the product mixture shows pyridine, 
pyrrole as well as various methyl and dimethyl pyrroles. The percentage of pyridine in- 
creases by the use of this catalyst and lies between 8 and 18 % (determined by GC-MS). 
4-(N-methylamin0)-butanol(7) 
Between 400 and 600 "C, thermal rearrangement of(7) in the ernpty reactor yields pyri- 
dine, pyrrole, N-methylpyrrole and various methyl pyridines. 
The application of iodine in combination with the calcium-oxide-filled reactor produces 
smaller amounts of pyrrole and N-methylpyrrole. In comparison to the N-rnethyl 
derivatives (5) and (6), the yield of pyridine does not obviously increase. 
N-Methyl-3-pyrrolidinol(8) 
The thermal conversion of (8) by use of the ernpty reactor or with the addition of iodine 
leads to wmparable results as the pyrolysis of (7). 
Conclusions 
In alt cases the thermal rearrangernent of the N-methyl compounds (5) - (8) produces 
mixtures of various substances, which wntain pyridine as the basic stnicture. Additional 
pyrrole is generated. That means that only aromatic systerns are stable under the 
reaction wnditions. The occurrence of alkylated compounds demonstrates, that besides 
cyclization or isomerization reactions also the cleavage of the C-N bonds takes place. 
The attachment of the alkyl fragments causes the high quantities of alkylpyridines and 
alkylpyrroles. 
Thermal rearrangment of (5) - (8) without dehydrogenation catalysts yields the broadest 
spedrum of products. The application of palladium or iodine in combination with a 
calcium oxide filled reactor leads to a decreasing number of by-products. By use of the 
dehydro-genation catalysts, the percentage of pyridine was nearly unchanged. The 
presence of a hydroxy group in the molecule does not produce the desired results. 
The highest yields of pyridine (up to 18 %) were obtained by thermal conversion of 
N-rnethylbutylamine (5) and N-methylpyrrole (6), if the dehydrogenation catalysts were 
used. The thermal rearrangment of (6) leads to a small number of by-products. Thus, 
after optimization of the reaction conditions, the thermal rearrangement of these two 
compounds should be a possible way of synthesizing "C-ring labelled pyridine. 
This work will be continued by thermal rearrangernent of the "C-labelled substances 
(5) and (6). 

60th methods are widely used for the calculation of glucose metabolic rates in brain. 
A three-compartment model for FDG uptake is the base for these methods. 
If the rate constants are known the metabolic glucose rate MRGI can be calculated as: 
MRGI = C,/ LC * k,k3 I (k,+k3) 
C, = plasma glucose concentration 
LC = lumped constant (converts from FDG to glucose) 
The determination of the rate constants is possible on the base of the three-compartment 
model. It requires to measure the complete time functions of the plasma activity 
concentration and also of the tissue activity concentration. This extensive dynamic 
method is usually replaced by the autoradiographic method or the graphic one. 60th 
methods allow to determine the quotient k,k3 I (k,+k3) which is proportional to the 
metabolic glucose rate. 
The autographic method uses the normal values of the rate constants and the measured 
PET and plasma concentration results to determine the actual value of this quotient. 
The PATLAK plot gives this quotient as the dope of a linear regression using the results 
of the PET scan and plasma concentration measurement. 
We have tested our programs with data from a dynamic patient study performed in 
Montreal. Slope values calculated by the program TCN for three small ROl's in grey 
matter and two large ROI's over a half of the slice are shown in the following table : 
The large ROl's contain a mixiure of grey and white matter. All calculated slope values 
for grey matter agree with the values of about 0.028 ... 0.033 min-' given in the Iiterature 
[31. The slope values for the large ROSS are between the values for grey matter and white 
matter (0.014 min-' ) as expected. 
To test the program GLUCOSN with the Same ROl's we used only the last frames of the 
dynamic study. The k,k,I (h+kJ - values are 15% smaller than the one determined with 
the PATLAK plot. 
Stabilization of data acquisition for high count rates 
The PET-studies with the POSITOME lllp in Montreal were performed up to an activity 
concentration of 40 k0qlcm3[2 1. In our measurements the carnera became instable, if 
we used activities of more than 20 KBq/cm3. The reason for these instabilities was a bad 
synchronization of the three parallel switched FIFO's (74S225), used as a fast buffer 
for the coincidences. We changed the form of the reset signal and the acquisition 
software to reset the interface after each 30 seconds. Tests with an activity concentration 
of up to 60 KBqlcm3 indicate no failure. 
Transmission sources 
The POSITOME lllp PET camera can measure the transmission and emission 
coincidences simultaneously. The transmission sources were prepared by DUPONT 
using electroplated "Ge on a 0.5 rnm thick nicke1 foil 5 mm in diameter and a second 
one as a cover 111. 
We have manufactured lead collimators as described in [ I ]  to instail the 68Ge sources 
into the PET camera. This new mechanical arrangement of the sources and collimators 
requires also a new EPROM-mask to decide which coincidences are emission or 
transmission one. This mask was calculated on the base of the data measured with the 
transmission sources in defined positions. 
Cross phantom 
The daily check of the PET camera and the weekly comparison with the well Counter 
have to be done with a phantom of homogeneous and constant activity concentration. 
This cross phantom we have filled with the "Ge chloride in a hydrochloric acid solution. 
The phantorn was made from a PVC cylinder of 15 cm diameter. We used PVC to avoid 
corrosion of the cover. The phantom is enclosed in a second cylinder of meta! sheet io 
guarantee a correci lowfion in the camera pori and to prevent coniamination. 
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29. QUANTITATIVE AUTORADIOGRAPHIC STUDIES OF THE 
DISTRIBUTION OF [~HIKETANSERIN IN HORIZONTAL RAT BRAlN 
SECTIONS AFTER INFLUENCE OF SEVERAL DISPLACING 
COMPOUNDS INCLUDING Re COMPLEXES 
M. Kretzschmar. P. Brust 
Iniroduction 
For the development of radioligands with affinity to serotonin receptors it is 
necessary to use reference methods with known serotonergic compounds. [JHlketan- 
serin shows high-affinity binding to 5-HT2 receptors in brain tissues of several 
species [I-41. The characteristic Parameters of receptor binding, 16 and B„, and 
the distribution of the 5-HT2 binding sites were therefore studied in several rat brain 
regions using f~lketanserin. 
The density of 5-HT2 receptor binding sites was measured by quantitative in vitro 
autoradiography on horizontal rat brain sections using the FUJI BAS 2000 bio- 
imaging analyzer (FUJI Photo Film Co., Tokyo), which resulted in one tenth of the 
exposition time compared with the conventional film autoradiography. 
Two rhenium complexes were studied to search for possible serotonergic receptor- 
affine properties. These compounds inhibited t~lketanserin binding in homogenates 
of rat frontal cortex with lCso values of 1.25 PM and 0.93 PM [6]. The Re complexes 
were used as model compounds for planned [9sm~c]compiexes. The receptor-binding 
properties of compounds were gained indirectly by comparison of their inhibition of 
f~lketanserin binding with mianserin, as a displacer which has high affinity to 5-ifi2 
receptors. 
Materials and methods 
6 male Wistar rats weighing 229 - 300 g were used. The rats were sacrificed by CO2 
inhalation and their brains rapidly removed, frazen quickiy in an isopentanddry ice 
Solution at -70 "C. 
To prepare sections, the brains were mounted on cryostat chucks and 20 pm 
horizontal sections were cut at -20 "C, thaw-mounted onto gelatincoated micros- 
cope slides, dried at room temperature and kept at -20 "C until used. Every loth 
section was stained with cresyl violet to facilitate identiiication of brain regions by 
using the atlas of Paxinos and Watson 151. 
Serotonin-binding sites in brain tissue were Iabelled as described by Hrdina, P. D. et 
al. [I]. In brief, the frozen sections were warmed to room temperature and pre- 
incubated for 15 min in 50 ml Coplin jars containing 50 mM tris - HCI buffer (pH 7.6) 
to remove endogenous ligands. The sections were then incubated in a solution of 50 
mM tris - HCI buffer (pH 7.6). 1 nM f~lketanserin (sp.act. 2.99 TBqImmol) and 2 pM 
tetrabenazine to mask the vesiwlar arnine uptake sites, and incubated for 40 min at 
room temperature. 
The nonspecific binding was determined by incubating adjacent sections of the Same 
brain areas in the presence of 2 PM tetrabenazine and 10 PM mianserin. 
To examine the inhibition of f~lketanserin binding by the two Re complexes 
compounds 16 and 17 [7], adjacent sections of the Same brain areas were incubated 
under the Same conditions. The test substance was used at a concentration of 1 PM, 
which is close to the ICm value measured in binding studies with homogenates 161. 
The sections were washed for 2 X 10 min in ice cold buffer, rinsed in distilled water, 
and dried with cold air. 
For autoradiography, the sections together with tritium labelled polymer layer 
Standards (Amersham, Braunschweig) calibrated for intact brain grey matter were 
apposed to tritium-sensitive imaging plates and kept at 4 "C for one week. The 
exposed imaging plates were inserted into an image reading unit and then scanned 
with a fine laser beam in the FUJI BAS 2000 device. The image data were recorded 
as digital values and evaluated with the TlNA 2.07~ program (Raytest, Strau- 
benhardt). 
In addition, the equilibrium dissociation constants (IQ and receptor densities (B„) 
were estimated. For this purpose, Saturation experiments were performed in several 
rat brain regions. Alternating adjacent sections were incubated with increasing 
concentrations of the radioligand [3~]ketanserin ( 0.3 - 5 nM ).The incubation and the 
determinations of the specific and nonspecific binding were carried out as described 
above. The data were analysed by Eadie-Hofstee plots and with the figure P 
computer program. 
Furthermore, the radioactivity in some of the slide-mounted tissue sections adjacent 
to those used for autoradiography was measured after incubation, using the LS 
counter 6000 (Beckman Instruments, Fullerton). 
Results and discussion 
From the LSC measurement of the sections a relatively high nonspecific binding 
(defined with mianserin as a displacer) of about 64 % was calculated. However, this 
measurement includes the whole brain, i.e. also areas with low receptor densities 
Using compounds 16 and 17 as displacer, about 78 and 72 %, respectiiely, of the 
total binding remained on the sections. Thai means that these compounds inhibited 
Fig. I: Autoradiograms illustrating the 
bin ding sites of f~lketanserin in 
the rat brain sections 
A = incubation f~lketanserin and 
tetrabenazine (total binding) 
B = incubation SHlketanserin, tetra- 
benazine and mianserin (non- 
specific binding) 
C = incubation f~lketanserin and 
compound 17 
The radioactive concentration decreases from red to yeliow and green 
(Cereb. cortex = cerebellar coriex, Cerebr.cort. L4 = cerebral cortex lamina 4) 
the specific binding of f~lketanserin by more than 50 %, which corresponds to the 
data obtained from binding studies with homogenates [6]. These results are also 
confirmed by the autoradiograms. Fig. 1 shows the distribution of total S~lketan- 
serin binding (A), nonspecific binding (B) and the autoradiogram obtained after 
inhibition with compound 17 (C). Fig. 1A shows a highly selective distribution of 
S~lketanserin in various brain areas, with the highest labelling in the frontal and 
parietal cortex, in Wich different binding of the label in certain laminae is evident. A 
medium level of 5-HT2 receptor density is visible in the caudate-putamen and 
thalamus, as also demonstrated in Fig. 2. The image of the nonspecific f~lketan- 
serin binding (Fig. 1B) displayed a homogeneous low level of labelling. 
Fig. 2: Specific binding of [3~]ketanserin in different areas of the rat brain, n = 6 
Cerebr.cort. front. L4 = cerebral cortexfrontal lamina 4; 
Cerebr.cort.par. L 1-3 = cerebral cortex parietal lamina 1-3 
Preliminary results from the saturation experiments are shown in Table I 
The afFinity of the ligand estimated for the wfiole section is lower than for the cortical 
region, which may be explained by a different contribution of 5-HT2 receptor sub- 
types to the total binding. 
Fig. 3 shows the percentage of total binding wfiich remained after inhibition with 
mianserin and the Re complexes, respectively, in several areas of the brain (See 
Table 1: Parameters of f~lketanserin binding in different brain areas 
also Fig. 1 B and 1 C). 
- 
Area 
Whole brain section 
Cortex right 
Cortex left 
nianserin 
corrpound 17 
compound 16 
Fig. 3: Inhibition of V~lketanserin binding (percentage of total binding) by various 
compounds, n = 6 
KD (nM) 
2.32 t: 0.73 
1.56 f 0.75 
1.64 f 0.8 
Bmax 
(fmollmg tissue equivalent) 
23.07 f 3.32 
43.35 f 8.22 
49.67 t: 9.1 
The amount of nonspecfic binding, measured with mianserin, varied between 20 and 
40 % of the total binding in cortical areas and 60 and 80 % in the other structures of 
the brain. The values for the remaining t~lketanserin binding sites after inhibition 
with the Re compounds displayed in Fig. 3 show a relatively small decrease of the 
total binding to about 80 - 90 % in the cortical areas. However, a higher inhibition of 
t~lketanserin binding was found in the hippocampal region and cortical area of the 
cerebellum. Compounds 16 and 17 inhibit [3~]ketanserin binding even more than 
mianserin. This is confirmed more clearly in Fig. 4, which shows the part of the 
specfic t~lketanserin binding (measured with mianserin) which is not inhibited after 
use of the Re complexes. 
Whole Cerebral Cerebral Cauda- Hippo- Thala- Cerebel- 
brain cortex CO&X te puta- Campus mus lar cortex 
section front. L4 par. L4 men 
Fig. 4: Percentage of the specific t~lketanserin binding which remained after 
addition of the Re compounds &Y the incubation medium. n = 6 
The specific f~lketanserin binding which remained after the use of compounds 16 
and 17 as displacers was about 40 % and 20 %, respectively, in the whole brain 
section. The non-displaceable speclic P~lketanserin binding was about 60 - 80 % in 
the cortical areas and 20 - 50 % in the caudate putamen and thalamus. The greater 
inhibition in the hippocampus and cerebellar cortex indicates that [3H]ketanserin 
probably binds to a heterogeneous population of receptors. This ligand can probably 
labe1 both 5-HTx and 5-iiT2,, receptors. In addition, it binds with low affinity to a1 - 
adrenoceptors or histamine H, receptors [8]. Further studies are planned with dis- 
placer compounds for the identiication of these different binding sites. 
The Re complexes used in this study suggest that it might be possible to obtain 
$Sm Tc-labelled serotonergic ligands. The fact that the two Re compounds inhibit 
f~lketanserin binding in the hippocampus and cerebellum more than mianserin 
indicates that they have an affiniiy to a second binding site which is labelled by 
[3~]ketanserin. They have a higher affinity than mianserin to this binding site. 
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30. BIOLOGICAL CHARACTERIZATION OF 9smT~-DMS ESTER 
COMPLEXES IN RATS 
R. Syhre, S. Seifert, H. Spies, B. Johannsen 
Studies of the biological behaviour of -C-DMS esters in rats were carried out to 
test the influence on distribution and excretion of ester functions and the number of 
ester groups within the molecule. Furthermore it seems to be interesting to study the 
effect on biodistribution of the arrangement of ester groups in the molecule. 
Experimental 
Table 1 gives a summary of the s 9 m ~ ~ - ~ ~ ~  compounds used for the investigations. 
Table 1: s 9 m ~ ~ - ~ ~ ~  compounds used for investigations 
I COMPLEX / FORMULA 
R = Ethyl- 
%!/ , COOR 1-1 
R = Methyl- 
ROOC COOR 1 -2 
EtOOC COOEt 
I EtOOC COOEt 
1 COOR 
Preparation, characterization and enzymatic hydrolysis of the ester wmplexes are 
described in [I] and [2]. The reference substance for these studies was 99m~c01)- 
DMSA (complex 6). a radiopharmaceutical used for tumour diagnosis. 
For in vivo studies 0.5 ml complex solution (5 - 10 MBq '"'TC) are injected into the 
taii vein of male Wistar rats (5 - 6 weeks old). After the incubation time the rats were 
sacrificed by heart puncture under light ether anaesthetic and the selected Organs 
were isolated for weighing and wunting. 
Table 2: Distribution of VC-DMS compounds in rats (means f SD; n 2 6) 
Results and discussion 
No target Organ was found for the ester complexes. The radioactivity in the brain, in 
the spleen and the pancreas was not higher than the background activity in the 
remaining parts of the animal. Table 2 shows the distribution data 10, 60 and 120 
rninutes after injection for sorne interesting Organs. With the exception of complex 4 
the blood elimination and the distribution data are within the normal range. The renal 
and the hepatobiliary parts of distribution and excretion are demonstrated in Figs. 1 
and 2, depending on the number of carboxyl groups and the nature of the alcohol 
function of the complexes. 
COMPLEX 1 COMPLEX 2 COMPLEX 3 COMPLEX 5 COMPLEX 6 
R: ETHYL- 4 3 2 1 0 
Fig. 1: s 9 m ~ c - ~ ~ S  cornplexes - renal and hepatobiliary parts of excretion and 
accumulation and skeleton uptake in rats ( 60 min. p.i.; rneans; n 2 6) 
Fig. 1 shows that the renal pari increases with the number of carboxyl groups in the 
molecules, Wich is consistent wiih a decrease of lipophilicity [2]. The results also 
demonstrate that the affhity of 9 S m ~ ~ ~ - D M S A  to the bone disappears in the 
presence of only one ester group (complex 5). Fig. 2 documents that the 
hepatobiliary part of distribution and excretion increases with increasing lipophilicity 
from methyl (complex 1-1 ; log P - -1) to diisobutyl (complex 1-2 ; log P - +I) 
derivatives. 
COMPLEX 1-1 COMPLEX I 
0 
10 60 123 10 60 120 10 60 120 
MINUTES p.i. 
LNER INTESTINE 
Fig. 2: g S m ~ c - ~ ~ ~  tetraester compounds - hepatobiliary parts of excretion and 
accumulation in rats (means; n 2 6) 
COMPLEX 3 
KIDNEY > 
Fig. 3: 9 9 m ~ c - ~ ~ ~  diester complexes - comparison of symmetric and asymmetric 
form in rats (means; n 2 6) 
The Nt vivo behaviour differs significantly between symmetric (complex 3) and an 
asymmetric (complex 4) diester complex (Fig. 3). After injection of complex 4 a very 
high accumulation in the liver was observed. The activity is not much excreted via 
the biliary tract. 
COMPLEX 4 
WIE- 80LUltON hWOIPlAS&M 
Fig. 4: In vivo stability of asymmetric 5-DMS diester (complex4) 
in the blood and lNer of rats 
The chromatography of the liver extract shows that the complex is not metabolized in 
vivo in the h e r  (Fig. 4). The high accumulation of complex 4 in the he r  cannot be 
explained. 
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31. IN VITRO EVALUATION OF s s m ~ c - ~ ~ ~ ~ ~  COMPLEXES BY 
ENZYMATIC METHODS IN COMPARISON WITH IN VlVO 
METABOLISM AND BlODlSTRlBUTlON IN RATS 
R. Syhre, S. Seifert, H. Spies, B. Johannsen 
The biological screening of potential radiopharmaceuticals in rats is more compli- 
cated when the tracers are subject to in viv0 metabolism as well as to a significant 
species- dependent variation of this metabolism. This is to be expected for ester 
groups bearing @"'TC -complexes if the ester bonds are metabolizable. 
Unfortunately, compounds with metabolizable ester groups show wide interspecies 
variations in biological behaviour [1,2,3,4]. The reason for these variations is, that 
the metabolic enzyrnes, especially the esterases, vaty considerably from tissue to 
tissue and from one species to another. The esterases of blood and her, for 
instance, have a low specficity to Substrates and a high specificity to stereoisomeric 
compounds. The activity of these enzymes is variable in different animals and in 
man. Because of the different behaviour of the species, especially between humans 
and rats, the extrapolation from animal to man of the biodistribution data is limited 
15,6,71. 
In screening new ="TC-ester complexes it appears reasonable to clariQ whether the 
complexes actually may be metabolized under the conditions of interest. 
Systematic investigations of the enzymatic hydrolysis from =TC-DMS esters are 
carried out: 
to find a simple and reliable in vitro test system. This system is supposed to show 
diierences in metabolism and biodistribution in species prior to animal 
experiments. 
to compare the in vifm and in vivo data in order to extrapolate from rat to man 
Experimentai 
The @ s m ~ c - ~ ~ ~ - e s t e r  complexes used for the investigations are already described in 
an other articie of this report 1101. @"'TC-ECD was used as reference compound. The 
conditions of the in vifro hydrolysis are summarized in Table 1. Analytical data of 
metabolites have been described in this report [9]. 
For in vivo studies 0.5 ml complex solution (5 - 10 MBq %TC) are injected in the tail 
vein of male Wistar rats. After the incubation time rats were sacrificed by heart 
puncture under a light ether anaesthetic. Blood plasma and urine were analysed by 
HPLC. 
Table 1: Conditions of enzymatic hydrolysis of 99m~c-ester complexes 
VOLUME 3 1 mf 
RAMOACTNIN 3 > 5 - 10 MBq %TGCOMPLEX(~.C.~.) 
ENZYMEMEDiA 3 . PLASMA / 1 :I /PHOSPHATE BUFFER , pH 
7.4 
. HOMOGENATE1 I :B/ PHOSPHATE 
BUFFER, PH 7.4 
. PIG LIVER ESTERASE, PLE (EC31 .$.I) ;  
$ r n u ~ m l  
INCUüATiON + 2 10s IZOMINUTES; 3PC; SHAKE 
ANALYSIS 3 COMPLEK 
METABOLITES : HPLC SEPARATION 
PRP-7 
Results and discussion 
Hydrolysis of the DMS-ester complexes is markedly species dependent. The 
complexes I, 2, 1-1 and 1-2 are partially hydrolysed in rat plasma, in rat liver 
homogenates and in pig liver esterase (PLE), as exemplified in Fig. 1 and Fig. 2. In 
rats, in vitro and in vivo data are consistent. The HPLC analysis of urine 120 minutes 
p. i. shows only the metabolites. No rnetabolism can be obsewed for complexes 3, 4 
and 5 under the sarne conditions. In vif10 non hydrolysable esters (complexes 3, 4, 
5) are also stable in vivo (Fig. 3). All complexes (1 - 5 ; 1-1 and 1-2) are stable in 
human plasma 18.91. 
As Seen in Figs. 1 and 2, oniy 20 - 40 % of the parent cornpounds are found 
hydrolysed in the blood of rats 10 minutes after injection. 
From the results obtained wiih complex 1 and complex 2, as Seen in Figs. 1 and 2, 
the following conclusions can be drawn: 
The complexes investigated represent a type of ester- bearing compounds Wich 
is metabolized in rat plasma both in vitro and in vivo, but not in human plasma. In 
this case, metabolites are not of interest for the evaluation of the potential radio- 
pharmaceutical. Therefore only the data of initial biodistribution during the first 
minutes after injection as obtained in rats should be used for an extrapolation from 
rat to man. 
The identification of a possible target Organ depends on the Speed of the hydro- 
lysis and on the portion of parent complex still present in the blood pool of test 
animals. 
WMPLM 1 PLASMA 
-RUWER- -1NVITRO- 
PLASMA URINE 
-1NWVO- 
Fig. 1: Comparison of in vitm and in vivo metabolism of complex 1 in rats 
(HPLC Patterns) 
COMPLEX 2 PLASMA PLASMA URINE 
- EUWER - -IN VITRO - -1NVIVO- 
Fig. 2: Comparison of in vitm and in vivo rnetabolism of compiex 2 in rats 
(HPLC patterns) 
COMPLEX 6 P L A W  PLASMA URNE 
-BUFFLII - -1NWRO- 
-IN VIV0 - 
77.4 11.4 11.4 11.4 
Fig. 3: Comparison of in vitro and in vivo stabiliiy of complex 3 in rats 
(HPLC pattems) 
In the following, these conclusions have been applied to a known ester- bearing ra- 
diopharmaceutical in order to validate ihe conclusions. We tested the brain perfu- 
sion imaging agent 9 9 " ' T c - ~ ~ ~  (Fig. 4), for Mich species dependent enzymatic 
hydrolysis to its mono and diacid form is known [ I  ,2]. 
m 
HN\ 11 / N COOEt EtOOcy Tc 
s' ' S 
Fig. 4: 9 9 m ~ ~ - ~ ~ ~  ( 9 9 m c - ~ , ~ - 1  ,2-ethylene-diylbis-L-cysteine diethyl ester) 
Our results of in vifro and in vivo hydrolysis are demonstrated in Fig. 5, Mich  agree 
weli with the literature. In human plasma, only a small percentage of the parent 
compound ( 9 9 m ~ c - ~ ~ ~ )  is partially hydrolysed to the monoacid compound (9Bm~c- 
ECM). In rat plasma however, the monoacid metabolite and a small amount of diacid 
complex is quickly formed in vitro and in vivo. The rapid brain uptake in rats shows 
the ability of 9 9 m ~ c - ~ ~ ~  to pass the biood-brain barrier of the rat. The slow wash out 
of the brain activity 10 - 60 minutes aiier injection documents the aifinity to the brain 
(Fig. 6). 
Fig. 5: Comparison of in vRro and in vivo rnetabolicm af mTc-ECD 
in rats 
0.5 --.-.-____ 
i 5 $0 30 80 
MINUTES P.I. 
Fig. 6: Brain uptake and brain wash out after injection of9 ' " '~c-~c~ in rats 
(mean; n = 3) 
99 Actually, according to our results, Tc-ECD behaves simiiarly to the complexes I 
and 2 described above and thus belongs to the type of compounds for which we 
have drawn our conclusions. %"'TC-ECD is quickly metabolized in rat plasma both in 
vitro and in Wo but in human plasma only a small percentage is hydrolysed to the 
monoacid compound, as iilustrated in Fig 5. According to our hypothesis, the early 
biodistribution paiterns in rats, the rapid brain uptake and the slow wash out (Fig. 6) 
are pedictive for man. 
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32. UPTAKE OF g s m ~ c ( ~ ) - ~ ~ S  COMPLEXES IN TUMOUR CELLS 
IN VITRO 
G. ~ampf', U. ~enzel ' ,  W.-G.   ranke', S. Seifert, P. Brust, B. Johannsen 
I Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum "Carl Gustav 
Carus", Technische Universität Dresden 
SSm Tcw-dimercaptosuccinic acid (DMSA) has proved to be a useful imaging agent 
mainly for meduilary thyroid carcinoma [W] but also for bone and soft tissue 
tumours and their metastases [5,6]. Replacement of the technetium by the B-emitter 
rhenium-I86 [7] is of high therapeutic interest for palliation of metastatic pain, 
provided the nuclide can be enriched in the malignant tissue in an amount sufficient 
to yield an effective dose. 
Since the compounds of the pentavalent technetium with DMSA are accumulafed by 
some tumours in imaging-relevant amounts, it seems reasonable to syntheske and 
study derivatives of the compound with the aim to find a modiiied tracer which 
accumulates still higher in these or other tumours. 
In this sense the methyl, ethyl, and isobutyl esters of the 9 9 m ~ c ~ - ~ ~ ~ ~ ,  where aii 
carboxylic groups are esterified, were to be studied for their uptake in tumour cells in 
v h .  With the introduction of the ester groups a change from the hydrophilic DMSA 
molecule to more lipophilic compounds occurs with the lipophilicity increasing with 
the chain length of the alkyl group. This may have consequences for attachment at 
the cellular membrane and for cellular uptake. Therefore their uptake by human 
adenocarcinoma cells of the kidney has been studied; the first results are presented 
in this contribution. 
Materials and methods 
The 9 9 m ~ c ~ - ~ ~ ~  esters were synthesized according to the method described [8]. 
The cell strain used was the line KTCTL-2, a human adenocarcinoma of the kidney 
from the DKFZ Heidelberg. The methods for growing the cells and preparing them 
for radioactivity measurement have been reported in [SI. 
lncubation of the cell monolayers with the radiotracers was performed in cell culture 
medium RPMl 1640 for 1 h at 37 "C. In order to study the influence of plasma 
proteins On the uptake of the complexes, medium without and with 10 % of fetal calf 
Serum (FCS) was used.The concentration of the radiotracers was varied between 37 
and 600 KBqIml (I - 16 pCüml). 
raiieaotlvity mncentration I küq I ml 
Fig.1. Uptake of ""Tc(v)-DMs complexes by KTCTL-2 cells in dependence 
on the radiotracer concentration, n = 4. 
Results and discussion 
Fig.1 shows that cellular association of all four complexes studied in medium without 
serum grows linearly with 
C M M  cifmth. 
~ w k h o u t  FCS 
Mth. &ob* 
W w k h  FCS 
Fig.2. Uptake of 9 9 m ~ c ( V ) - ~ ~ ~  complexes by 
KTCTL-2 cells in the absence and presence 
of serum proteins, n = 6 
FCS = fetal caif serum. 
tracer concentration. 9 4 m ~ ~ ~ -  
DMSA shows the highest up- 
take into the cells, with the 
isobutyl ester adequate radio- 
activity in the cell pellet was 
measured with the two lowest 
wncentrations. With the 
methyl and ethyl esters, how- 
wer, uptake is strongly dimin- 
ished. 
The higher cell association of 
the isobutyl ester is not 
readily interpretable, possibly 
it does not represent a real 
cellular uptake but only an 
outer attachment at the cell 
membrane as a sequel of the 
high lipophiliciiy. 
It has to be noted that with all 
compounds studied at 
concentrations above 300 
KBqlml, representing of Course a correspondingly high concentration of the free 
ligand, the cells began to detach themselves from the plastic dish, i. e. their normal 
adherence is disturbed. With the isobutyl ester, this signal was already obsewed at 
150 kBqIml, therefore in Fig.1 only the first two concentrations were utilized. Hence 
the following experiments were perfarmed with radiotracer concentrations of 100 
kBqlml. 
in Fig. 2 the infiuence of serum proteins on the uptake of the complexes is repre- 
sented. It is evident that the addition of FCS leads to a strong diminution of the cellu- 
lar uptake resp. the association of the compounds. The effeci is especially pro- 
nounced with ester substitution, and increases with the chain length of the alkyl 
group: in these experiments uptake in the presence of serum decreases to 66 % with 
the DMSA complex, to 16 % with the methyl and ethyl esters, and to only 8 % with 
the isobutyl ester. It may be a consequence of the growing lipophilicity of the 
compounds that their affinity to the serum proteins increases, and the protein-bownd 
portion is no Ionger available for cellular uptake. The Same phenomenon is observed 
with the ' Y b  citrate complex 1101. 
Additional information is provided by a comparison of the ratlos of radioactivities 
released by the trypsin-EDTA treatment of the cells to the radioactivities in the cell 
pellets. After incubation with the radiotracer and 12-fold rinsing of the monolayers 
with bufFer solution, the cells are dissociated from the surface of the petri dish by 
trypsin-EDTA solution. This treatment also dissociates the protein particles or 
complex molecules aitached outside at the cell membrane. 
Table 1. Ratio of radioactivities released by trypsin to the radioactivities of the cell 
pellets, using the 9 9 ' " ~ ~ ~ - ~ ~ ~ ~  complex and three 9 9 ' " ~ c ~ - ~ ~ ~  
complexes 
As is shown in Table I, with the methyl and ethyl esters more radioactivity is found in 
the trypsin-EDTA solution than in the cell pellet itself, and this ratio seems to be 
independent of the serum content of the medium. This means that the complexes 
aitach to the cells but they are not incorporated - in contrast to the DMSA complex. 
For interpretation of the results with the isobutyl ester further studies will be 
necessary. 
These investigations show that the 9 9 m ~ c ~ - ~ ~ ~ ~  omplex exhibits the highest 
celiular uptake in vifm of the four complexes studied and is least affected by the 
presence of serum proteins. 
Analogous studies with the normal fibroblast ce11 line could not yet be performed. 
Compound 
Condition 
without FCS 
with FCS 
R = C4H9 
0.86 
0.48 
R = H  
0.26 
0.23 
R = CH3 
1.14 
1.42 
R = C2Hs 
I .76 
1.62 
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33. EVIDENCE OF ACTIVE UPTAKE OF l6Vb COMPLEXES INTO 
TUNlOUR CELLS IN VlTRO, STABlLlTY OF THElR CELLULAR 
FIXATION, AND THE ROLE OF THElR PROTEIN BINDINO 
G. ~ampf', G. ~nop', U. ~enzel ' ,  W.-G.  ranke', P. Brust, B. Johannsen 
'Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum "Cari Gustav 
Carus". Technische Universität Dresden 
In our endeavour to improve the uptake of metal complexes in tumour iissue we 
perforrned in viiro cell uptake studies with various '64/b wmplexes. These studies 
showed a clear dependence of the uptake on the complex stability [I] and of '"b
c~trate (CIT) uptake on the metabolic activity of normal and tumour cells as mea- 
sured by ["F~FDG trapping, but this was not exhibited with '%-NTA (nitriio- 
trtacetate) nor vvith '%-DTPA {diethylenetriaminepentaacetic acid) [2]. 
The recent investigafions were aimed at elucidating the following points: 
1 The quesiion of adive uptake of the wmplexes by the celt. 
2 The stability of ihe metakeif association. 
3. The influence of protein-binding of the Yb complexes on their cellular uptake. 
Materials and methods 
The methods for growing, incubating, and preparing cells for radioactivity measuring 
were described in [2]. The cell lines used were also the KTCTL-2 cells from a human 
adenocarcinoma of the kidney (Heidelberg) and the V7914 hamster lung fibroblasts. 
The studies of the role of metabolic activity for the cellular uptake of both complexes 
were extended to other approaches: to the influences of the growth stage of the 
culture and the incubation temperature. The stability of the fixation of the incor- 
porated "$Yb was checked by postincubation with the strong complexing age~nt 
DTPA. 
The determination of protein-binding was performed by separating the protein-bound 
portion of the radiometal or its ligand complex from the non-bound part by ultra- 
filtration. For the protein-binding assay 100 - 200 PI of the M* complex solution are 
added to 1 ml of the protein solution, and the mixture is incubated for 30 min at 
37 "C. 1 ml of this mixture is then put into a Centricon tube (Amicon) with an ultra- 
filter (pore diameter for 10,000 or 30,000 daltons), which is centriiuged for 30 min at 
5,000 g. Big pariicles as proteins are concentrated on the filter. The full volume of 
the concentrate can be easily recovered by reverse centrifugation of the filter mem- 
brane. The volumes of concentrate and filtrate and their radioactivity as well as that 
of the membrane are measured (calibrator). Since there are still ma l l  residual 
amounts of non-bound complex in the volume of the concentrate, the radioactivity 
value of the concentrate has to be corrected according to the volumes of the filtrate 
and concentrate. The protein-associated radioactivity is determined in percent of the 
whole radioactivity concentration added to the tube, considering the corrected radio- 
activity content of the concentrate. 
Results and discussion 
Evidence of active uptake 
lnfluence of fhe growth stage of the culfure: 
When cells are propagating in a culture, they consume the nutrients and produce 
metabolites so that the growth wnditions are impaired up to standstill of mitotic acti- 
vity. In these cases metabolic activity decreases to a minimum of breathing. 
With cultures of different cell densities on the petri dish reflecting different growth 
stages the uptake of 168yb-CIT and I64/b-NTA was checked. The different cell densi- 
ties were reached by inoculating different cell numbers in the dishes and assaying 
them at the same time, 48 h later. With 7 - 8 X 106 cells the petri dish (60 mm 
diameter) is completely full, the cells can scarcely divide further. 
The uptake of the '@Yb-NTA complex per cell is independent of the cell density on 
the petri dish in the range studied, whether incubated for 2 or 4 h. The uptake of the 
I @Yb-CIT complex, however, shows a dependence on cell density after 4 h incuba- 
tion. Overpopulation leads to a diminished uptake (not shown). 
These Observations confirm the results observed with ["FIFDG 121: the metabolic 
activity of the cell culture exhibits a clear influence on the uptake of '@Y~-cIT, but 
not of '@Yb-NTA That is to say that the uptake of "8yb-ClT proceeds via an active 
cellular transport process, but there is no indication as to the way of Yb uptake from 
the aminopolycarboxylic acid wmplex 
Does this mean that there is no cellular adivity at all necessary for '@%~-NTA 
uptake? We tried to answer this question using the well-known test of temperature 
dependence. 
Influence of tenaperature: 
In these experirnents cells were incubated in RPMI 1640 medium without and with 
10 % of fetal caF serum (FCS, Sigma), and radioactivity concentration after incu- 
bation was checked not only in the cell pellet, but also in the trypsin-EDTA solution 
used for cell dissociation after incubation and 10 - 12 rinsings of the monolayer kdth 
buffer. We suppose that this is a measure for labile association of complex mole- 
cules to the cellls. 
As can be seen from Fig. 1, with both complex species the cellular uptake is 
drastically diminished by low temperatures, the great jump occurring between 37 and 
try no s. try s. celk no s. celk s. 
n 3 ~ c  ~ 2 2 2 ~ ~  m20c 
NTA 
120 
trynos try s. celh no s. celk s 
Fig.1: Temperature dependence of '671b uptake using the CIT and NTA complexes 
incubation time: CIT - 2 h, NTA - 4 h; radioactivity at 37 "C was taken as 
100 % in each group; try = trypsin, cells = cell pellet, 
s resp. no s = 10 % FCS resp. no serum; n = 6 
22 "C (analogous results were obtained with the fibroblast line V 7914). However, the 
mere adsorption of the complex molecules to the cell monolayer is not impaired by 
the low temperature with the exception of a moderate drop in the assay without 
serum at 2 "C. These results show that also in the cold the complex molecules 
adhere to the cell surface as they do at 37 'C, but they are not incorporated. 
Stability of 'Yb  incorporation 
We performed experiments of postincubation with Na-DTPA (0.25 mglml) dissolved 
in RPMl 1640 medium without or with 10 % FCS. As controls cell monolayers were 
incubated with the radiotracer and not postincubated (K,), and postincubated wiih 
RPMl 1640 (K2). The results of the assays with and without FCS showed no 
diierence. Neither the RPMl 1640 medium a-lone nor the DTPA-containing me-dium 
released any considerable a-mount of radioactivity from the cells (Fig. 2). Results 
with the fibroblasts were analogous. 
Fig. 2: Effect of 60 min postincubation without (K 2) and with DTPA On  '6$Yb reiease 
after 2 h (CIT) and 4 h (NTA) incubation with the '% complexes. n = 8, 
K I is taken as 100 % 
lnfiuence of protein-binding 
Binding of metals to plasma proteins plays an important role for their uptake into 
tumours. Unlike gallium, the lanthanides thulium and ytterbium are reported io bind 
scarcely to transferrin, but with moderate stability to albumin [3,4,5]. 
The following experiments were performed in Order to elucidate ihe proiein-binding 
of Yb compiexes in the incubation medium and its influence on Zheir ceilular uptake 
in dependence on ihe ligands CIT and NT& 
For protein-binding studies as well as for incubation of the cells with the radiotracers 
different portions of fetal caif senim (FCS), human serum albumin (HSA), or human 
transferrin (TF) (all products from Sigma) were added to the incubation medium: 
40 mglml HSA resp. 3 mglml TF corresponding to 100 % of their natural plasma 
concentration were dissolved in fresh RPMl 1640 and diluted with the Same medium. 
The complexes 'W-CIT and 'vb-NTA behave quite differently vhen contacting 
the plasma proteins in the incubation medium (Fig. 3). '?~-cIT binds to nearly 
100 % already to small amounts (3 %) of FCS, much less to HSA and, surprisingly, 
up to about 80 % to rising portions of TF. This protein-association of the '6%-CIT 
complex has consequences for the cellular uptake of the radiotracer: the highest 
uptake occurs in medium wfiere protein is absent; with increasing serum or protein 
concentrations in the medium cellular uptake drops down to 3 % (FCS) resp. 15 % 
(TF) of the level in protein-free medium. 
These results can only be interpreted in that protein association withdraws a great 
portion of the radiotracer from the pool available for cellular uptake. 
By contrast, 'vb-NTA shows no protein association at all in the incubation medium, 
and the addition of increasing amounts of serum even stimulates uptake. HSA also 
shows an uptake-stimulating effect, but only at higher concentrations, and TF with 
maximum 3 mglml protein shows no effect. This stimulating effect is interpreted as a 
simple matrix support of cellular adherence by the proteins. 
Comparing the absolute uptake amounts of both 164/b complexes in pure serum 
(Fig. 4). it becomes evident that there is no difference. 
Though the pool of bioavailable 'Yb-NTA should be much greater than that of 
'@Yb-CIT, d i c h  is trapped by protein-binding, the uptake of the Yb complexes with 
the aminopoiycarboxylic acids NTA, EDTA, and DTPA occurs only to a small extent 
111. 
In these studies no diierences in the principal uptake behaviour were obse~ed  
between the fibroblasts and the tumour cells, the uptake pathways seem to be the 
Same in both cell types and possibly represent a general cellular feature. 
On the basis of earlier animal experiments and theoretical calculations it was as- 
sumed that the tumour accumulates metallic radionuclides preferably in protein- 
bound form 161. The results presented here with cultured fibroblast and tumour cells, 
indicate, however, other relations: 'Yb-CIT showing high protein affinity is not taken 
120 , , 120 
FCS 1 1  FCS 
NTA 
Fig.3. Relative uptake by KTCTL-2 cells (m) and proteirbbinding (U) of ' Y b  using the CIT and NTA 
wmplexes. lncubation with different portions of fetal calf seium (FCS). human serum albumin (HSA), 
and human apotransferrin (TF). lncubation times: CIT - 2 hrs, NTA - 4 hrs, n = 4 - 8. 
X-axis: concentration in pure serum is taken a s  100% level, wnespondingly 40 mglml NSA or 3 
mglml TF. y-axis:uinditions for the highest uptake (100% level) are wiih '"lb-C~T : medium without 
FCS or other proteins, with '%NTA : medium with 10% FCS. 
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34. USE OF BRAIN MICRODIALYSIS FOR STUDYING CHANCES OF 
AMINO ACID CONCENTRATIONS IN THE BRAIN INTERSTITIAL 
SPACE 
R. Bergmann, P. Brust 
Introduction 
Microdialysis is a new bioanalytical sampling technique with remarkable potential. It 
Opens up the possibility of sampling substances from the extracellular space of 
essentially any tissue in the body - including the blood [I]. It provides a sample 
which is already clean and ready to be analysed. 
Brain microdialysis as an in vivo perfusion method was originally used by Ungetstedt 
and his group at the beginning of the 1980s to measure the release of rat striatal 
dopamine [2,3]. 
The analysis of rnicrodialysis perfusates using HPLC provides a method with the 
high sensitivity and selectivity necessaiy to detect low levels of endogenous 
substances (e.g. neurotransmitter, amino acids) in the brain extracellular space with 
a few minutes time resoiution. The technique of microdialysis may also be used 'to 
recover exogenous substances and their metabolites such as drugs. Furthermore, it 
is possible to study the direct effects of drugs upon neurotransmission and 
metabolism. 
Here we report on attemps to establish microdialysis as a tool to study the transport 
and metabolism of radiopharmaceuticals for PET and SPECT, among them amino 
acids such as ["~]methionine or ['~FIDOPA. First we used microdialysis to monitor 
changes in the extracellular concentration of endogenous amino acids. lt is known 
that stimulation with KCI elicits increases of excitatory amino acids. Therefore we 
used this model in our investigation. 
Materials and methods 
Micf odialysis 
Anima1 experiments were carried out in compliance with the relevant national laws 
relating to the conduct of animal experimentation (registration number 7519185.81- 
4). Maie Wistar rats (weighing 300 - 400 g) were tracheotomized and anesthetized 
with a mixture of 40 % oxygen and 60 % N20 containing 0.8 % halothane. The body 
temperature was kept at 37 "C. The rats were mounted in a stereotaxic instrument 
(Stoelting Inc.). The skull was exposed, and a burr hole was made. After a small tear 
was made in the dura, the dialysis probe (CMA/lO; Carnegie Medicin, Sweden) was 
implanted in the dorsal hippocampus at the coordinates anteroposterior with respect 
to the bregma of +3.0 mm, lateral with respect to the midline suture of +2.5 mm, and 
dorsoventral with respect to the dura of 3.0 mm. The Position of the probes 
implanted in the brain was verified &er termination of the experiment. The probes 
were continuously perfused at 2.0 MI min-' with Krebs-Ringer bicarbonate solution 
(155 mM NaCI, 5.5 mM KCI, and 2.3 mM CaCI2). Perfusate samples were collected 
every 10 min. Upon collection of 3 samples for determination of the basal amino acid 
concentration (starting 30 min after insertion of the probe, See results) 50 mM of KCI 
(equal reduction in NaCI) was periodically (10 min on, 40 min off) added to the 
perfusate. 
HPLC 
Aliquots of each dialysis sample (10 MI) were injected into the HPLC System (Hewlett 
Packard). Amino acids were detected fiuorimetricaily after precolumn derivatization 
with o&ho-phthalaldehyde (OPA) and fluorenylmethoxychloroformate (FMOC) 141. 
Mobile Phase A 
1 0 ml EDTA solution (4.0 g EDTA disodium salt (dihydrate) in 100 ml water) and 
180 p1 sequencer-grade triethylamine (TEA) were added to 1000 ml of HPLC-grade 
water. The pH was adjusted to 7.2 with 1-2 % acetic acid. Aiter pH adjustment 3.0 ml 
of unstabilized, UV-grade tetrahydrofuran (THF) was added and the pH rechecked. 
Mobile Phase B 
2.72 g sodium acetate trihydrate was dissolved in 200 ml of HPLC-grade water. The 
pH was adjusted to 7.2 with 1-2 % acetic acid. 400 ml methanol and 400 ml 
acetonitrile were added and mixed well. 
Amino acid sfandards 
Individual amino acids and a mixed standard were purchased from Sigma. 
Derivatization 
Derivatization was done using an automatic sampler (Hewiett Packard). Arnpoules of 
OPA and FMOC (Hewiett Packard) were used. They were transferred to microvials in 
50 - 100 pl aliquots and capped. Borate buffer (0.4 N, pH 10.4) was pipetted into 2.0 
ml sampler vials for pH control during derivatization. HPLC-grade water was placed 
tnto a 2.0 ml sampler via1 for use as a needle wash. 
Results and discussion 
Fig 1 shows an example of a standard chromatogram obtained under the conditions 
defined in "Materials and methods". 
The concentrations of nearly all amino acids detecied by HPLC were artificially high 
immediately after insertion of the dialysis fiber into the brain (See Fig. 3). Th& is a 
well known phenornenon, since acute intracerebral implantation of probes leads 
~mmediately to a number of reversable disturbances in the viciniiy, including 
spreading depression, damage to the blood-brain barrier and disrupted glurtose 
metabolism [3,5]. 
A stable levet was reached about 30 min afier hsertion. Perfusate sarnples dleGted 
over the first 30 min &er surgety have therefore io be discarded. The 
concentrations of the different amino acids detecied in the dialysates wer@ between 
0 1 pmoVI (aspartate) and 9.8 pmolll (glutamine) (Table I]. Yhey are in the mnge 
wtitch may be expected from data published by others f6,q. 
Fig. 1: Chromatogram obtained with a sample of a standard mixture of amino acids 
(0.5 mmolll). 
This standard chromatogram was used to define the peaks in chromatograms of 
diaiysate samples (Fig. 2). 
Fig. 2: Chromatogram of a dialysate sample obtained from a probe inserted into the 
dorsal hippocampus of rats 
Stimulation with KCI induces a massive depolarization of nerve cells and is known to 
evoke a marked and short-lived increase in neurotransmitter output [3]. In our study 
it elicited an immediate increase in the concentrations of the amino acid neuro- 
transmitters glutamate and aspartate (Fig. 3) by about the factors 10 and 5. 
However, also the concentrations of most other amino acids were more or less 
increased during the period of stimulation while methionine remained quite stable 
under these circumstances (Table 1). 
In conclusion, we have set up a standard microdialysis procedure wkrich should allow 
to study the transport and metabolism of radiopharmaceuticals for PET and SPECT. 
To obtain quantitative data in absolute terms it will be necessary to estimate the in 
vwo recovely of these substances and to estabiish an I-IPLC procedure with 
radioactive detection. Because of the expected low recovery of most 0f the 
radiopharmaceuticals, a high sensiiiity of detection will be a cruciaf point. 
total arnino acids r  
Fig. 3: Changes of amino acid concentrations in microdialysates from the rat dorsal 
hippocampus during the study. Arrows indicate stimulation with 50 mM KCE 
(10 min) in the perfusate. 
Table 1: Concentrations of amino acids in microdialysates (pmolll) from the dorsal 
hippocampus of rats before and after stimulation with KCI in the perfusate 
1 I I i I I 
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35. CEREBRAL CAPILLARY ENDOTHELIAL CELLS OF ADULT PIG AS 
AN IN VlTRO MODEL FOR THE BLOOD-BRAIN BARRIER 
B. Ahlemeyer, S. Matys, P. Brust 
lntroduction 
The blood-brain barrier regulates the transfer of water, electrolytes and nutrients 
between the blood and the extracellular fluid of the brain. Cerebra1 endothelial cells 
are the main constituents to form this selective permeability barrier because of their 
characteristic properties, e.g. formation of tight junctions, lack of fenestrations and 
low vesicular transport. Numerous in vitro studies revealed that brain endothelial 
cells possess biochemical and functional features of the BBB, such as different 
receptors, transporters, enzyme activities and ion channels [I]. In order to examine 
the characteristics and mechanism of the transport of radiotracers across the BBB, it 
was the aim of our work to establish an in vifro model of the blood-brain barrier. 
Materials and methods 
Materials 
Dispase, fetal calf serum, collagen iype 111, percoll, dextran, glycylglycine, N(-3-(2- 
furyl) acryloyi-)-phenylalanylglycylglycine, captopril, levamisol, mouse anti a-smooth 
muscle actin, ALP reaction mixture Sigma kit NO85 and protein assay kit were 
purchased from Sigma Chemicals, Deisenhofen, Germany. Collagenaseldispase, L- 
glutamic acid a-(4-methoxy-ß-naphthylamide), p-nitrophenylphosphate, lg G frac- 
tions of mouse anti-human factor Vlll, mouse anti-vimentin, mouse anti-neuro- 
filament, mouse anti-galactocerebroside, mouse anti-fibronectin and rat anti-mouse 
lg G fluorescein were from Boehringer, Mannheim, Germany. Medium 199 and 
antibiotics were obtained from Gibw BRL, Eggenstein, Germany. MiniMacs 
Separator, MiniMacs separaration columns and rabbit anti-rat lg G microbeads were 
obtained from Miltenyi Biotec GmbH, Bergisch Gladbach, Gerrnany. lg G fradions 
from rat anti-alkaline phosphatase were from BioTrend, Köln, Germany. All other 
chemicals were derived from Merck, Darmstadt, Germany. 
Ce11 cuItures 
Primary cultures of porcine brain microvessel endothelial cells were obtained 
according to [2]. Briefly, pig brains, cleaned of meninges and white matter, were 
minced and incubated for 3 h at 37 "C in medium 199 containing 0.8 % dispase. 
After centrifugation with 15 % dextran at 6800 X g for 10 min, isolated capillaries 
were digested with 1 % collagenase for 3 h. Endothelial cells were separated from 
erythrocytes and cell debris by a percoll-gradient. Cells were seeded on collagen 
type III coated petri dishes (Becton Dickinson, Heidelberg, Germany) with a density 
of 10-20 000 cells/cmz and on 12-well Costar filters, 0.45 pm Pore size (Bodenheim, 
Germany), or Nunc filters, 0.45 pm Pore size (Wiesbaden, Germany), with a 3-times 
higher seeding density. The cells were cultivated for 7 days in medium 199 with 
10 % fetal calf serum, 100 Ulml penicillin, 100 pglml streptomycin and 2.5 pglml 
amphotericin at 37 "C with 5 % CO2 and 95 % air. The medium was changed every 
second day. 
Astrocytes were derived from white matter of porcine brain according to 121. The 
minced tissue was incubated for 30 min in 1 % dispase. The homogenate was then 
centrifuged at 200 X g for 10 min and the pellet was pressed through nylon meshes 
of 250 pm, 125 pm and 50 prn Pore size, successively. Cell suspension was seeded 
in uncoated petri dishes and cells were cultivated until confluence at 37 "C in MEM 
with 10 % fetal calf serum, 100 Ulml penicillin, 100 pglml streptornycin and 2.5 pglml 
amphotericin at 37 "C wiih 5 % CO2 and 95 % air. The medium was changed every 
second day. 
Chondrocyte-derived matrix was produced by a chondrocytic cell line after 
confluence in uncoated petri dishes. The cell layer was washed extensively with 
bidistilled sterile water until the cells were disrupted osmotically. Complete removal 
of the cells was controlled microscopically. Chondrocyte-derived matrix was always 
prepared immediately before use. 
lmmunostaining 
Cells were washed three times with PBS" and fixed with 99 % ethanol for 20 min at 
room temperature. In order to reduce unspecific binding the monolayer was 
preincubated with 1 % BSA in PBS" for 30 min before addition of mouse anti-human 
factor VIII-related antigen (dilution 1:lO). After 30 min the cells were washed several 
times and fluorescein conjugated sheep anti-mouse-lgG (1:20) was added for 1 h. 
Thereafter, the cells were washed and obsewed in an inverted Olympus IMT 2 
microswpe equipped for epifluorescence and photography. 
Enzyme assays 
Histochemisfry 
ALP activity was determined histochemically, using the reaction mixture Sigma kit 
NO85 acwrding to manufacturersp instructions with naphthol AS-Bi phosphate as 
substrate and Fast blue RR as diazonium salt for 15 min. yGT activity was 
determined histochemically, using a reaciion mixture containing L-glutamic acid a- 
(4-methoxy-ß-naphthylamide) as substrate and glycylglycine as acceptor (60 rnin). A 
red azo dye was produced by reaciion with Fast blue BB. 
Biochemistry 
For the biochemical ALP and y-GT assay, the cells were washed 3-times with Saline, 
then scraped from the petri dish and homogenized by short sonification. Cell 
suspension was used for both enzyme activity and protein determination. 
ALP activity was determined by incubating the cell suspension with substrate 
solution containing 4 mM p-nitrophenylphosphate, pH 10.37. Formation of p-nitro- 
phenol was measured kinetically at 420 nm and was compared to the saiinel 
substrate soiution. Specificity of the test was demonstrated with levamisol (5 mM) 
which inhibited ALP adivity completely. One unit of enzyme activity was defined by 
formation of 1 pmol p-nitrophenol per min at 25 "C, using an extinction coefficient of 
17300 1 M' cm-'. 
7-GT activity was determined by incubating the cell suspension with substrate solu- 
tion containing 2.7 mM L-y-glutamyl-3-carboxy-4-nitroanilide and 20 mM glycyl- 
glycine in Tris-buffer pH 9. Formation of carboxy-4-nitroanilide was measured 
kinetically at 410 nm and was compared to the salinelsubstrate solution. One unit of 
enzyme activity was defined by formation of 1 nmol carboxynitroanilide per min at 
25 "C, using an extinction coefficient of 9500 1 M" cm-'. 
Angiotensin-converting enzyme (ACE) activity was determined by incubating the cell 
suspension with substrate solution containing 0.8 mM N(-3-(2-furyl)acryloyl-)- 
phenylalanylglycylglycine in Tris-buffer pH 7.5. Formation of N(-3-(2-furyl)acryloyl)- 
phenylalanine was measured kinetically at 340 nm and was compared to the 
salinelsubstrate solution. Specificity of the test was demonstrated with captopril (1 
mM), M ich  inhibited ACE activity completely. One unit of enzyme activity was 
defined by formation of 1 nmol N(-3-(2-furyl)acryloyl)-phenylalanine per min at 25 "C, 
using an extinction coefkient of 2750 1 M' cm-'. 
Protein defermination 
Cell protein was determined by a modified Lowry test. 
Results and discussion 
Characten'zation of endothelial cells and ast7ocytes 
1) lmmunohistochemical studies were performed to ensure the identity and purifi- 
cation of endothelial and astrocyte cell cultures (Table 1). 
Confamination was lower than 5 % after 6 days in endothelial cell cultures. After 
4 - 5 days some cells appear on the top of the monolayer. These cells are mainly 
endothelial cells (with a higher content of smooth muscle actin and vimentin) and 
pericytes (because of the absence of factor Vlll immunoreactivity). Astrocytes were 
of 99 % purity. 
2) For transport studies low permeability of cerebral capillary endothelial cells is 
necessary. Determination of the electrical resistance, an indication of continuous 
tight junctions and therefore of low permeability, was performed in endothelial cells 
grown on Costar filters using the "VOM System from WPI, Wiesbaden, Germany. 
Table 1: lmmunofluorescence of endothelial cells of porcine microvessels affer incu- 
bation with various antigen Ig-G-fractions and a second incubation with anti- 
IgG antibodies coupled with FlTC ( I&.= data of the literature, GFAP= glial 
fibrillary acidic protein) 
Antigen Endothelial cells Lit. Astrocytes Lit. 
Factor Vlll + 
Neurofilament - 
GFAP - 
Galactocerebroside - 
Fibronectin - 
Vimentin + 
Smooth muscle actin - (+) 
Fig. 1: Electrical resistance of cerebral capillary endothelial cells grown on Costar 
filters (subtracted by the resistance of the cell-freefilters) als a function of 
time. Mean values of 6 - 8 filters +I- Standard deviation are shown 
For comparison, [3] measured 800 Ohm/cm2 for cloned endothelial cells of mouse 
microvessels, [4] measured 160 Ohm/cm2for bovine brain endothelial cells, 151 found 
30 - 35 and 161 14 - 20 Ohmlcm2 for murine and bovine brain endothelial cells, 
respectively. 
3) Endothelial cells and astrocytes were also characterized by ensyme actiiities. 
Table 2: Enzyme activities of endoiheliai cells and astrocytes in culture. All values 
are in the same range found in the literature. Values are given as mean +/- 
standard deviation of 4 petri dishes (n.d. = not detectable, DIV = days 
in vifro). 
Activity [Ulmg proteinl: ALP y-GT ACE 
Endothelial cells (0 DIV) 1.10 +I- 0.38 26 +I- 12 n.d. 
Endothelial cells (4 DIV) 0.28 +I- 0.01 2.1 +I- 0.7 55.7 +I- 11 
Astrocytes n.d. n.d. n.d. 
4) Electron microscopy. The growth of cells on Costar filters may induce polarization 
of the cells. Fig. 2 shows an electron micrograph of endothelial cells (6 DIV) grown 
Fig. 2: Electron micrograph of endothelial cells after 6 days in culture grown On 
Costar filters (magnification 1 : 6000). 
Close apposition of the cells is visible. Electron micrographs reveal that the cells 
sometimes grow as multilayers, that they are not confluent over the whole area of 
the filter and that they contain villi on the luminal side - an indication for polarization. 
Cerebra1 endothelial cells as an in vifro model for the blood-brain bamer 
Two enzymes are considered as marker enzymes of endothelial cells of the BBB: y- 
glutamyltranspeptidase (y-GT) [7-81 and alkaline phosphatase (ALP) 19-111. Both 
enzymes are highly concentrated in brain endothelia in contrast to peripheral 
endothelia, astrocytes and neurons. In primary cultures of endothelial cells of 
porcine brain microvessels the activities of both enzymes decrease as a function of 
time [12-131 leading to the debate whether a differentiated function of the BBB is 
prese~ed in culture. 
It was the aim of our studies to increase the activities of ALP and Y-GT by variations 
in culture conditions: 
a) culturing endothelial cells on petri dishes and on Costar filters 
b) culturing endothelial cells with or without Serum and drugs and on various 
extracellular matrices 
C) culturing endothelial cells as "Sandwich" cultures 
a) Endothelial cells on petri dishes and on Costar filters. Fig. 3 shows the activities 
of ALP and y-GT as a function of time in collagen-coated petri dishes and Costar 
filters. 
Histochemical analysis revealed a decrease in ALP and y-GT activities during cell 
cultivation, mainly due to a decrease in cell clusters with extremely high enzyme 
activities. We found higher enzyme activities on Costar filters than on petri dishes 
(data not shown). Biochemical analysis shows a decrease in ALP and rGT  
activitieslmg protein as a function of time (Fig. 3). but in Costar filters ALP and y-GT 
activitieslmg protein were significantly lower than in collagen-coated petri dishes. 
However, calculating both enzyme activities in relation to the area of growth surface 
(CR?), they were higher in Costar filters than in collagen-coafed peiti dishes (data not 
shown). We suggest that permeable supports induce a polarized distribution of both 
enzymes at the luminal side of the plasma membrane. This would explain why ALP 
and y-GT activities related to protein are lower in Costar filters than on collagen- 
coated petri dishes. 
, J collapencoatad pebi diih 
days in viiro 
Fig. 3A: ALP-activities as a function of time in endothelial cells grown on collagen 
coated petri dishes and filters. Values are given as means +I- Standard 
deviation of 4 petri dishes and 6 Costar filters 
b) Enzyme activities of endothelial cells grown under the influence of various 
medium additives and on various extracellular matrices. 
We did not find any change in ALP and y-GT activities after 7 days in culture by 
adding to the culture medium 0.4 mg molsidomine (release NO), 20 mgll phenyl- 
butazone (increase yGT activity in the her) or 20 mM ATP (increase the [~a"],) one 
day after seeding. Phenylbutazone and molsidomine increase the contamination with 
astrocytes, probably due to toxic effects on endothelial cells. 
Addition of several growth factors (endothelial growth factor, basic fibroblast growth 
factor) to medium 199 did not enhance the low resting ALP or reinduce lacking Y-GT 
activities as revealed by histochemistry after 6 days in culture. Interestingly, culturing 
cells in serum-free medium with and without antibiotics for 7 days resulted in an 
increase in Y-GT activity from 2 Ulmg protein to 7.5 and 14.5 Ulmg protein, 
respectively. However, a lack of serum reduced the cell density and changed cell 
rnorphology (retained diierentiation). Cell proteinldish decreased from 30 pglpetri 
dish (with serum, with antibiotics) to 3 pglpetri dish (without serum, with antibiotics) 
and 6.5 pglpetri dish (without serum, without antibiotics). Because the cell density 
was strongly reduced, these cultures cannot be used for BBB transport studies. 
L eollagen-coated pebi dish 
days in viiro 
Fig. 38: y-GT-activities as a function of time in endothelial cells grown on collagen 
coated petri dishes and filters. Values are given as means +I- standard 
deviation of 4 petri dishes and 6 Costar filters. 
By coating petri dishes with gelatin, we observed - &er 6 days - the same low 
resting level of ALP and no y-GT activity of the cells as in collagen-coated petri 
dishes. Wrth a matrix derived from a chondrocytic cell line as growth surface, adhe- 
rence of the endothelial cells was reduced. Aiter 6 days, no induction of ALP and y- 
GT was observed by histochemistiy (data not shown). 
C) Endotheliai cells as "sandwich" cultures 
In sandwich cultures, a cellular monolayer is covered with a coverslip or, as in our 
case, with extracellular matrices. Sandwich cultures could be used to reinforce 
cellular diierentiation. We covered 4 day-old endothelial cell cultures grown on 
collagen coated petri dishes with collagen (10 pgtcm3, gelatin (10 pg/cm2) and 
fibronectin (5 ~g/cmZ). 
As shown in Table 3 covering endothelial cell monolayers with gelatin on day 4 
increases ALP activity by about 60 % on day 7. However, we observed cell-free 
areas in the monolayer, probably due to the Stress of covering the cells with matrices 
on day 4. Nonconfluent cell layers could not be used for transport studies. Further 
studies (e.g with Costar filters) will be carried out to reach confluent sandwich 
cultures with increased ALP activities. 
Table 3: ALP activities in endothelial cells after 7 days under sandwich conditions. 
Values are given as mean +I- Standard deviation of 4 petri dishes. 
Matrix ALP [Ulmg protein] pg proteinlpetri dish 
Collagen 0.413 +I- 0.025 63.2 +I- 1.4 
Fibronectin 0.353 +I- 0.014 53.8 +/- 0.6 
Gelatin 0.451 +I- 0.029 65.3 +I- 4.4
Control 0.264 +I- 0.01 104 +I- 7 
Conclusions 
In order to establish an in vifro model for the blood-brain barrier, our studies have 
shown that it is usefui to culture endothelial cells on permeable supports (e.g. Costar 
filters). This resulted in a polarized distribution of ALP and y-GT as revealed by a 
comparison of histochemical and biochemical analyses. On the other hand, filters 
&er the possibiliiy to study not only the uptake of drugs or tracers into the cell, but 
also mechanisrn and direction of the transcellular transport. However, before using 
permeable supports for BBB transport studies, the quality of the monolayer have be 
carefully checked. 
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36. HETEROGENEITY OF ALP AND y-GT ACTIVITIES IN CEREBRAL 
ENDOTHELIAL CELLS 
B. Ahlemeyer, S. Matys, P. Brust 
lntroduction 
It was the aim of our work to establish an in Mtro model for the blood-brain banier to 
characterize the transport of radiotracers [I]. Cerebra1 capillary endothelial cell 
cultures with high activities of the marker enzymes ALP and yW, as found in viw, 
are desired. 
Materials and methods 
Materials, cell cultures, enzyme assays as previously descfibed [I] 
Magnetic cell sorting 
Freshly isolated endotheUal cells were incubated for 10 rnin with anti-ALP antibodies 
and for 15 min with anti-lg G magnetic antibadies (microbeadsf. Thereafter. cells 
containing the first and second antibody were separated by magnetic columns. Cells 
without microbeads ("ALP negative cells") passed the column and were collected 
separately. whereas cells with microbeads ("ALP positive cells") were retained On 
the column. After removal of the magnet, cells with microbeads were washed from 
the column and collected. Thereafter, we cultured separate monolayers of "ALP 
positive" and "ALP negative" cells with a seeding density of 5 X l o 4  cells per petri 
dish. Control cells were seeded with a density of 1.5 X 10' cells per dish. 
Results and discussion 
Heterogeneity of ALP and rGT  actiMty 
During preparation of pig brain endothelial celis we measured the ALP and y-GT 
activities in endothelial cells after the second digestion and purification with a percoll 
gradient. We observed variations in the ALP and y-GT activities b e b e n  the 
preparations and in the Same preparation after various times of storage in liquid 
nitrogen (Table 1). 
Table 1 : ALP and y-GT activity of endothelial cells after preparation and storage in 
liquid nitrogen. The coefficient of variance for the ALP and y-GT assay is 
2 % and 5 %, respectively. 
Preparation ALP [U/mg protein] y-GT [Ulmg protein] 
I 0.80 
II 0.83 
111 1.80 
IV 1.26 
Storage in liquid nitrogen 
0 0.83 
3 weeks 1.83 
5 weeks 0.85 
6 weeks 1.19 
Histochemical analysis revealed heterogeneity of ALP and y-GT activity in purified 
endothelial cells before seeding. Fig. 1 shows heterogeneity of the ALP activity in 
endothelial cells at the end of the second digestion - the capillary structure is still 
visible. Similar heterogeneity was found for Y-GT (data not shown). 
During the first 3 days of cell culture, we found high ALP and y-GT acitivities of the 
cells on collagen-coated petri dishes exclusively in cell aggregates or clusters as 
already mentioned by [2]. Cell clusters disappear after 3 - 4 days, resulting in an 
overall decrease of ALP and Y-GT activity. We observed no yGT. but resting ALP 
activity after 6 days with great intercellular differences as shown in Fig. 2. 
Heterogeneity is also found for ALP and y-GT by cultivating the cells on permeable 
supports (data not shown). 
Fig. 1: Histochemical localization of ALP in endothelial cells of porcine 
microvessels before seeding. Cells were stained for ALP after 
15 min of incubation with substrate (magnification 1 : 100) 
Fig. 2: Histochemical localization of ALP in cerebral endothelial cells after 6 
days cultured in a collagen-coated petri dish. Cells were stained for 
ALP after 15 min of incubation with Substrate (magnification 1:100). 
We suggest that heterogeneity of ALP and y-GT in endothelial cells before culture 
(after the second digestion and purification with a percoll gradient) caused the 
heterogeneity during cell culture on collagen-coated petri dishes and on permeable 
filters. Heterogeneity in the distribution of y-GT in brain microvessels from different 
regions of the brain [3] and a decrease in ALP activity from precapillary arterioles to 
venules [4] have already been described. In addition. [5] showed that endothelial 
cells from larger vessels with more pericytes had higher levels of -&T than cells 
from smaller vessels and they found a heterogeneity of Y-GT in pericytes. Here we 
demonstrate (Fig. 2) that even porcine brain endothelial cells frorn the sarne section 
of rnicrovessel (and therefore from the Same brain region) show a heterogeneous 
distribution of ALP (the Same was found for Y-GT. data not shown). Enzyme 
heterogeneities presumably depend on various parameters. 
Our results suggest that endothelial cells of porcine brain rnicrovessels consist of 
different cell populations with high and low activities of the rnarker enzyrnes ALP and 
y-GT. There was no correlation between ALP and y-GT activity. Obviously, the 
existence of two or more endothelial cell populations with different activities of 
marker enzymes would complicate the establishment of an in vitro model for the 
blood-brain barrier. Therefore, we separate endothelial cells with a high ALP activity 
from those with low activity by magnetic cell soriing. 
Separation of cell populations with different ALP activities 
Endothelial cells were separated by magnetic cell soriing into two fractions: one with 
a high expression of ALP ("ALP positive cells") and another with a low expression of 
ALP ("ALP negative cells"). During the very short time of incubation (10 min) with 
anti-ALP antibodies, we suppose that only cells with a high concentration of ALP in 
the plasma membrane bind the first antibody. The second magnetic antibody binds 
only to cells containing the first antibody. Magnetic columns allowed the separation 
of cells with different expression of ALP. 
We measured the ALP activity of each fraction of separation and found only a very 
low activity in the "ALP positive cells". The antibody complex (first and second 
antibodies) on the "ALP positive cells" probably binds to the catalytic side of the 
enzyme. However. the antibody complex is biodegradable (according to information 
from Miltenyi Biotech) and will disturb the biochemical assay only in the first 2 days 
after separation. Each fraction was cultivated for at least 7 days. ALP activity was 
determined by histochemistry: 
"ALP positive cells" 
Until day 4, the "ALP positive fraction" shows homogenous ALP activity The cells 
were flat and larger than control cells. We obsewed only a few clusters and cell 
density was low. The cultures did not reach confluence at alt. After 4 days. the 
heterogeneity of the ALP activity reappeared - in contrast to the aim of our 
separation. However. greater areas of the monolayer showed the Same ALP activity 
The intensiv of histochemical staining was the Same as in the "ALP negative 
fraction" and control cells. 
'ALP negative fraction" 
Until day 3, the "ALP negative cells* showed homogenous ALP activtty. The cells 
were elongated and we obsewed fewer clusters than in control cultures The celi 
density was lower than in control cultures and htgher than in the "ALP positive celi 
cultures". Confluence was reached after 6 days in culture. Heterogeneity reappeared 
on day 4 and was found to be diffuse, e.g. neighbouring cells show different ALP 
activity. 
Control cultures 
Until day 3. many cell clusters with a high ALP activity were found. The cells were 
elongated and confluence was reached on day 5. Heterogeneity reappeared on day 
4 and was found to be diffuse, e.g. neighbouring cells show different ALP activity. 
Biochemical analysis of the ALP activity as a function of culture time will be 
performed to clarify the success of our Separation and the utility of enriched cultures 
as an in vitro model of the blood-brain banier. 
Conclusions 
Although we separated cells with a high ALP activity from those with a low ALP 
activity, heterogeneity reappeared, suggesting that heterogeneity may be a 
prerequisite for the differentiated function of endothelial cells. The existence of cell 
prerequisite for the differentiated function of endothelial cells. The existence of cell 
populations with different ALP activity may complicate the establishment of an in 
vitro model of the blood-brain barrier. Transport characteristics of each cell 
population may be different, 
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37. ANALYSES OF AN IMAGE OF A HUMAN BRAlN OBTAINED BY 
POSITRON EMISSION TOMOGRAPHY IN TERMS OF FRACTAL AND 
MULTIFRACTAL GEOMETRY 
M. Obert. P. Brust, R. Bergmann 
In recent years many different investigations have shown how successfully the 
irregularity of biological shapes can be described in terms of fractal theory [I]. The 
branching structures of neurons [2], arterial vessel Systems [3], or the heart rate 
variability [4] have all been studied. In most examinations it is very difficult 
(especially for h i n g  organisms) to obtain unambiguous digitized data Sets of the 
structures of interest. In our analysis positron emission tomography (PET) is applied 
as a method which allows the noninvasive in vivo mapping of dynamic structures of 
biochemical or physiological processes, e.g. in the human brain [5]. The resulting 
space-time distributions are characteristic with respect to the physics and chemistry 
of a Special marker molecule and to the biological function of that tracer. An 
example: ['8~]2-fluoro-2-deoxy-~-glucose (FDG) mimics glucose and allows the esti- 
mation of the spatial and temporal distribution of the glucose metabolism. Depending 
On the actual activation of certain regions of a volunteer's brain, an FDG-PET irnage 
of the brain looks different at rest or during visual Stimulation [6]: Investigations of 
functional neuroanatomy are possible. 
We introduce the concept of fractal and multiractal geometry to describe the 
irregular spatial distribution of FDG in a section of a human brain 17. 81. A contour 
diagram of the spatial radioactivity distribution of the analyzed section is shown 
below. The higher the radioactivity, the denser are the contour lines. The given units 
are lattice sites or pixels of the PET scan. 
In order to investigate the fractal properties of the irnage. we construct binary 
subsets from the image data for different ranges of radioactivity. Such subsets 
contain only spatial information. which allows the determination of selfsimilar 
properties. A detailed description of how to conduct the fractal and multifractal ana- 
lysis is given in Refs. 7, 8. For a subset generated frorn low to high radioactlvity we 
find a fractal dimension D of 1.9. For a subset representing basically high radio- 
activity we find a D of 1.2. This indicates a multifractal behaviour of the Set. 
Further, the data is analyzed as a "landscape" wtiere 2 dirnensions are given by the 
spatial coordinates of the Cross section of the brain and the third dirnension, the 
height of the "landscape", is defined by the radioactiviiy at the spatial Position on the 
Slice. The analysis of this seifaffine Set with the mass radius relation [I] gives a D of 
2.3. 
We have shown in prelirninary studies [7, 81 that D can serve as a rnathernatically 
well-defined measure to describe the global irregularity of a PET image. The power 
of the sofiware rnethods (e.g. the clinical relevance as a tool of cornputer aided and 
autornated diagnosis) will be exarnined as soon as irnage data of patients are 
available. wtiich are produced at the PET center Rossendorf. 
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N. C. a. "C-ring labelling of aromatic compounds: Synthesis of nitro-[I-"~lbenzene 
and [I-"~laniline 
5Ih international Symposium on the Synthesis and Applications of Isotopes and 
lsotopically Labelled Compounds, Strasbourg, France, June 20 - 24, 1994 
Noll B., P. Leibnitz, St. Noll, B. Johannsen, G. Reck, H. Spies, H.-J. Pietzsch 
Synthesis and X-ray structures ofAsPh4 [ReO(MA&)] and AsPh4 [TcO(MAG2)] 
3oth Intern. Conf. Coord. Chem., Kyoto, Japan, July 24 - 29, 1994 
Noll B., St. Noll, H. Spies, B. Johannsen, L. Dinkelborg, W. Semmler 
Technetium complexes of N-alkylated mercaptoacetyl glycines as potential 
unspecific tracers in arteriosclerotic diagnostics 
dh Intern. Symp.on Technetium in Chemistry and Nuclear Medicine, Bressanone, 
Italy, September 12 - 14, 1994 
Obert M., P. Brust, H. Linemann, R. Bergmann, F. Jestczemski 
The distribution of a radiotracer in a human brain is a multiiractal - A novel approach 
for the analysis of Positron emission tomography images 
Intern. Workshop on Nonlinear Dynamics, Fractality, and Seiforganization of 
Complex Systems, Wüaburg, October 1 - 3, 1994 
Pietzsch H.-J., H. Spies, K. Klostermann, P. Leibnitz, G. Reck 
Rhenium complexes with bi- and tetradentate thioether ligands 
3oth lntern. Conf. Coord. Chem., Kyoto, Japan, July 24 - 29, 1994 
Pietzsch H.J., M. Glaser, H. Spies, F. E Hahn, 0. Kintzel, T. Lügger 
Trigonal-bipyramidal rhenium and technetium complexes containing tris(2-thiolato- 
ethy1)amine 
3dh lntern. Conf. Coord. Chem., Kyoto, Japan, July 24 - 29, 1994 
Pietzsch H.J., H. Spies, P. Leibnitz, G. Reck, K. Klosterrnann 
Technetium and rhenium complexes with muitidentate thioether ligands 
4th Intern. Symp.on Technetium in Chemistry and Nuclear Medicine, Bressanone, 
Italy, September 12 - 14, 1994 
Seifert S., R. Syhre. H. Spies, B. Johannsen 
Enzymatic cleavage of technetium and rhenium complexes with DMSA ester ligands 
4th Intern. Symp.on Technetium in Chemistry and Nuciear Medicine, Bressanone, 
Italy, September 12 - 14, 1994 
Spies H., T. Fietz, H.4. Pieksch, P. Leibnitz, G. Reck 
Neutral oxorhenium0l) complexes with tridentatelmonodentate wordination 
3dh Intern. Conf. Coord. Chem., Kyoto, Japan, July 24 - 29, 1994 
Spies H., T. Fietz, M. Glaser, H.-J. Pieizsch, B. Johannsen 
The n+l concept in the synthesis sirategy of novel technetium and rhenium tracers 
dth Intern. Symp.on Technetium in Chemistry and Nuclear Medicine, Bressanone, 
Iialy, September 12 - 14, 1994 
iv. 
POSTDOCTORAL QUALIFICATION 
Peter Brust Ph.D. 
Habilitation 
Thesis: "Peptide als auslösende Signale von Transportveränderungen an der Blut- 
Hirn-SchrankeK 
November 1994 
In multidisciplinary research such as carried out by this Institute, collaboration, the 
sharing of advanced equipment, and above all, exchanges of ideas and information 
obviously play an important role. Effective collaboration has been established with 
colleagues at universities, in research centres and hospitals. 
Cooperative relations and joint projects 
The Technische Universität Dresden (Dr. Scheller. Dr. Klostermann, inst. of Ana- 
Iytical Chemistry) plays an essential part in SPECT tracer research by performing 
anaiytical characteruation of new tracers and providing support with the synthesis of 
organic compounds (Dr. Habicher, Inst. of Organic Chemistry), as weil as in bioche- 
mical research (Dr. Fischer, Dr. Kaspar, Institut für Pathologie). 
Common objects of radiopharmacological and medical research link the Institute with 
the Universitätsklinikum "Carl Gustav Carus", above all with its Department of Nu- 
clear Medicine (Prof. Franke). A joint team of staff members from both the Institute 
and the Clinic of Nuclear Medicine are currently working at the Rossendorf PET 
centre. 
Very effective cooperation also exists with the Bundesansfalt für Materialforschung 
Berlin (Dr. Reck, Mr. Leibnitz) who have carried out X-ray crystal structure analyses 
of new technetium and rhenium complexes. 
Our long-standing cooperation in technetium chemistry with the University of Padua 
(Prof. M a i )  and the "Demokrifos" National Research Centre for Physical Sciences 
in Athens (Dr. Chiotellis) has been continued. 
Joint work on technetium complexes with tripodal ligands has been canied out with 
the Freie Universität Berlin (Prof. Hahn, lnst of lnorganic and Analytical Chemistry). 
Cooperation on a Special topic concerning bioinorganic chemistry is in Progress with 
the Ameimitteherk Dresden (Dr. Unverferth). 
ldentiication of wmmon objects in PET radiopharmacy has led to collaborative 
research with the Humboldf-Universifät Berlin (Dr. Michael of the "Charite Hospitals, 
Clinic of Nuclear Medicine) and the Universität Leipzig (Dr. Günther, Radiology, 
Nuclear Medicine). 
In the field of PET tracers, woperation exists with the Montreal Neurological lnsfiute 
(Prof. Gjedde, Prof. Thompson), the Turko Medical PET Centre (Prof. Wegelius, Dr. 
Solin), the CO2-Group of the Max-Planck-Gesellschaft an der Universität Jena (Prof. 
Dinjus) and the Hans-Knöll-lnstituf Jena (Dr. Kasch). 
The fruitful contacts to the Paul Scheerer InsMut, Villigen, Switrerland, are very 
appreciated. 
Cooperation on the biochemical aspects of radiotracer research exists with the 
Universitäf Münsfer (Prof. H.-J. Galla, Institute of Biochemistry), the University of 
Minnesofa in Duluth (Prof. L.R. Drewes, Department of Biochemistry and Molecular 
Biology) and the Frfediikh-Schiller-Universitat Jena (Dr. R. Bauer, Institute of Patho- 
physiology). 
In helpful discussions both abroad and at Rossendorf numerous colleagues have 
wntributed to deiining areas of cooperation and shaping projects. 
Special thanks go to Dr. K. Deutsch, Mallinckrodt Medical Inc., St. Louis, USA, Dr. U. 
Scheffel, The Johns Hopkins Institutions, Baltimore, USA, Prof. Yoshihara, Tohoku 
University Sendai, Japan, and Prof. C.J. Thompson, Montreal Neurological Institute, 
Canada. 
VI. 
INTERNATIONAL ACTIVITIES 
TEACHING ACTlVlTlES FOR THE INTERNATIONAL ATOMIC ENERGY AGENCY 
(IAEA) 
B. Johannsen 
One week course within the Regional Training Course on the Production and Control 
of Tc-99m Generators and Tc-99m Radiopharmaceuticals, Tehran, Iran, 
May 14 - 30,1994 
B. Johannsen 
One week course within the Regional Training Course on Hospital Radiopharmacy, 
Rabat, Morocco, November 14 - 25, 1994 
EUROPEAN RESEARCH PROGRAMME 
H. Spies 
Set up and chairing a working group on "New chelating systems for Tc and Re for 
medical application" within the EU research Programme COST-B3 
VII. 
SEMINARS 
Prof. H.-J. Galla, lnstitut für Biochemie, Westfäl. Wilhelms-Universität Münster 
Kapillarendothelien in Kultur: Ein in vifro-Modell der Blut-Hirn-Schranke 
27. Januar 1994 
Dr. W. Burchert, Medizin. Hochschule Hannover 
PET in der klinischen Praxis 
11. Februar 1994 
Dr. U. Scheffel, The Johns Hopkins Institutions, Baltimore, USA 
New ligands for dopamine and serotonin transporters 
March 11, 1994 
Prof. J. Krieglstein, Institut für Pharmakologie und Toxikologie der Philipps- 
Universität Marburg 
Experimentelle Nachweise von neuroprotektiver Arzneistoifwirkung 
25. März 1994 
Prof. W. Forth, Walter-Straub-Institut für Pharmakologie und Toxikologie, 
Universität München 
Interaktionen von Metallen bei der Aufnahme in den Organismus 
15. April 1994 
Prof. E. Hoyer, Universität Leipzig 
Neues über Schwefelliganden 
22. April 1994 
Prof. M. Eisenhut, Radiologische Universitäts-Klinik Heidelberg, Abt. Nuklearmedizin 
'"1 markierte, paraphenylenverbrückte Fettsäuren: Verlängerung der 
Henmuskelretention durch metabolischen Einfang 
6. Mai 1994 
Dr. M. Gerlach, Universität Wü~burg 
Interaktionen von Neurotransmittersystemen in den Basalganglien und ihre 
Relevanz für die Pathophysiologie neurodegenerativer und psychiatrischer 
Erkrankungen 
13. Juni 1994 
Dr.Dr. H.J.Gross, University of Texas, MD Anderson Cancer Center Houston, USA 
Rare Event Analysis: Eine Herausforderung für die Flow Cytometrie-Grundlage zum 
Nachweis von Minimal Residual Disease 
August 22,1994 
Prof.Dr. F.F. Knapp, Jr., Oak Ridge Nat. Laboratory, USA 
New developments at Oak Ridge ( ' 88~ l ' s8~e  generator; mACh receptor ligand) 
August 30,1994 
0. Knoesen, Atomic Energy Corporation, Pretoria, Süd-Afrika 
Current research and development program on radiopharmaceuticals at the AEC 
September 9,1994 
Prof. C.J. Thompson, Montreal Neurological Inst., Canada 
Quantitative Auswertealgorithmen am POSITOME lllp am Beispiel von FDG-Studien 
(Demonstration am Tomografen) 
12. September 1994 
Prof. Yoshihara, Tohoku University Sendai, Japan 
Trajectory of technetium chemistry of the group of Tohoku University 
September 16, 1994 
Dr. Kasch, Hans-Knöll-Institut Jena 
Immunregulierende und anticancerogene Wirkung von DHEA (Dehydro- 
epiandrosteron) und seiner Derivate 
23. September 1994 
Prof. Dinjus, Arb.-Gruppe CO2-Chemie der Max-Planck-Ges. an der Universität Jena 
Zur Chemie des CO2 
28. Oktober 1994 
Prof. Joo, Szeged, Ungarn 
Regulation by second messenger molecules of the permeability of the blood-brain 
barner: basic research and clinical applications 
November 24,1994 
VIII. 
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the Federal Republic of Gerrnany and the Free State of Saxony on a f i i - f i  basis. 
In addition, the Free State of Saxony provided support for a project (7541.82- 
FZR1309) covering the establishrnent of cell cultures as a tool to replace anirnal 
experirnents. 
The research projects concerning technetium tracer design and PET radiochernistry 
were supported by the Deutsche Forschungsgemeinschaff and the Fonds der 
Chemischen Industrie. 
Support by Mallinckrodf Medical Inc.,Petien, is highly appreciated. 
The work on technetium chemistry was supporied in part by a contract with the 
Institut für Diagnostikforschung, Berlin. 
A nurnber of projects were facilitated by financial and material support provided 
within a scientific job-creating Programme (ABM). 
